Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.8101574942940936,-2.332418787448568,0.0,0.0,0.0,7/22,3.93%,NR2F2;ALDH1A2;PTGDS;RBP1;CYP26B1;ABCA4;RBP4
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.8292981276099036,1.89276959661846,0.0031397174254317113,0.14314349994862946,0.221,7/16,7.87%,PTPRM;PTPRB;PTPRG;PTPRR;PTPRE;PTPRU;PTPRO
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.8292981276099036,1.89276959661846,0.0031397174254317113,0.14314349994862946,0.221,7/16,7.87%,PTPRM;PTPRB;PTPRG;PTPRR;PTPRE;PTPRU;PTPRO
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.7393177584569268,-1.8597911503106126,0.0,0.17604975872716316,0.26,5/13,6.78%,BMP6;BMP5;BMP7;BMP4;SRC
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.8773259139459721,1.830483993120443,0.001669449081803005,0.2625111739672249,0.497,2/10,0.09%,PRDM16;MECOM
prerank,BMP receptor binding (GO:0070700),-0.7393219943954727,-1.8068435154295714,0.0,0.23122953385060235,0.437,5/12,6.78%,BMP6;BMP5;BMP7;BMP4;SRC
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.569710150590754,1.7915508966609686,0.0,0.3695838147137822,0.701,29/147,7.13%,RASGRF2;EPS8L2;PREX2;SPATA13;FGD5;CYTH3;CCDC88C;RAPGEF2;KALRN;DOCK9;ARHGEF28;ELMO1;DENND3;ARHGEF15;RAPGEF1;ARHGEF2;RASGRP2;RAPGEF5;ABR;HERC2;CYTH1;NUCB2;BCR;RAPGEF4;RAPGEF6;FGD6;SMCR8;MADD;RAB3GAP2
prerank,amino acid binding (GO:0016597),0.6918193586208478,1.7768639455564463,0.0058823529411764705,0.3605457438979131,0.775,7/31,10.91%,NOS1;NOS3;CASTOR1;ASS1;GRIN2B;CAD;GRIN3A
prerank,platelet-derived growth factor binding (GO:0048407),-0.7461157128367735,-1.7593236960423626,0.009779951100244499,0.2914017648185432,0.614,7/11,2.72%,COL1A2;COL3A1;COL1A1;PDGFRB;COL5A1;PDGFRA;COL6A1
prerank,FMN binding (GO:0010181),0.8479200997226625,1.7569799704638067,0.00667779632721202,0.3888813172665838,0.848,2/11,0.41%,NOS1;NOS3
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.6085353117865442,-1.748767737457053,0.0030120481927710845,0.2621302079197283,0.656,5/21,2.89%,PDE1A;PDE5A;PDE7B;PDE3A;PDE8B
prerank,retinoic acid binding (GO:0001972),-0.7100951358960641,-1.7478707113190535,0.00980392156862745,0.22036875271519527,0.659,2/12,2.57%,NR2F2;CYP26B1
prerank,P-type ion transporter activity (GO:0015662),0.8212419150278292,1.7466336675190999,0.0049833887043189366,0.3831583689507439,0.873,5/12,4.38%,ATP2A3;ATP2B4;ATP2B2;ATP2C1;ATP7A
prerank,carboxylic acid binding (GO:0031406),0.6538955703209164,1.737419871341113,0.009589041095890411,0.3743471223059294,0.901,8/38,11.31%,NOS1;NOS3;CASTOR1;GLUD1;GRIN2B;CAD;GRIN3A;HIF1AN
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.567942547423239,-1.720821438572509,0.00967741935483871,0.24459279911859172,0.754,8/27,6.82%,SLC22A8;SLC26A7;SLC39A14;SLC26A2;ANO1;SLC39A8;SLC22A6;SLC5A5
prerank,cadherin binding (GO:0045296),0.5192209889929089,1.7136836558677013,0.0,0.43817001576994197,0.951,95/315,16.50%,PTPRM;PTPRJ;EPS8L2;PTPRB;CDH13;EHD4;LIMA1;CD2AP;MRTFB;DOCK9;BMPR2;F11R;FASN;COBLL1;FLNB;ESYT2;MACF1;DAB2IP;STXBP6;TMPO;LRRFIP1;CBL;CEMIP2;IQGAP1;PPFIBP1;SWAP70;PACSIN2;CDC42EP1;PROM1;ACVR1;SLK;STK24;EHD1;PDLIM5;SHTN1;TAGLN2;STK38;CSNK1D;FNBP1L;SH3GL1;MYH9;BSG;PLEC;FXYD5;RANGAP1;STAT1;CTNNA1;TJP2;GPRC5A;PTPRO;NUMB;CCT8;PCMT1;CDH15;CDH3;APC;TJP1;CDH12;RTN4;TRIM25;EPN2;UNC45A;RPL34;HNRNPK;PTPN1;RANBP1;CDH2;EEF2;PCBP1;KLC2;WASF2;MARK2;GCN1;CTNNA2;TMOD3;TBC1D10A;SPTAN1;CAPG;RAN;RPL23A;CTNNB1;VAPA;EIF2A;EVPL;CHMP2B;DDX6;RACK1;CDH22;PKN2;PAK2;UBFD1;AHSA1;ANK3;ATXN2L;NCK1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.677382614602115,1.7037758914085166,0.0072992700729927005,0.4370517919933239,0.973,6/29,8.57%,PTPRJ;ACE;DUSP1;GCH1;DUSP16;NBR1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.645341684722523,1.7014562194383969,0.01002865329512894,0.4066465670275058,0.973,3/35,3.24%,BMX;FYN;FES
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.72557504379539,-1.6988580449909665,0.012690355329949238,0.2624980730872179,0.827,3/10,6.05%,SLC6A13;SLC6A12;SLC6A1
prerank,solute:anion antiporter activity (GO:0140323),-0.6590608639852892,-1.6885806663682712,0.007936507936507936,0.2587902257641085,0.859,6/14,18.92%,SLC7A11;SLC26A7;SLC26A2;SLC4A2;SLC4A3;SLC26A6
prerank,monocarboxylic acid binding (GO:0033293),-0.60308519819284,-1.6721163253453448,0.011142061281337047,0.2704334502716363,0.898,3/18,6.72%,NR2F2;CYP26B1;NAPEPLD
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.5632784609809961,-1.665069093165587,0.009259259259259259,0.26190088937376077,0.911,5/23,2.89%,PDE1A;PDE5A;PDE7B;PDE3A;PDE8B
prerank,growth factor activity (GO:0008083),0.5685661074231273,1.6638406603172222,0.005018820577164366,0.5437498820574218,0.994,4/74,0.88%,VEGFC;JAG1;JAG2;PDGFB
prerank,chemoattractant activity (GO:0042056),0.6692428918406499,1.66156324963662,0.01483679525222552,0.5125957834862971,0.994,3/26,3.84%,VEGFC;PDGFB;VEGFD
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.7946744596321986,1.6613106201480226,0.008090614886731391,0.47744743205683765,0.994,2/11,1.44%,KCNQ1;KCNE3
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.6956579973376205,-1.6524398327132221,0.03722084367245657,0.26932985476916754,0.93,7/10,23.29%,HAT1;USP22;ATF2;MSL3;NAA60;NAA40;NAA50
prerank,receptor antagonist activity (GO:0048019),0.7144054941378633,1.6463753536200234,0.027993779160186624,0.5083467001588643,0.998,2/17,5.02%,DKK2;WFIKKN1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.7316586922909925,1.643877549706931,0.029275808936825885,0.48866650451746285,0.998,2/14,1.44%,KCNQ1;KCNE3
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.7720893866211296,1.641740997428707,0.00980392156862745,0.4675656984870911,0.998,3/12,3.84%,VEGFC;DAB2IP;VEGFD
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6172722268326982,-1.6216897018154983,0.0225,0.3205682173837897,0.962,4/15,6.18%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1
prerank,anion:anion antiporter activity (GO:0015301),-0.6035532622579423,-1.6160926737767864,0.025495750708215296,0.31103375283865115,0.968,7/17,18.92%,SLC26A7;SLC26A2;SLC25A4;SLC19A1;SLC4A2;SLC4A3;SLC26A6
prerank,calcium-activated potassium channel activity (GO:0015269),0.7709863097955134,1.6148664527383108,0.03333333333333333,0.5609575003675148,0.999,2/11,2.72%,KCNN4;KCNN3
prerank,transferrin receptor binding (GO:1990459),-0.6952952168840327,-1.6074059999510102,0.03768844221105527,0.3120197315868886,0.976,5/10,16.07%,RGMA;SNX1;CD81;CHUK;SNX2
prerank,peptidoglycan binding (GO:0042834),0.7857137778723509,1.606799705996265,0.01867572156196944,0.5673800017723114,1.0,2/10,1.72%,NOD1;NOD2
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6928981118349546,1.6055754575823475,0.040498442367601244,0.5450200974153278,1.0,2/19,0.70%,AFAP1L2;EFNA5
prerank,amino acid:sodium symporter activity (GO:0005283),-0.6708922880583068,-1.6012139159247045,0.02756892230576441,0.3065105127690087,0.977,4/11,6.05%,SLC1A3;SLC6A13;SLC6A12;SLC6A1
prerank,WW domain binding (GO:0050699),0.6479789931237209,1.598834301052065,0.03513909224011713,0.5471231646013112,1.0,7/26,9.95%,RAPGEF2;CDC25C;ENAH;TCEAL9;NDFIP2;PMEPA1;TCEAL1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.6559137041421599,1.5948147773665569,0.02582496413199426,0.5398859402344212,1.0,4/23,1.66%,PLCG2;PLCB1;CCR1;PLCB4
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.7452046729385899,1.5897214919071614,0.04582651391162029,0.5372288767919182,1.0,6/12,16.66%,ATP2A3;NOD1;CASP1;CASP8AP2;RACK1;PYCARD
prerank,protein tyrosine phosphatase activity (GO:0004725),0.5514159855320849,1.5803887443906641,0.009950248756218905,0.5560042032987579,1.0,16/71,10.63%,PTPRM;PTPRJ;PTPRB;PTPRG;PTPRR;PTPN14;DUSP1;PTPRE;CDC25C;DUSP3;PTPN12;PTPRU;PTPRO;DUSP11;CDC14A;PTPN1
prerank,nucleoside-diphosphatase activity (GO:0017110),0.7471812011867948,1.579199820366201,0.03164556962025317,0.5387276459500091,1.0,1/12,0.10%,ENTPD1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.6432951841479085,1.5762014978301344,0.02967359050445104,0.5298827380613481,1.0,6/25,5.48%,FCHSD2;HIP1;HIP1R;TTPA;ARAP3;PLEKHA1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.7187562509945318,1.5746237434665833,0.03365384615384615,0.5170608841527032,1.0,7/14,16.66%,ATP2A3;NOD1;MAL;CASP1;CASP8AP2;RACK1;PYCARD
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.7442834299096794,1.5741094480793014,0.043973941368078175,0.5004788094254616,1.0,8/11,20.65%,SGMS1;SGMS2;GNPTAB;PTDSS1;PIGF;DPAGT1;AASDHPPT;PIGO
prerank,pyridoxal phosphate binding (GO:0030170),-0.5610531996027912,-1.566344113768599,0.008595988538681949,0.37670629672505884,0.992,13/20,34.15%,ABAT;PDXK;PYGB;PYGM;ACCS;OAT;AGXT;PLPBP;CTH;PYGL;SHMT2;GLDC;SHMT1
prerank,growth factor receptor binding (GO:0070851),0.5226909088483642,1.5663197341844464,0.008373205741626795,0.5133422067123262,1.0,12/95,8.22%,VEGFC;PTPRJ;PDGFD;HIP1;PDGFB;FYN;VEGFD;ADAM17;IL1RAP;FRS3;PLSCR1;JAK2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.6104608599206227,-1.5618400508321109,0.033766233766233764,0.36903299341813306,0.994,3/14,3.00%,SLC7A11;SLC1A3;SLC25A13
prerank,anion transmembrane transporter activity (GO:0008509),-0.6357124135123607,-1.5613722849928822,0.034912718204488775,0.3509931560483426,0.994,5/12,8.43%,SLCO2B1;SLC39A8;SLC22A6;SLC19A1;SLC4A2
prerank,Notch binding (GO:0005112),0.6402425959306451,1.5557440563167948,0.041916167664670656,0.5362262987836713,1.0,6/22,6.32%,JAG1;JAG2;NOTCH4;DLL4;CUL3;ADAM17
prerank,calcium-dependent phospholipid binding (GO:0005544),0.5653229711607983,1.55079082364957,0.033288948069241014,0.538186780055675,1.0,9/49,6.63%,SYT15;DOC2B;MCTP1;DYSF;ESYT2;CPNE8;ANXA3;SYT7;CPNE2
prerank,SH3 domain binding (GO:0017124),0.5351843208818876,1.5490988339026501,0.026184538653366583,0.5282996664059699,1.0,16/62,7.88%,AFAP1L2;CD2AP;ELMO1;AFAP1L1;DAB2IP;CBL;CRK;EVL;ADAM15;LANCL1;AKAP5;SHANK3;ADAM12;PTPN12;ENAH;PLSCR1
prerank,metalloendopeptidase activity (GO:0004222),-0.4003263842268147,-1.548472188702087,0.0,0.3639763071475618,0.994,22/76,13.35%,TRABD2B;ADAMTS2;ADAMTS12;ADAMTSL3;THSD4;ADAMTSL5;MMP14;ADAMTS17;ADAMTS5;ADAMTS10;ADAMTS3;ADAM19;ADAM9;ADAMTS15;ADAMTS9;MMP2;ADAM33;ADAMTSL4;MMP16;ZMPSTE24;MMP19;ADAMTS14
prerank,protein tyrosine kinase binding (GO:1990782),0.5389993224070557,1.5437743890381523,0.018270401948842874,0.5323357090860293,1.0,24/71,17.42%,CEACAM1;BMPR2;PITPNM3;PTPN14;CBL;NEDD9;CRK;ACVR1;ANGPT1;TRIM6;HYAL2;CD247;DUSP3;TJP2;PTPN1;GRM5;TOB1;DUSP22;GRB14;RACK1;NCK1;ELMO2;SOCS5;PTPN2
prerank,alanine transmembrane transporter activity (GO:0022858),0.7144069267143881,1.5428439731833887,0.05115511551155116,0.5197824701005542,1.0,1/12,0.19%,SLC6A6
prerank,leak channel activity (GO:0022840),-0.5565706023776313,-1.541018490908986,0.03896103896103896,0.3661134285967871,0.996,3/18,2.94%,KCNK2;NALCN;KCNK5
prerank,sialyltransferase activity (GO:0008373),0.6483458355772176,1.532900900857337,0.047244094488188976,0.5416421620679295,1.0,5/20,5.90%,ST6GALNAC3;ST8SIA6;ST3GAL6;ST6GALNAC2;ST6GAL2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.6090093358404202,-1.5325721720588916,0.05048076923076923,0.37135272037618433,0.997,4/13,6.18%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1
prerank,phospholipase C activity (GO:0004629),0.6197988482777927,1.5303194602411507,0.03840682788051209,0.53639457517724,1.0,4/25,1.66%,PLCG2;PLCB1;CCR1;PLCB4
prerank,microtubule plus-end binding (GO:0051010),0.6342871723882731,1.5297687176344352,0.061788617886178863,0.5238251941667769,1.0,9/20,11.08%,CLIP2;DST;TTBK2;CLIP1;CLASP1;MAPRE3;APC;CLASP2;NUMA1
prerank,sodium channel regulator activity (GO:0017080),0.5786526496298858,1.5273526287114276,0.027210884353741496,0.5179855948383583,1.0,8/37,13.00%,NOS1;ATP2B4;CAMK2D;FXYD5;SCN1B;SGK1;NEDD4L;YWHAH
prerank,filamin binding (GO:0031005),0.7212012102757323,1.5242986136896548,0.06491228070175438,0.5157525317130456,1.0,3/11,2.02%,NEBL;CEACAM1;FBLIM1
prerank,voltage-gated calcium channel activity (GO:0005245),-0.4671446652157802,-1.5206784568721021,0.012048192771084338,0.386921040140919,0.998,9/37,12.41%,CACNA2D3;CACNA1C;ITGAV;CACNG4;CACNA2D1;CACNA1G;NCS1;CACNB1;CACNB2
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.6839749977304561,1.5082143331480933,0.04730831973898858,0.5587970486049227,1.0,4/13,3.84%,PTPRJ;PDGFD;PDGFB;VEGFD
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.6197172319081398,1.5024989286262587,0.061654135338345864,0.5665208159125646,1.0,5/22,6.93%,DUSP12;DUSP1;PPM1F;DUSP16;DUSP3
prerank,GTPase activator activity (GO:0005096),0.4557158773424557,1.499186146006069,0.001026694045174538,0.5641989534786546,1.0,59/313,9.67%,RASGRF2;EPS8L2;PREX2;SPATA13;FGD5;CYTH3;CCDC88C;RAPGEF2;ARHGAP31;KALRN;DOCK9;RGS3;PLCB1;ARHGEF28;RABGAP1;SIPA1L2;ELMO1;DENND3;ARHGEF15;CHN2;GNAQ;RAPGEF1;ARHGEF2;RASGRP2;RAPGEF5;ABR;ASAP2;HERC2;IQGAP1;SIPA1L3;CYTH1;RALGAPA1;ARAP3;NUCB2;BCR;TBC1D30;SGSM1;RAPGEF4;ARHGAP8;RAPGEF6;FGD6;TBC1D8;RAP1GDS1;SMCR8;MADD;RGS7;RAB3GAP2;LRRK2;RANGAP1;ARHGAP25;TBC1D12;ARRB1;TBC1D5;DENND2C;DENND6B;TBC1D1;JUN;EIF2B2;RAP1GAP2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.7002628365757136,1.4985726172424383,0.08485856905158069,0.5530549480513838,1.0,8/12,22.76%,PIK3R6;PIK3C2A;PIK3C3;PIK3CB;ATM;PIK3C2B;PIK3R3;PIK3CA
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.5578698584931561,1.4971903845180576,0.035961272475795295,0.545548613595715,1.0,2/44,0.09%,PRDM16;MECOM
prerank,aspartic-type peptidase activity (GO:0070001),-0.634928558090518,-1.4933714816286898,0.07416267942583732,0.44240165737855774,0.998,2/10,5.12%,BACE2;BACE1
prerank,NADP binding (GO:0050661),0.5809002092205606,1.4928879930530767,0.056708160442600276,0.5497318364352524,1.0,2/32,0.41%,NOS1;NOS3
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.4823136607291865,-1.4919136340264607,0.030100334448160536,0.428615472292162,0.998,12/29,22.40%,SLC13A3;SLC26A7;SLC1A5;SLC26A2;SLC25A13;SLC19A1;SLC1A4;SLC25A12;SLC26A6;SLC25A18;SLC25A14;SLC13A5
prerank,transforming growth factor beta receptor binding (GO:0005160),0.6445660348605973,1.4902258406505808,0.045454545454545456,0.5468935588629416,1.0,6/18,5.38%,ENG;SMAD6;SMAD7;TGFB2;FKBP1A;SMAD2
prerank,phosphotyrosine residue binding (GO:0001784),0.5593095436131605,1.4897009586881609,0.05614973262032086,0.5370661793149217,1.0,7/37,9.11%,PLCG2;SHE;CRK;SHB;BCAR3;YES1;STAP1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.7029142970328222,1.4800231005900937,0.0867430441898527,0.5597700661387033,1.0,5/11,9.55%,MAP4K2;DAB2IP;STK38;TCF3;MAP3K11
prerank,actin monomer binding (GO:0003785),0.6246687414790459,1.476800236722889,0.06794682422451995,0.5595527968319971,1.0,2/22,0.46%,NOS3;LIMA1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5694729084898533,-1.4727237485331832,0.0525,0.46908872566475346,1.0,7/15,22.64%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC26A6;SLC4A8;CFTR
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.6235280072723932,-1.4721613089769745,0.07772020725388601,0.4534278805205078,1.0,4/10,14.78%,PRKAG2;PRKAR2A;PRKAR2B;PRKAR1A
prerank,calcium activated cation channel activity (GO:0005227),0.6431618699205557,1.471376012824376,0.07009345794392523,0.5674931383628941,1.0,2/17,3.92%,KCNN4;ANO6
prerank,CARD domain binding (GO:0050700),0.6652575159531198,1.4678924881544553,0.07754442649434572,0.5685698518336982,1.0,6/14,14.50%,NOD1;NOD2;CARD10;IRGM;CASP1;CARD19
prerank,MAP kinase phosphatase activity (GO:0033549),0.6745344666545223,1.4640810937110011,0.0755336617405583,0.5704695009766855,1.0,3/12,6.93%,DUSP1;DUSP16;DUSP3
prerank,fibroblast growth factor binding (GO:0017134),-0.502814955041793,-1.4582632830000883,0.03374233128834356,0.47518419951538565,1.0,9/21,19.60%,FGFR2;THBS1;ITGAV;KL;CEP57;GPC1;FGFRL1;FGFR4;GLG1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5390839251601268,1.4556228276849477,0.07407407407407407,0.5893504290498791,1.0,8/42,9.67%,PLCG2;SHE;CRK;SHB;BCAR3;YES1;STAP1;FBXW7
prerank,BMP binding (GO:0036122),0.7078106619666648,1.4533692303409125,0.06833333333333333,0.5864160902332363,1.0,3/11,2.97%,ENG;BMPR2;UCMA
prerank,wide pore channel activity (GO:0022829),0.5853158686932658,1.447426717328874,0.0943952802359882,0.5960418947286958,1.0,4/23,9.88%,GJA5;GJB1;GJA4;GJD2
prerank,protein kinase binding (GO:0019901),0.43571083432266666,1.4443353771532126,0.0,0.5963207457026217,1.0,114/479,16.07%,PTPRJ;PLCG2;KCNQ1;TRPV4;GATA6;PTPRR;UTRN;CEACAM1;CAVIN2;MAP4K2;TRIM14;BMPR2;ACE;CCND2;RND1;ACVRL1;NOD2;CCND3;DUSP1;DAB2IP;CAV1;CAV2;RHOB;OXSR1;EMP2;IQGAP1;NEDD9;HDAC9;HDAC7;CRK;FBXO7;GCH1;PDE3B;TIRAP;ACVR1;MSN;PDLIM5;NBEA;PKN1;STK38;TRIM6;SPAG9;SIKE1;CDC25C;WARS1;SMCR8;DUSP16;ADIPOR1;CD247;CEP68;DUSP3;IRGM;HNRNPA0;PRKCSH;ELAVL1;HSPB1;MAPRE3;TJP2;BCL2L1;TOM1L1;JAK2;APC;NBR1;STAP1;PTK2;DSP;TCF3;ADAM10;TAOK2;MAP3K11;MAD2L2;ADCY4;CCDC88A;PLCG1;NEFH;PTPN1;RAC1;TPCN2;POLA1;CADPS;ACTB;NPM1;EEF2;GRM5;PRKD2;VRK1;CALM3;IRF5;CTBP2;CAVIN3;PRC1;DUSP22;PPM1D;INKA1;PIN1;RND2;CNKSR2;HIF1A;AP1B1;RHOH;NSF;LYST;NELL1;LRBA;KIZ;FRMD5;PDCD10;RACK1;NELL2;CDKN2D;PAK2;VDAC1;RICTOR;NEK9
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5799637062662583,1.442965564568598,0.08695652173913043,0.5904530094881195,1.0,2/25,0.41%,NOS1;NOS3
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.6966075180930653,1.44227571520495,0.07263513513513513,0.5829176633191098,1.0,3/11,11.28%,ITPR3;MCOLN1;TRPM2
prerank,actin binding (GO:0003779),0.45006120853670634,1.4417666952313886,0.019438444924406047,0.5748428329631372,1.0,19/170,4.46%,EPS8L2;MYRIP;NOS3;SYNPO;LIMA1;TRPV4;UTRN;CEACAM1;SYNE1;ABLIM1;NOD2;FLNB;MACF1;PARVB;KLHL2;ACTN4;FLII;VASH2;PDLIM5
prerank,serotonin receptor activity (GO:0099589),0.5972481461470773,1.44063538306571,0.07692307692307693,0.5508889336347343,1.0,9/22,19.34%,HRH2;CHRM3;HTR5A;HTR1B;HTR2A;HTR1F;HRH3;HTR4;HTR6
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5972481461470773,1.44063538306571,0.07692307692307693,0.5508889336347343,1.0,9/22,19.34%,HRH2;CHRM3;HTR5A;HTR1B;HTR2A;HTR1F;HRH3;HTR4;HTR6
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5972481461470773,1.44063538306571,0.07692307692307693,0.5508889336347343,1.0,9/22,19.34%,HRH2;CHRM3;HTR5A;HTR1B;HTR2A;HTR1F;HRH3;HTR4;HTR6
prerank,ephrin receptor binding (GO:0046875),0.6061260168928223,1.4380570316898709,0.0899390243902439,0.550581748542862,1.0,7/21,10.63%,EFNA5;FYN;CBL;CRK;EFNA1;ANKS1B;PTPN1
prerank,gap junction channel activity (GO:0005243),0.5886639489829041,1.4343695735350566,0.09701492537313433,0.5550016695427183,1.0,4/22,9.88%,GJA5;GJB1;GJA4;GJD2
prerank,death receptor activity (GO:0005035),0.6863589827461896,1.4320489836250465,0.09764309764309764,0.5533629320145915,1.0,3/11,5.71%,FAS;TNFRSF25;TNFRSF1B
prerank,protein kinase C binding (GO:0005080),0.528729855708474,1.4255569247373916,0.07065217391304347,0.5658084005105666,1.0,17/43,15.51%,TRPV4;CAVIN2;HDAC9;HDAC7;TIRAP;PDLIM5;PKN1;PRKCSH;HSPB1;DSP;ADCY4;CCDC88A;PRKD2;CAVIN3;NELL1;RACK1;NELL2
prerank,protein phosphatase 2A binding (GO:0051721),0.5892679575696905,1.4222646637192558,0.09585121602288985,0.5674698049005216,1.0,13/23,22.00%,FOXO1;DAB2IP;CTTNBP2NL;MFHAS1;STRN3;GRIN3A;ARPP19;BOD1;STRN4;STRN;PPME1;SMG7;IGBP1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.6885614233030563,1.417836637916498,0.10899653979238755,0.573450505867281,1.0,7/10,22.76%,PIK3C2A;PIK3C3;PIK3CB;ATM;PIK3C2B;PIK3R3;PIK3CA
prerank,protein tyrosine kinase activity (GO:0004713),0.46381269780664797,1.4175659538945156,0.04337899543378995,0.566074235588511,1.0,15/108,9.21%,BMX;TEK;FLT1;TIE1;FYN;FLT4;MERTK;INSR;FES;FGFR3;ALK;LMTK2;JAK2;YES1;PTK2
prerank,cAMP response element binding (GO:0035497),-0.6267623014130548,-1.417485616115139,0.09839816933638444,0.5880768677523314,1.0,6/10,13.29%,CREB5;ATF7;CREB3L1;ATF2;CREB1;HMGA2
prerank,phospholipase inhibitor activity (GO:0004859),-0.5935048286402222,-1.4147474361773338,0.0906801007556675,0.5769877565129652,1.0,6/10,25.64%,ANXA2;ANXA1;ANXA5;ANXA4;ANGPTL3;ANXA9
prerank,cytokine receptor binding (GO:0005126),0.4808292174275589,1.4090888372404735,0.06971153846153846,0.5846899001314666,1.0,10/83,8.22%,VEGFC;KITLG;LIFR;TGFB2;FKBP1A;VEGFD;SMAD2;ADAM17;IL1RAP;JAK2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.5988402655424974,1.4070005487919237,0.09794628751974724,0.5827715033720725,1.0,9/19,19.59%,GRID1;GABRA4;GRIK5;GRIK2;GABRA2;GABRE;GRIK1;GABRG3;GRID2
prerank,LRR domain binding (GO:0030275),-0.537695486299604,-1.4037512691574328,0.09313725490196079,0.5924154904650403,1.0,2/14,0.42%,ROBO1;PAWR
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.4379383592616659,1.4034501559876933,0.02145922746781116,0.5863346661718319,1.0,33/188,12.28%,PRDM16;SOX17;SOX13;GATA6;SMAD6;SMARCA2;TAL1;HNF1A;HNF4A;SOX18;HHEX;FLI1;KLF4;MAFK;MEF2C;ZBTB48;GATA3;CEBPA;NFE2L2;NR1D1;KLF11;JUN;EGR1;HMGB1;DHX9;ARID5A;ZBTB14;BRCA1;ARID5B;SOX10;HINFP;SOX6;SUV39H2
prerank,phosphatidic acid binding (GO:0070300),0.5980981120776973,1.39759464790465,0.10361067503924647,0.596827216111963,1.0,5/19,5.77%,RAPGEF2;PACSIN2;RAPGEF6;PLTP;UQCC3
prerank,myosin V binding (GO:0031489),0.6176453010868892,1.397206821478781,0.12171052631578948,0.5899239268245426,1.0,2/15,2.22%,RAB11A;RAB6B
prerank,protein phosphatase binding (GO:0019903),0.4582533480693401,1.396909084173165,0.04883720930232558,0.582905084705486,1.0,35/117,20.22%,KCNN4;KCNQ1;CEACAM1;FLT4;ITGA1;FBXL2;ATP2B4;FOXO1;DAB2IP;IQGAP1;AKAP5;PPP1R16B;CTTNBP2NL;SHOC2;MFHAS1;HSP90B1;PTK2;STRN3;GRIN3A;ARPP19;CTNNB1;CDC27;ANK1;BOD1;RACK1;ANAPC7;STRN4;MAPK14;PPP1R16A;PPP1R9B;STRN;ANAPC4;PPME1;SMG7;JUP
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5216874275033532,1.3967551207486806,0.0905292479108635,0.5757109688970385,1.0,18/42,21.96%,IZUMO1;STXBP6;ESAM;CDC42EP1;PDLIM5;ROBO4;CD47;BSG;CD200;LRRC4C;TMOD3;MYPN;NPTN;DSCAM;CNTN4;PDLIM1;CNTN6;PAK4
prerank,low-density lipoprotein particle binding (GO:0030169),0.6224434908356234,1.3934831705888278,0.1166407465007776,0.5786522531055761,1.0,2/16,5.63%,CDH13;PLTP
prerank,FAD binding (GO:0071949),-0.47143095159031845,-1.3896553639737537,0.08823529411764706,0.6210680760768523,1.0,9/24,21.31%,MICAL3;MICAL2;DDO;PRODH;CRY2;SQLE;MICAL1;NDOR1;MTHFR
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.6597515771563368,1.3894125945576123,0.10673234811165845,0.5835725114734271,1.0,2/12,6.38%,CDK19;MAPK1
prerank,protein phosphatase 1 binding (GO:0008157),0.5760336073185038,1.3885767267269993,0.12149532710280374,0.5786220553935051,1.0,3/21,6.72%,KCNQ1;PPP1R16B;SHOC2
prerank,neurexin family protein binding (GO:0042043),-0.6044516071023076,-1.3851169358260118,0.09662921348314607,0.6175357344117534,1.0,4/10,11.37%,NLGN2;CPE;SYTL5;SYTL4
prerank,AMP binding (GO:0016208),-0.5703061466251851,-1.3850755088907003,0.10752688172043011,0.5994347447723303,1.0,2/11,0.60%,PRKAG2;MPPED2
prerank,cAMP binding (GO:0030552),0.6579311602310891,1.3848560512247854,0.1201923076923077,0.5827723634853971,1.0,4/11,15.62%,RAPGEF2;RAPGEF4;POPDC3;PDE4D
prerank,lipid phosphatase activity (GO:0042577),0.6222421021448098,1.3812116457917023,0.14262023217247097,0.5869287602494851,1.0,3/14,3.52%,SGPP2;PLPP1;INPP5K
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.42269703019241056,1.3806768946345724,0.017580144777662874,0.5814035455750833,1.0,32/254,9.84%,PRDM16;MECOM;SOX17;ERG;CASZ1;NR4A2;FOXO4;FOXO1;ELK3;NR1I3;KLF7;IRF2;HNF1A;HNF4A;KLF6;SOX18;HHEX;KLF4;LEF1;MAFF;FOXF2;MEF2C;SMAD2;FOSL2;GATA3;ZBTB16;CEBPA;PLSCR1;JUN;TCF3;EGR1;PLAG1
prerank,semaphorin receptor binding (GO:0030215),0.5606403310605037,1.3754273400690362,0.12275449101796407,0.589584761538485,1.0,3/23,4.67%,SEMA3G;SEMA3F;SEMA7A
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5418683056504865,1.3716178838840631,0.11294765840220386,0.5942095361104979,1.0,9/32,17.87%,KCNQ1;KCNE3;KCNG3;KCNC1;KCNC4;KCNA1;KCNC2;KCNH1;KCNQ3
prerank,phosphatidylinositol binding (GO:0035091),0.45765889774490426,1.3707026664526616,0.07398568019093078,0.5900926260881706,1.0,23/91,13.74%,HIP1;MYO1E;ITPR3;HIP1R;ESYT2;FES;FCHO2;ING2;PLEKHF2;EPB41;SH3YL1;SNX10;MCF2L;PASK;PITPNA;CCDC88A;AIDA;EXOC8;NUMA1;SNX11;SNX22;ZFYVE9;SNX24
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5143819927351574,-1.3699847042888917,0.09116809116809117,0.6130794168344443,1.0,13/17,38.43%,EPHA3;EPHA7;EPHB4;EPHB2;EPHB3;EPHA6;EFNB3;EPHB6;EPHA8;EFNA4;EFNA3;EPHA1;EPHA5
prerank,ephrin receptor activity (GO:0005003),-0.5143819927351574,-1.3699847042888917,0.09116809116809117,0.6130794168344443,1.0,13/17,38.43%,EPHA3;EPHA7;EPHB4;EPHB2;EPHB3;EPHA6;EFNB3;EPHB6;EPHA8;EFNA4;EFNA3;EPHA1;EPHA5
prerank,antiporter activity (GO:0015297),0.5721079303130292,1.3692361129147117,0.12153846153846154,0.588014274136147,1.0,6/20,9.52%,SLC25A16;ATP1A3;SLC35D2;SLC35E4;CLCN3;SLC25A30
prerank,glutamate receptor binding (GO:0035254),0.610313953031573,1.369221686695192,0.125193199381762,0.5813004129960466,1.0,5/17,6.95%,HIP1;HOMER2;AKAP5;SHANK3;SHISA6
prerank,ATPase binding (GO:0051117),-0.3733187921872456,-1.3689277391027188,0.021621621621621623,0.6002309644058019,1.0,19/71,15.65%,ANK2;EGFR;TMTC4;SNTA1;SLC2A13;ABCA1;ATP6V0A4;ATP1B3;TOR1AIP1;PTPN3;ATP5IF1;SRC;TCIRG1;METTL21A;ATP1B1;PIH1D1;ATP1B2;WFS1;ZNHIT6
prerank,lipoprotein particle binding (GO:0071813),0.5863167671903758,1.3671901602628351,0.1328358208955224,0.5804351228137258,1.0,2/20,5.63%,CDH13;PLTP
prerank,chemorepellent activity (GO:0045499),0.5522777880945255,1.36485881560464,0.11773472429210134,0.5810603997224458,1.0,4/25,4.67%,SEMA3G;SEMA3F;APOA1;SEMA7A
prerank,phosphoric ester hydrolase activity (GO:0042578),0.5011445146755001,1.364205433145095,0.0978120978120978,0.5765040678249619,1.0,12/49,10.00%,PTPRJ;DUSP12;ACP6;SMPDL3A;PRUNE1;APEX1;DUSP16;DUSP3;PTPRO;GDPD1;ENPP6;DUSP11
prerank,poly-pyrimidine tract binding (GO:0008187),-0.4730556146496338,-1.36179066113494,0.1021021021021021,0.6055669155652019,1.0,10/23,22.51%,RBMS3;RBMS1;HNRNPH1;SSB;DAZAP1;HNRNPU;U2AF2;PABPC1;PABPC4L;KHDRBS1
prerank,poly(U) RNA binding (GO:0008266),-0.49671194845355215,-1.3588962230907145,0.10416666666666667,0.5992294504857977,1.0,5/20,8.92%,RBMS3;RBMS1;HNRNPH1;SSB;DAZAP1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.6368596138759269,1.3585077931726628,0.1389776357827476,0.587198119130679,1.0,5/12,4.11%,LTBP4;ENG;BMPR2;ACVRL1;ACVR1
prerank,mRNA 3'-UTR binding (GO:0003730),-0.35278225477185404,-1.3570044828363754,0.028409090909090908,0.5902133851536625,1.0,26/79,19.02%,CELF2;RBMS3;RBMS1;DDX5;CPEB1;FXR2;NUDT21;HNRNPA2B1;PUM1;CSDC2;DAZAP1;GEMIN5;YBX3;CCT5;LARP4B;TARDBP;CPEB2;CPEB3;TUT1;PCBP4;HNRNPU;ELAVL3;LARP1;RC3H1;PABPC1;ZFP36
prerank,clathrin adaptor activity (GO:0035615),0.6149882485037094,1.3545886209021576,0.14668769716088328,0.5926255599594542,1.0,5/15,9.72%,HIP1;HIP1R;AP2B1;STON1;AP2M1
prerank,pre-mRNA binding (GO:0036002),-0.44278738401557005,-1.3529669251480656,0.09446254071661238,0.5881997399337108,1.0,11/28,24.13%,CELF2;DDX5;PRPF8;SRSF6;HNRNPL;HNRNPU;U2AF2;SLBP;CELF1;CELF5;U2AF1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.620439400780766,1.352793755289435,0.1440677966101695,0.5917585592944038,1.0,2/13,2.53%,PIP5K1B;PIK3C2A
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.6277720954787168,1.351175707764117,0.15055467511885895,0.5902551481071037,1.0,1/13,0.28%,KCNQ1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.5124338977279782,-1.3474867454293247,0.1266490765171504,0.5904361062414624,1.0,5/15,14.19%,SLC1A3;SLC1A5;SLC25A13;SLC1A4;SLC25A12
prerank,amyloid-beta binding (GO:0001540),0.4661546493347511,1.34652310902736,0.07563025210084033,0.5979885920972348,1.0,20/79,11.85%,FZD6;APBB2;APBA1;INSR;ATP1A3;CACNA1A;TGFB2;ADRB2;APOA1;FCGR2B;IAPP;PFDN6;ITGAM;VBP1;GRIA1;GRIN2B;PRNP;PFDN2;CLU;ACHE
prerank,cell adhesion mediator activity (GO:0098631),0.5570235014163518,1.3464819319478971,0.1537313432835821,0.5918715023473193,1.0,11/24,20.90%,BCAM;ESAM;ROBO4;CD47;BSG;LRRC4C;MYPN;NPTN;DSCAM;CNTN4;CNTN6
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.41980807269437165,1.34136532156808,0.054884742041712405,0.6011714732369836,1.0,25/173,11.01%,PRDM16;SOX13;KLF8;DACH1;ZFP69;ELK3;KLF12;HEY1;LRRFIP1;HHEX;HEY2;MAFK;GATA3;BCL6B;ZBTB16;GTF2IRD1;NR1D1;SNAI2;ERF;FOXP1;JUN;TCF3;ZBTB14;ZBTB34;DEAF1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5856886425046851,1.3393652707725812,0.15695067264573992,0.6007998999376235,1.0,5/18,4.11%,LTBP4;ENG;BMPR2;ACVRL1;ACVR1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.37416681931168155,-1.3363871080649532,0.053811659192825115,0.6090429487267927,1.0,6/53,3.00%,SLC7A11;SLC1A3;SLC7A2;SLC47A1;SLC1A5;SLC25A13
prerank,glycerophospholipid flippase activity (GO:0140333),0.6307216455436913,1.3335669033831676,0.17792421746293247,0.6121016805125694,1.0,4/11,12.78%,ATP10A;ABCB4;ATP11C;ATP8B1
prerank,disordered domain specific binding (GO:0097718),0.5512783601794387,1.3326222104693048,0.13623595505617977,0.6089705552422069,1.0,7/23,12.72%,FYN;SMAD2;DFFB;GAPDH;NUMA1;CALM3;KCNA1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5893392795230359,1.3283237726460664,0.1614420062695925,0.6158851510309599,1.0,3/15,12.63%,CCR1;CMKLR1;CX3CR1
prerank,carboxy-lyase activity (GO:0016831),0.5479572261145258,1.3271580934217186,0.15429403202328967,0.6132477132912642,1.0,4/23,8.74%,AMD1;AZIN1;PCK2;ACOD1
prerank,GTPase activity (GO:0003924),0.40978182576484723,1.3230650480958461,0.05285868392664509,0.6196924440269207,1.0,47/192,16.68%,RND1;GBP5;GNAQ;RAB11A;RAB6B;ATL2;RHOB;GNAL;GBP4;DNM3;MTG2;GCH1;KRAS;NRAS;RRAS;GNG3;ATL1;GBP3;RAB23;GNAI2;IRGM;LRRK2;RAB35;MMAA;RRAGD;RHEBL1;RRAS2;GTPBP1;RAC1;MFN1;EEF2;GNG5;GBP2;RAB19;RHOT2;RND2;GNB2;RHOH;RAN;RHEB;SRPRA;ARL8A;GNA14;EFL1;RAB27B;RIT2;GBP7
prerank,SH2 domain binding (GO:0042169),0.506842066418092,1.3229442192204761,0.1340057636887608,0.6140908760266649,1.0,8/31,10.33%,AFAP1L2;TRPV4;CRK;NLK;ARHGAP5;JAK2;PTK2;CCDC88A
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.468664379609963,1.3217909384411286,0.12402088772845953,0.6116947716966168,1.0,6/55,4.28%,ATP2A3;TRPV4;ATP2B4;ATP2B2;ATP2C1;ORAI1
prerank,insulin-like growth factor binding (GO:0005520),-0.500931632288746,-1.3213683673626273,0.13031914893617022,0.6438595925009437,1.0,5/15,7.26%,IGFBP5;IGFBP2;IGFBP6;ITGAV;IGFBP3
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.5583591076409367,1.320773714163456,0.16716867469879518,0.603174227431777,1.0,2/21,2.26%,CDK19;CDK14
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.5583591076409367,1.320773714163456,0.16716867469879518,0.603174227431777,1.0,2/21,2.26%,CDK19;CDK14
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.5328798974569158,-1.3190070265614584,0.1513647642679901,0.6371424700919779,1.0,2/12,3.22%,B3GALT1;B3GNT2
prerank,nucleoside-triphosphatase activity (GO:0017111),0.4021111844225087,1.316986300497157,0.04672897196261682,0.6085181993455168,1.0,60/248,16.68%,MYO1E;RND1;GBP5;GNAQ;RAB11A;RAB6B;ATL2;RHOB;GNAL;GBP4;DNM3;MTG2;GCH1;DDX4;KRAS;NRAS;KIF26A;RRAS;GNG3;ATL1;GBP3;MYH9;KIF2A;THTPA;RAB23;GNAI2;IRGM;LRRK2;HSPA1B;MYL6;RAB35;MMAA;DHX9;RRAGD;RHEBL1;RRAS2;ABCG4;GTPBP1;RAC1;MFN1;EEF2;GNG5;GBP2;CLU;RAB19;PIN1;RHOT2;RND2;GNB2;RHOH;RAN;RHEB;SRPRA;ARL8A;KIF1A;GNA14;EFL1;RAB27B;RIT2;GBP7
prerank,protease binding (GO:0002020),-0.329514498465342,-1.3144850997016249,0.06206896551724138,0.6367951688158388,1.0,22/99,13.45%,COL1A2;COL3A1;COL1A1;CCBE1;BCL2;SLC2A13;ANXA2;ITGAV;PRKN;DPP4;TIMP2;NTRK2;LCOR;FAP;F3;BDKRB2;CFLAR;ADAMTSL4;SERPINE1;ATP9A;BFAR;ECM1
prerank,metallopeptidase activity (GO:0008237),-0.32398771996112113,-1.3126389449448888,0.03305785123966942,0.6288593541018171,1.0,28/113,13.36%,TRABD2B;ADAMTS2;ADAMTS12;ADAMTSL3;THSD4;PAPPA;ADAMTSL5;MMP14;ADAMTS17;ANPEP;ADAMTS5;ADAMTS10;ADAMTS3;ADAM19;ADAM9;ADAMTS15;ADAMTS9;PRPF8;MMP2;ADAM33;METAP1D;ADAMTSL4;MMP16;ZMPSTE24;MMP19;METAP1;ADAMTS14;RNPEP
prerank,PDZ domain binding (GO:0030165),0.46191953737133107,1.3120531080262263,0.12265331664580725,0.6169105217437253,1.0,19/61,14.82%,CCDC88C;RAPGEF2;F11R;ATP2B4;ATP2B2;TMEM88;CADM1;SNTG2;USHBP1;PLEKHA1;ADAM17;GRIA1;ACOX1;CLCN3;SLC22A5;GNG5;TBC1D10A;NSF;FZD3
prerank,MHC class I protein binding (GO:0042288),0.6054139003076833,1.310902416084081,0.16282894736842105,0.6144289282312502,1.0,5/13,13.20%,TUBB;TUBB4B;ATP5F1A;TAP1;TAPBP
prerank,pyrophosphatase activity (GO:0016462),0.47047077950310046,1.3093251439294578,0.11810012836970475,0.6133124383003294,1.0,11/50,13.99%,ENTPD1;ALPL;PLPP1;PRUNE1;DCPS;DHX9;ADPRM;PRUNE2;TRPM2;PLPP4;NUDT9
prerank,transforming growth factor beta binding (GO:0050431),0.548447945754574,1.3069619610656895,0.15295815295815296,0.6147720196172579,1.0,6/23,5.33%,LTBP4;ENG;ACVRL1;ACVR1;WFIKKN1;HYAL2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.626469228710973,1.3051664910929528,0.18416523235800344,0.6089148440422987,1.0,2/10,6.26%,DUSP1;DUSP16
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.626469228710973,1.3051664910929528,0.18416523235800344,0.6089148440422987,1.0,2/10,6.26%,DUSP1;DUSP16
prerank,phosphatase activity (GO:0016791),0.4561849224732002,1.304824188354528,0.12300123001230012,0.6045715318204291,1.0,19/73,16.64%,PTPRJ;ALPL;DUSP12;PLPP1;INPP5K;MINPP1;ACP6;PRUNE1;DUSP16;DUSP3;PTPRO;DUSP11;OCRL;PLPP6;PLPP4;DUSP28;DUSP26;PLPPR1;ARMT1
prerank,receptor ligand activity (GO:0048018),0.3978169230026609,1.302802787059963,0.05213764337851929,0.6052812029427189,1.0,14/245,4.67%,VEGFC;SEMA3G;JAG1;JAG2;EDN1;PDGFB;KITLG;DAND5;TGFB2;SEMA3F;TAFA1;APOA1;VEGFD;SEMA7A
prerank,ligand-gated calcium channel activity (GO:0099604),0.555435496856615,1.3021768635649802,0.16510903426791276,0.6017279893701232,1.0,5/19,11.28%,ITPR3;MCOLN1;GRIN2B;GRIN2C;TRPM2
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.5347310402127515,-1.3021302105915806,0.18829516539440203,0.6497418520784966,1.0,4/12,6.60%,SULF1;SULF2;GNS;ARSI
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5405141564829387,-1.2994218031760427,0.16321243523316062,0.6448901609664527,1.0,6/12,16.70%,XDH;AOX1;FDX1;CIAPIN1;FXN;SDHB
prerank,calcium channel inhibitor activity (GO:0019855),0.6185583533435395,1.2959082702515148,0.20411663807890223,0.614042308219504,1.0,3/11,7.19%,FKBP1A;MCUB;SLC30A1
prerank,N-acyltransferase activity (GO:0016410),0.509233117347792,1.2940437270074523,0.18156424581005587,0.6138826841230551,1.0,6/32,9.27%,SATL1;CERS4;GLYAT;NMT1;CERS6;CERS5
prerank,kinase binding (GO:0019900),0.3897911000807977,1.2924085931248128,0.023232323232323233,0.6127323468790822,1.0,91/434,16.29%,PTPRJ;PLCG2;TRPV4;GATA6;PTPRR;UTRN;CEACAM1;TRIM14;FAS;CCND2;RND1;ACVRL1;NOD2;CCND3;ATP1A4;DAB2IP;TTC28;CAV1;CAV2;RHOB;OXSR1;EMP2;IQGAP1;HDAC7;BTG1;CRK;FBXO7;MSN;NBEA;TRIM6;BCAR3;SIKE1;CDC25C;WARS1;SMCR8;ADIPOR1;CEP68;DUSP3;IRGM;HNRNPA0;ELAVL1;HSPB1;PDE8A;MAPRE3;CEBPA;BCL2L1;TOM1L1;JAK2;WWC2;APC;STAP1;PTK2;ADAM10;CASP1;PLCG1;NEFH;PTPN1;RAC1;TPCN2;POLA1;CADPS;ACTB;NPM1;EEF2;PIK3IP1;VRK1;CALM3;IRF5;CTBP2;PRC1;INKA1;RND2;CNKSR2;HIF1A;AP1B1;RHOH;NSF;LYST;CTNNB1;LRBA;KIZ;FRMD5;PDCD10;CDKN2D;PAK2;VDAC1;RICTOR;NEK9;PFKM;SGO1;ESR1
prerank,potassium ion antiporter activity (GO:0022821),-0.49999053010406924,-1.2916748581833055,0.14854111405835543,0.6558720623338767,1.0,3/15,6.64%,SLC24A3;SLC9A2;SLC9A9
prerank,GTP binding (GO:0005525),0.4041650466305623,1.2913002790889236,0.07934782608695652,0.6106804605316957,1.0,43/172,16.73%,RND1;GBP5;INSR;ATL2;RHOB;GBP4;MTG2;GCH1;KRAS;NRAS;SCG5;RRAS;RAB39A;TUBB;GLUD1;ATL1;GBP3;TUBB4B;MFHAS1;LRRK2;RAB35;MMAA;EIF2B2;TUBA8;ARF3;RRAGD;RHEBL1;RRAS2;RAC1;GBP2;RHOT2;RND2;TUBA1A;RRAD;RHOH;RAN;RHEB;ARL8A;ARL5B;RAB27B;RIT2;GBP7;ARFIP2
prerank,ion channel inhibitor activity (GO:0008200),0.4953426377249242,1.2895939567102077,0.18376068376068377,0.6105122731261721,1.0,9/35,10.96%,FKBP1A;MCUB;VTI1B;STX7;CAMK2D;SLC30A1;VAMP8;SCN1B;NEDD4L
prerank,heme binding (GO:0020037),0.4533637188170344,1.2891251135334052,0.11728395061728394,0.6068356560712425,1.0,6/65,9.30%,NOS1;NOS3;JAK2;HEBP1;NR1D1;HMOX2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.35672309711736494,-1.288250812193497,0.09047619047619047,0.6539962591100728,1.0,14/55,10.94%,SLC6A13;SLC16A12;SLC7A2;SLC13A3;PDPN;SLC6A12;SLC16A6;SLC16A9;SLC38A11;SLC19A1;SLC22A4;SLC38A10;SLC38A5;SLC16A11
prerank,myosin binding (GO:0017022),0.45411127781098304,1.287533558666752,0.14513981358189082,0.6064569156691797,1.0,14/55,16.81%,MYRIP;SHROOM4;MYBPC3;RAB11A;RAB6B;SPATA6;LMTK2;NKD2;SHROOM1;CXCR4;RAB27B;STXBP5L;PYCARD;STXBP5
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.49515778011849954,1.286779375712986,0.17614424410540916,0.6037626722747926,1.0,5/34,3.63%,CYTH3;FCHSD2;HIP1R;IQGAP1;ARAP3
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.5228824315140845,-1.2867251769750718,0.17674418604651163,0.6460076163810404,1.0,3/11,7.11%,SLC25A47;SLC25A20;SLC22A4
prerank,chemokine receptor activity (GO:0004950),0.5124297322961601,1.2846169541608476,0.1839080459770115,0.6045232505550331,1.0,4/24,14.74%,CCR1;CMKLR1;CX3CR1;CXCR4
prerank,insulin-like growth factor I binding (GO:0031994),-0.5136715471858895,-1.2832394731908336,0.15159574468085107,0.6438136206226249,1.0,5/13,7.26%,IGFBP5;IGFBP2;IGFBP6;ITGAV;IGFBP3
prerank,glucose transmembrane transporter activity (GO:0005355),0.5605299407103352,1.282751047453373,0.18225039619651348,0.6045948133596569,1.0,2/17,3.02%,SLC2A1;SLC5A10
prerank,DNA-binding transcription factor binding (GO:0140297),0.39999684839786165,1.2769140269208543,0.08423326133909287,0.6160544485843745,1.0,30/189,11.53%,PRDM16;LDB2;LMO2;FOXO4;TBXT;TAL1;HNF4A;HDAC9;HDAC7;HHEX;RBBP8;HEY2;KLF4;MEF2C;SMAD2;BBS7;CHCHD2;STAT1;HSPB1;PURA;RBL1;NFE2L2;JUN;TCF3;HMGB1;DHX9;MAD2L2;CRTC1;NPM1;DMAP1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.5018063608487888,1.2750542543501544,0.17210682492581603,0.6162854656888238,1.0,9/28,19.59%,GRID1;GABRA4;GRIK5;GRIK2;GABRA2;GABRE;GRIK1;GABRG3;GRID2
prerank,transmitter-gated ion channel activity (GO:0022824),0.5040036222522352,1.2745161614799503,0.17196531791907516,0.6130179574329309,1.0,15/29,26.34%,GRID1;GABRA4;GRIK5;GRIK2;GABRA2;GABRE;GRIK1;GLRA2;GABRG3;GABRB1;GRID2;GABRB3;GRIA2;GABRA3;GRIA4
prerank,adenylate cyclase binding (GO:0008179),-0.5420914118753992,-1.274233321312472,0.17906976744186046,0.6597243307968154,1.0,4/10,7.03%,ADCY5;AKAP12;ADCY2;CALM2
prerank,protein serine/threonine kinase activity (GO:0004674),0.38818524289226625,1.2736654356276447,0.05549845837615622,0.6105312866787412,1.0,66/334,12.94%,NUAK1;CDK19;KALRN;MAP4K2;STK10;BMPR2;RPS6KA5;PLK3;ACVRL1;MAP4K3;MYLK;SBK1;CDK14;SNRK;PRKD1;MAST4;OXSR1;CDC42BPA;TRIO;MAP3K6;PKN3;CDC42BPG;BCR;ACVR1;SLK;STK24;CAMK2D;MAP4K4;PKN1;STK38;STK38L;CSNK1D;NLK;TTBK2;IRAK2;MAPK1;UHMK1;MAST1;AKT3;SIK2;LRRK2;LMTK2;TLK1;PRKAA1;STK39;PASK;PIM3;NEK7;ROCK1;CSNK1G3;SGK1;TAOK2;MAP3K11;MARK3;PRKCG;RPS6KA1;MINK1;LIMK2;NEK11;PRKD2;MARK2;VRK1;TTBK1;STK33;RPS6KA3;RPS6KB1
prerank,I-SMAD binding (GO:0070411),0.5823705292013991,1.2724572329718191,0.2052980132450331,0.6091926208642184,1.0,5/13,14.24%,SMAD6;SMAD7;SMAD2;SMURF1;CTNNB1
prerank,GABA-A receptor activity (GO:0004890),0.5463128812328544,1.2720778640897554,0.19873817034700317,0.6057435911244499,1.0,7/18,21.41%,GABRQ;GABRA4;GABRA2;GABRE;GABRG3;GABRB1;GABRB3
prerank,calcium ion binding (GO:0005509),0.3898143127597409,1.270911100285431,0.05112474437627812,0.6045481349519087,1.0,44/323,11.44%,CDH13;LTBP4;NOTCH4;SYT15;RAPGEF2;ITPR3;PITPNM3;MCTP1;DYSF;PLSCR4;ESYT2;EML1;CLGN;RASGRP2;AOAH;CALML4;AGRN;CEMIP2;IQGAP1;ANXA3;SYT7;SLC8A1;NUCB2;SPOCK2;STIM2;MEX3B;TPD52;ASAH2;EFCAB9;PPP3CA;HSP90B1;CASQ1;PLSCR1;CDH15;CDH3;CRACR2A;DSPP;CDH12;DHH;PRNP;CDH2;SPOCK1;TRPM2;PCP4
prerank,carbohydrate kinase activity (GO:0019200),-0.5329304967722885,-1.2688569095975484,0.17548076923076922,0.6632656744534469,1.0,5/11,21.13%,GALK2;HK2;NAGK;GALK1;POMK
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.43699955450071254,-1.2679261094794734,0.17094017094017094,0.654312013725625,1.0,10/22,21.36%,IKBKE;TAB3;OPTN;PRPF8;OTUD7B;WDR81;ZRANB1;TNFAIP3;ZRANB3;RNF168
prerank,histone acetyltransferase activity (GO:0004402),-0.4127738871097015,-1.2677594236375531,0.14067278287461774,0.6434044756498459,1.0,14/30,23.29%,TADA2A;CREBBP;KAT2B;TAF1;HAT1;CLOCK;USP22;ATF2;NAA60;TADA3;NAA40;MCM3AP;TAF10;NAA50
prerank,transcription cis-regulatory region binding (GO:0000976),0.3817693698452432,1.2673514710072198,0.038657171922685654,0.6096816587118038,1.0,58/406,12.28%,PRDM16;EPAS1;SOX17;SOX13;GATA6;SMAD6;MSX1;DACH1;SMARCA2;CASZ1;ZFP69;ELK3;NR1I3;TAL1;IRF2;HNF1A;HNF4A;SOX18;HHEX;ACTN4;FLI1;KLF4;SIM2;LEF1;MAFK;ZBTB46;FOXF2;MEF2C;SMAD2;ZBTB48;FOSL2;GATA3;SETX;PURA;RBL1;CEBPA;NFE2L2;NR1D1;SNAI2;KLF11;FOXP1;JUN;TCF3;EGR1;HMGB1;ARID5A;ZBTB14;XRN2;DEAF1;NPM1;PHOX2A;E2F7;BRCA1;ARID5B;SOX10;HINFP;SOX6;SUV39H2
prerank,double-stranded RNA binding (GO:0003725),0.44362953134839894,1.2636846244825293,0.15782828282828282,0.6150486219434987,1.0,16/70,13.08%,ADARB1;IFIH1;LRRFIP1;VIM;TLR3;MSN;MBNL1;TUBB4B;ELAVL1;ZNF346;OAS2;ADAR;DHX9;AGO4;ILF2;FXR1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.5121627768079471,-1.2625436015567308,0.19047619047619047,0.6470440231715994,1.0,8/12,22.80%,CYFIP2;EIF4E2;NCBP1;EIF4E3;GEMIN5;LARP1;NCBP3;NCBP2
prerank,alkali metal ion binding (GO:0031420),-0.5122046101942488,-1.256282508386021,0.19576719576719576,0.6538023976772694,1.0,5/13,14.71%,ATP1A2;PDXK;ADPRH;HDAC4;DRG1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.5291911089116752,-1.2552108371242818,0.21897810218978103,0.6353643115306231,1.0,5/11,23.64%,SIL1;BAG1;BAG3;GRPEL2;BAG2
prerank,adenyl nucleotide binding (GO:0030554),-0.5291911089116752,-1.2552108371242818,0.21897810218978103,0.6353643115306231,1.0,5/11,23.64%,SIL1;BAG1;BAG3;GRPEL2;BAG2
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.524458906337963,-1.2509876089980008,0.21674876847290642,0.6364067397569988,1.0,2/10,7.47%,B3GALT1;B4GALT1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.5112897015103852,-1.249211859749052,0.19730941704035873,0.6313600634229578,1.0,4/11,20.69%,PPP1R1A;PPP1R14B;PPP1R2;PPP1R11
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3618274210248481,-1.2477131065989973,0.11068702290076336,0.6259455740565134,1.0,10/47,7.99%,SLC7A11;SLC6A13;SLC7A2;SLC47A1;PDPN;SLC1A5;SLC38A11;SLC6A1;SLC22A4;SLC38A10
prerank,translation elongation factor activity (GO:0003746),0.5665135971912147,1.2466277153097993,0.21009771986970685,0.657402419036141,1.0,8/14,26.99%,TUFM;GTPBP1;EEF2;GTPBP2;EEFSEC;GFM1;TSFM;EEF1A1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.4622819890441471,-1.240374062033867,0.21159420289855072,0.6371101302970339,1.0,8/16,22.40%,SLC13A3;SLC1A5;SLC25A13;SLC1A4;SLC25A12;SLC25A18;SLC25A14;SLC13A5
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.5983611720210018,1.238442441585117,0.2380191693290735,0.6756285401196057,1.0,3/10,8.80%,APEX1;EXD2;FEN1
prerank,channel activity (GO:0015267),0.4619892918412698,1.2381557264598755,0.1835883171070932,0.671555197662107,1.0,3/41,2.73%,TRPV4;AQP11;MCUB
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.4446975422050555,1.237623415443946,0.19544846050870146,0.6682309871322025,1.0,7/54,6.37%,ACER2;HDAC9;GLS2;GLS;HDAC11;ASAH2;SIRT4
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.43613729487166886,1.2367973212353203,0.18421052631578946,0.6656954072115383,1.0,10/72,4.08%,KCNQ1;HIP1;PLCB1;HIP1R;STXBP6;TTPA;FLII;SYT7;TIRAP;FCHO2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.45061224489795915,-1.235766108085975,0.21367521367521367,0.640212790624099,1.0,17/18,54.99%,HSD17B8;HSD11B1;HSD17B10;HSD17B2;HSD3B7;HSD17B14;HSD17B1;DHRS11;HSD17B7;SRD5A2;HSD3B2;AKR1C1;DHRS9;RDH16;HSD17B6;HSD17B3;RDH5
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.4930579979804538,-1.2316291516949778,0.22164948453608246,0.6422816013870565,1.0,6/12,18.57%,SHC1;IRS1;PIK3R1;SH2B1;GAB2;SH2B2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.40822227231098474,1.228376858043531,0.17076023391812867,0.6851525126368736,1.0,26/100,18.31%,CYTH3;FCHSD2;HIP1;HIP1R;DAB2IP;TTPA;IQGAP1;ARAP3;TECPR1;CERT1;PLEKHA5;MYO10;SNX11;SAP30L;SNX22;BTK;SNX24;PHLDA3;RUBCN;CLVS1;KIF16B;ZFYVE16;ARFIP2;KCNH1;GOLPH3L;GOLPH3
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.5771123194426344,1.2226457155205717,0.25333333333333335,0.6967940923535806,1.0,9/12,30.69%,GABRA4;GABRA2;GABRE;GABRG3;GABRB1;GABRB3;GABRA3;GABRB2;GABRA5
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.3840078659838335,-1.2217653907736974,0.16666666666666666,0.6605034538795315,1.0,14/33,16.43%,SCAF8;RRN3;PAF1;ERCC5;ERBB2;CTR9;URI1;UVSSA;RTRAF;GTF2B;HNRNPU;PCF11;MAF1;WAC
prerank,C2H2 zinc finger domain binding (GO:0070742),0.5941085577468932,1.218226390825756,0.2773109243697479,0.7053495025910091,1.0,2/11,4.58%,GATA2;LEF1
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5217844826390398,1.2152279111229016,0.2340764331210191,0.7096494417601537,1.0,8/17,17.26%,GRIA1;GRIN2B;GRIN2C;GRIK5;GRIK2;GRIN3A;GRIK1;GRIN2A
prerank,tRNA methyltransferase activity (GO:0008175),0.5365649402534209,1.214260353555768,0.25157232704402516,0.7074590922001762,1.0,5/16,11.12%,TRDMT1;TRMT5;METTL2B;METTL2A;ALKBH8
prerank,microtubule binding (GO:0008017),0.3775312869492916,1.212173858857369,0.13593256059009484,0.7090274329836899,1.0,52/222,15.66%,CCDC88C;TRPV4;IRAG2;MTUS1;RAB11A;EML1;ARHGEF2;MACF1;SAXO1;MAP4;DNM3;CLIP2;DST;KIF26A;VASH2;MAP4K4;FAM161A;EML6;TTBK2;CAMSAP2;CLIP1;KIF2A;CLASP1;MAST1;WHAMM;LRRK2;MAPRE3;HOOK1;REEP2;STARD9;APC;CCDC181;GAPDH;UXT;GAS2L3;CLASP2;PRNP;CCDC88A;NEFH;POLB;REEP1;NUMA1;REEP3;PRC1;KIF26B;MAP1LC3A;NAV3;SYBU;VAPA;MAP2;KIF16B;KIF1A
prerank,ligand-gated channel activity (GO:0022834),0.4702419225775324,1.212167654210191,0.2397743300423131,0.7042565129379255,1.0,11/29,19.59%,GRID1;GRIA1;GRIN2B;GRIN2C;GRIK5;GRIK2;GRIN3A;GRIK1;GRIN2A;GABRB1;GRID2
prerank,cGMP binding (GO:0030553),0.5756006569978346,1.211404981920986,0.2642740619902121,0.7017005388369835,1.0,1/11,0.63%,RAPGEF2
prerank,galactosyltransferase activity (GO:0008378),0.5739170127181835,1.2088004965489068,0.27946127946127947,0.7047024527163835,1.0,4/11,14.64%,B4GALT4;A4GALT;B4GALT6;A3GALT2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.447203808649707,1.2080552922529333,0.21001390820584145,0.7020673759657526,1.0,4/42,4.81%,CCNY;CCND2;CCND3;CCNE1
prerank,potassium ion leak channel activity (GO:0022841),-0.4630453601322031,-1.2073514663541016,0.21,0.691708374977329,1.0,2/15,2.94%,KCNK2;KCNK5
prerank,nuclear receptor coactivator activity (GO:0030374),-0.3424839326926477,-1.2058536624389902,0.1652892561983471,0.6863162832972197,1.0,16/52,13.96%,PPARGC1B;ZMIZ1;PRKCB;TACC1;CCAR1;FGF2;MED13;RNF4;MED14;RBM14;CCDC62;CALCOCO1;ZMIZ2;USP22;ATXN7L3;ELK1
prerank,Toll-like receptor binding (GO:0035325),0.5702866499940136,1.2057701523539084,0.2544861337683524,0.7042302788697774,1.0,2/11,3.82%,DAB2IP;TIRAP
prerank,ligand-gated ion channel activity (GO:0015276),0.4666330319435114,1.2057599434358202,0.24050632911392406,0.6996530113931606,1.0,11/30,19.59%,GRID1;GRIA1;GRIN2B;GRIN2C;GRIK5;GRIK2;GRIN3A;GRIK1;GRIN2A;GABRB1;GRID2
prerank,guanyl ribonucleotide binding (GO:0032561),0.3732490097094612,1.2045368445706344,0.14453961456102785,0.6984090706903632,1.0,44/196,16.73%,RAPGEF2;RND1;GBP5;INSR;ATL2;RHOB;GBP4;MTG2;GCH1;KRAS;NRAS;SCG5;RRAS;RAB39A;TUBB;GLUD1;ATL1;GBP3;TUBB4B;MFHAS1;LRRK2;RAB35;MMAA;EIF2B2;TUBA8;ARF3;RRAGD;RHEBL1;RRAS2;RAC1;GBP2;RHOT2;RND2;TUBA1A;RRAD;RHOH;RAN;RHEB;ARL8A;ARL5B;RAB27B;RIT2;GBP7;ARFIP2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.35569241810424446,-1.2016715126687325,0.16872427983539096,0.6886258294278055,1.0,12/48,11.69%,TRPM3;NALCN;PIEZO2;SLC12A2;SLC41A1;TRPM6;ATP6V1B2;ABCC9;TRPC6;DMAC2L;CALHM5;TRPV2
prerank,mannose binding (GO:0005537),-0.4807201273396703,-1.199193050901309,0.2416452442159383,0.6859809504234536,1.0,8/12,46.02%,LMAN1;CLN5;LMAN2;ACR;COLEC11;LMAN2L;LMAN1L;CLEC4D
prerank,SUMO transferase activity (GO:0019789),-0.4606601519692945,-1.1989699945353367,0.24653739612188366,0.6771742631130374,1.0,8/16,27.53%,PIAS3;HDAC4;CBX4;MDM2;TOPORS;PIAS4;UBE2I;NSMCE2
prerank,calcium channel activity (GO:0005262),-0.3127966072453556,-1.1936187268630105,0.1464968152866242,0.6825674267971988,1.0,16/84,12.41%,SLC24A3;CACNA2D3;CACNA1C;ANXA2;TRPC3;ITGAV;CACNG4;CACNA2D1;P2RX4;NCS1;TRPC6;TRPC4;CACNB1;PKD1;TRPV2;CACNB2
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.42455486831820516,1.1927948020191088,0.21679197994987467,0.7273763747031821,1.0,11/60,7.26%,TEK;FLT1;TIE1;FLT4;MERTK;ACVRL1;INSR;ACVR1;FGFR3;ALK;LMTK2
prerank,calcium:sodium antiporter activity (GO:0005432),-0.5083370675498194,-1.190604043786459,0.2708333333333333,0.6813283319241568,1.0,2/10,3.22%,SLC24A3;SLC8A3
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.49451851502920485,1.1880306403005263,0.27217125382262997,0.7366059031880007,1.0,2/22,3.89%,ATP2A3;ATP2C1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.43084517212667833,1.1877135096547504,0.2320730117340287,0.7328476701137308,1.0,6/53,8.17%,NOS1;NOS3;CYB5R1;ETFA;ETFDH;ACOX1
prerank,RNA cap binding (GO:0000339),-0.4445261860584727,-1.1877063351374622,0.25132275132275134,0.6801356743285062,1.0,9/16,18.59%,CYFIP2;EIF4E2;NCBP1;EIF4E3;GEMIN5;EIF3D;SNUPN;LARP1;NCBP3
prerank,anion channel activity (GO:0005253),0.41292881584629504,1.1824090563689449,0.2534854245880862,0.74381189298057,1.0,16/61,19.81%,LRRC8C;CLIC4;ANO6;GABRQ;BEST1;TTYH3;CLCN3;GABRA4;GABRA2;GABRE;VDAC1;GLRA2;GABRG3;GABRB1;VDAC3;CLCN7
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.5629339853902684,1.1821174892466715,0.3141891891891892,0.7401293551339614,1.0,4/10,17.50%,GABRA4;GABRA2;GABRE;GABRG3
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.43778006853923346,-1.180778341131147,0.22938144329896906,0.680995232036232,1.0,6/16,16.45%,ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP5F1B;ATP6V1A
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.43778006853923346,-1.180778341131147,0.22938144329896906,0.680995232036232,1.0,6/16,16.45%,ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP5F1B;ATP6V1A
prerank,GTPase regulator activity (GO:0030695),0.3680398332756201,1.1805030878804494,0.18479408658922913,0.7401447181644151,1.0,49/212,13.94%,PREX2;RAPGEF2;ARHGAP31;RGS3;PLCB1;RABGAP1;SIPA1L2;CHN2;GNAQ;ABR;ASAP2;IQGAP1;SIPA1L3;RALGAPA1;ARAP3;BCR;TBC1D30;SGSM1;ARHGAP8;TBC1D8;RAP1GDS1;SH3BP4;RGS7;RAB3GAP2;LRRK2;RANGAP1;ARHGAP25;TBC1D12;ARRB1;TBC1D5;TBC1D1;JUN;RAP1GAP2;CCDC88A;RANBP2;RANBP1;RALGAPB;OCRL;ARHGAP27;DOCK1;ITGB1BP1;USP6NL;TBC1D10A;TBC1D4;TBC1D9;RHOH;RGS12;RALGAPA2;SOS1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.526615328298615,1.1801543730040454,0.28054298642533937,0.7364760837456185,1.0,6/18,18.52%,TNFAIP8;RPS6KA1;RPS6KA3;NOL3;VIL1;XIAP
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.483723667284025,1.1785518677492712,0.2863849765258216,0.7361458920376743,1.0,6/23,15.50%,HIP1;HIP1R;PLEKHA5;PHLDA3;CLVS1;KIF16B
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.49418959887045955,-1.177760979944438,0.28705882352941176,0.6805306033367182,1.0,1/10,0.45%,DPYSL3
prerank,tubulin binding (GO:0015631),0.36136698979346843,1.1761700354815088,0.14699792960662525,0.7384632863197118,1.0,65/295,15.66%,CCDC88C;TRPV4;STMN2;FYN;RABGAP1;IRAG2;MTUS1;RAB11A;EML1;ARHGEF2;SAXO1;MAP4;DNM3;TTLL7;CLIP2;DST;KIF26A;VASH2;MAP4K4;FAM161A;EML6;PRUNE1;PHF6;GABARAPL1;CLIP1;KIF2A;CLASP1;MAST1;WHAMM;LRRK2;VBP1;MAPRE3;HOOK1;TTLL1;REEP2;STARD9;APC;CCDC181;GAPDH;UXT;GAS2L3;CLASP2;PRNP;CCDC88A;NEFH;POLB;REEP1;NUMA1;BRCA1;DIP2B;TTLL5;REEP3;TTLL11;PRC1;RAD51D;EFHC2;KIF26B;MAP1LC3A;NAV3;SYBU;VAPA;MAP2;ARL8A;KIF16B;KIF1A
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3496866678060358,1.1760121392441243,0.08341708542713568,0.7343953850481899,1.0,81/597,13.59%,PRDM16;SOX17;SOX13;ERG;IRF6;GATA6;GATA2;SMAD6;MSX1;KLF2;SMARCA2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;ELK3;NR1I3;KLF12;HEY1;TAL1;OLIG2;IRF2;ZNF296;HNF1A;HNF4A;KLF3;KLF6;SOX18;HHEX;FLI1;HEY2;HMBOX1;KLF4;LEF1;MAFK;IRF9;MAFF;MEF2C;ZBTB48;GATA3;BCL6B;RXRG;ORC3;CEBPA;NFE2L2;NR1D1;SNAI2;KLF11;FOXP1;JUN;TCF7L1;EGR1;HMGB1;DHX9;ARID5A;ZBTB14;POLA1;PHOX2A;E2F7;BRCA1;NR4A1;ARID5B;KLF13;SOX10;ORC5;HINFP;SOX6;TLX3;SUV39H2;IRF5;ELF2;TGIF1;POU3F2;ZNF32;UNCX;TBX20;NFATC1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.5328850767005315,1.1758142909395652,0.28317152103559873,0.7304064004204697,1.0,7/13,26.49%,GABRA4;GABRA2;GABRE;GLRA2;GABRG3;GABRA3;GLRB
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.475300586750366,1.1754878659820986,0.26420454545454547,0.7269540202169305,1.0,9/30,18.52%,TNFAIP8;PTTG1;RPS6KA1;SPOCK1;RPS6KA3;NOL3;VIL1;CST3;XIAP
prerank,CoA-ligase activity (GO:0016405),0.5294283702809816,1.171155695045605,0.29967948717948717,0.7347648792809766,1.0,5/14,14.78%,ACSM3;ACSBG1;ACSS2;AACS;SLC27A2
prerank,gamma-tubulin binding (GO:0043015),-0.41490089544560427,-1.1698927173870572,0.24539877300613497,0.6945557123037468,1.0,9/21,21.29%,BRSK1;TUBGCP4;DIXDC1;OFD1;DDX3X;NDRG1;TUBGCP5;BLOC1S2;RACGAP1
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.28018863382405845,-1.169084706672027,0.13392857142857142,0.688121964625774,1.0,23/134,8.86%,SLC1A3;SLC6A13;SLC16A12;SLC7A2;SLC13A3;PDPN;SLC26A7;SLC1A5;SLCO2B1;SLCO3A1;SLC26A2;SLC25A13;GJA1;SFXN2;SLC39A8;SLC22A6;SLC6A1;SLC19A1;SLC52A1;SLC6A9;SLC27A1;MPC2;SLCO2A1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.35500045184522394,-1.1662385019238992,0.23157894736842105,0.6876386935707935,1.0,8/35,7.53%,MPPED2;PLCE1;PLCL1;ENPP1;ENPP3;NAPEPLD;PLCB3;GPLD1
prerank,R-SMAD binding (GO:0070412),0.49941272744463244,1.1591979692768284,0.2873015873015873,0.7643334804058562,1.0,9/18,19.63%,SMAD6;SMAD2;JUN;PMEPA1;SMURF1;DROSHA;MEN1;SMAD4;TRIM33
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.37361732035192796,-1.1589968977359097,0.25874125874125875,0.6994250187935555,1.0,8/29,16.09%,PRKAG2;KAT2B;SPRED1;SPRED2;PRKAR2A;PRKAR2B;PRKAR1A;CDKN1A
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.38127008002276597,-1.1587022024781355,0.23076923076923078,0.6919869123416511,1.0,10/27,22.43%,SLC41A1;SLC8A3;SLC9A2;SLC9B2;SLC9A9;SLC9A1;SLC8A2;SLC9A6;KCNK1;SLC4A8
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.5597510838797364,1.1553582090388674,0.31951640759930916,0.7712525640142687,1.0,4/10,9.23%,IZUMO1;CD47;CD200;DSP
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.35274464149284956,1.155277772269651,0.17585848074921956,0.7669859205237847,1.0,54/269,14.74%,FZD6;SMAD6;ASB4;SMAD7;FOXO1;CASP8;HERC2;FBXO7;SUMO2;SUMO3;TUBB;GPI;NLK;SMAD2;TRAF1;TNFRSF1B;ARIH1;CUL3;GABARAPL1;ARRDC1;UBE2D1;MFHAS1;MC4R;STAT1;HSPA1B;PRR5L;ARRB1;UBA52;APC;ACTG1;RPS27A;JUN;RTN4;FBXW7;RBX1;CUL2;NKD2;NFKBIA;BAG6;LAPTM5;CCT2;SNCAIP;BRCA1;TMBIM6;CLU;DTX3L;UBE2T;YOD1;UBE2J2;HIF1A;UQCRC1;MAP1LC3A;RAD18;CXCR4
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.3786430853574949,-1.1529032486504291,0.2795031055900621,0.6993024094859341,1.0,5/26,10.93%,B3GALT1;B3GNT2;GBGT1;CHPF2;EXTL2
prerank,cation channel activity (GO:0005261),-0.29563146740499363,-1.1502691293998175,0.18064516129032257,0.6985405109037462,1.0,11/94,6.36%,SLC24A3;TRPM3;NALCN;PIEZO2;KCNK5;ANXA2;TRPC3;ANO1;TRPM6;ABCC9;KCNQ4
prerank,C-C chemokine receptor activity (GO:0016493),0.4687426735918163,1.1499619091518218,0.27786032689450224,0.7777854904100531,1.0,3/21,14.74%,CCR1;CX3CR1;CXCR4
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3880575619465585,1.1475149501998363,0.2775800711743772,0.7803360135901057,1.0,10/91,4.08%,KCNQ1;HIP1;PLCB1;HIP1R;STXBP6;TTPA;FLII;SYT7;TIRAP;FCHO2
prerank,calcium channel regulator activity (GO:0005246),0.438748554012147,1.147502243564591,0.2834978843441467,0.7758536403536557,1.0,6/37,9.30%,PRKG1;FKBP1A;MCUB;STIM2;SLC30A1;SGK1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.5332995227999273,1.146543456711141,0.3264659270998415,0.7742698230715518,1.0,2/12,8.59%,RRH;ELOVL4
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5217828730248302,1.143108712260182,0.3273615635179153,0.779716812006869,1.0,5/14,11.08%,RECK;SPOCK2;TIMP3;SPOCK3;SPOCK1
prerank,ubiquitin protein ligase binding (GO:0031625),0.35000693078584644,1.1419037789802253,0.19476439790575917,0.7789229274081777,1.0,51/254,14.74%,FZD6;SMAD6;ASB4;SMAD7;FOXO1;CASP8;HERC2;FBXO7;SUMO2;TUBB;GPI;NLK;SMAD2;TRAF1;TNFRSF1B;ARIH1;CUL3;GABARAPL1;ARRDC1;UBE2D1;MFHAS1;MC4R;HSPA1B;PRR5L;ARRB1;UBA52;APC;ACTG1;RPS27A;JUN;RTN4;FBXW7;RBX1;CUL2;NKD2;NFKBIA;BAG6;LAPTM5;CCT2;SNCAIP;BRCA1;TMBIM6;CLU;UBE2T;YOD1;UBE2J2;HIF1A;UQCRC1;MAP1LC3A;RAD18;CXCR4
prerank,ligand-gated anion channel activity (GO:0099095),0.4976673399738316,1.1416191452248812,0.3203125,0.7753502742054625,1.0,11/17,30.69%,GABRA4;GABRA2;GABRE;GLRA2;GABRG3;GABRB1;GABRB3;GABRA3;GLRB;GABRB2;GABRA5
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.35771629493979284,-1.141418524575592,0.24315068493150685,0.7151202208334669,1.0,15/32,24.21%,KDM7A;EGLN3;FTO;TET2;P4HTM;TET1;KDM4A;TMLHE;RIOX2;JMJD4;KDM8;PHF8;PHYHD1;BBOX1;PHYH
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.4695958550242146,1.1410604993974647,0.3040847201210287,0.7725094102569534,1.0,4/21,12.92%,KCNQ1;AKAP5;WASF2;AKAP1
prerank,potassium channel activity (GO:0005267),0.38400254608989487,1.1399917625114306,0.27837514934289126,0.7711795674010896,1.0,17/89,17.87%,KCNN4;KCNQ1;KCNH8;KCNG3;KCNK12;KCNC1;KCNH7;GRIK5;GRIK2;KCNK9;KCNC4;KCNA1;GRIK1;KCNC2;KCNH5;KCNH1;KCNQ3
prerank,sodium:proton antiporter activity (GO:0015385),-0.48382522734344835,-1.1390218357884827,0.3160493827160494,0.7136703686040827,1.0,5/11,19.40%,SLC9A2;SLC9B2;SLC9A9;SLC9A1;SLC9A6
prerank,RNA methyltransferase activity (GO:0008173),0.4913443852130716,1.1383926911068118,0.3089802130898021,0.7714007012021175,1.0,7/19,22.52%,TRDMT1;MRM2;TRMT5;FBLL1;FTSJ3;METTL4;FBL
prerank,histone acetyltransferase binding (GO:0035035),0.4783352363681533,1.1383042584934944,0.2907692307692308,0.7673493518072834,1.0,5/21,15.06%,EPAS1;STAT1;EGR1;HIF1A;KANSL1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.5442330672904488,1.1339681204996734,0.3276157804459691,0.7755400260878038,1.0,5/11,16.66%,CASP8;CASP2;CASP1;CASP7;PYCARD
prerank,sequence-specific DNA binding (GO:0043565),0.33603169526538657,1.1283648832493538,0.15175879396984926,0.7868714508450108,1.0,77/590,13.59%,PRDM16;EPAS1;SOX13;ERG;IRF6;GATA6;GATA2;MSX1;KLF2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;FOXO1;ELK3;NR1I3;KLF12;HEY1;OLIG2;IRF2;ZNF296;HNF4A;KLF3;KLF6;SOX18;HHEX;FLI1;HEY2;HMBOX1;KLF4;LEF1;MAFK;IRF9;SP4;MAFF;FOXF2;MEF2C;GATA3;BCL6B;RXRG;CHCHD2;NFE2L2;NR1D1;SNAI2;ERF;KLF11;FOXP1;MBD1;KMT2B;JUN;TCF7L1;STN1;EGR1;ARID5A;ZBTB14;TET3;PHOX2A;E2F7;NR4A1;KLF13;SOX10;CHTOP;TLX3;IRF5;ELF2;CBFB;TGIF1;POU3F2;ZNF32;UNCX;TBX20;HIF1A;NFATC1
prerank,hexose transmembrane transporter activity (GO:0015149),0.5250284949887668,1.1259383274412662,0.34098360655737703,0.789317770899402,1.0,1/12,1.22%,SLC2A1
prerank,metal ion binding (GO:0046872),0.3403133598661478,1.1257755864478596,0.1844758064516129,0.7855106841383568,1.0,70/477,12.46%,CDH13;LTBP4;NOTCH4;SYT15;RAPGEF2;ITPR3;PITPNM3;MCTP1;DYSF;PLSCR4;ESYT2;EML1;CLGN;RASGRP2;SNRK;AOAH;CALML4;OXSR1;CDC42BPA;AGRN;CEMIP2;IQGAP1;MAP3K6;ANXA3;SYT7;CDC42BPG;SLC8A1;NUCB2;SPOCK2;PIR;STK38;STK38L;NLK;STIM2;MEX3B;TPD52;ASAH2;APEX1;EFCAB9;THTPA;EXD2;ENDOV;MAST1;SIK2;LRRK2;PPP3CA;HSP90B1;MT2A;MTPAP;CASQ1;PLSCR1;CDH15;CDH3;CRACR2A;FEN1;DSPP;CDH12;DHH;HSPE1;PRNP;CDH2;SPOCK1;TRPM2;XXYLT1;PCP4;TESMIN;GSS;MARK2;CALM3;TPM4
prerank,ankyrin binding (GO:0030506),0.4866589625787545,1.1247060150559125,0.328149300155521,0.7843553569242838,1.0,4/19,7.89%,RHCG;SLC8A1;PLEC;NRCAM
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.4551882038840523,-1.1193426611670516,0.32186732186732187,0.7608727087058458,1.0,5/12,19.40%,SLC9A2;SLC9B2;SLC9A9;SLC9A1;SLC9A6
prerank,glutamate receptor activity (GO:0008066),0.47613560724073245,1.117447190718959,0.34662576687116564,0.8007947583408571,1.0,9/19,22.79%,GRID1;GRIA1;GRIK5;GRIK2;GRM5;GRIK1;GRM7;GRID2;GRIA2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.32819461034771175,-1.1166528138027312,0.2872340425531915,0.759962722996361,1.0,9/38,12.29%,SERPING1;TFPI;ANXA2;SERPINE2;SERPINH1;SERPIND1;SERPINE1;SERPINA2;SERPINF1
prerank,endodeoxyribonuclease activity (GO:0004520),0.4735800007054166,1.1165557954268506,0.3263785394932936,0.7989935254376098,1.0,6/20,14.21%,RBBP8;APEX1;ENDOV;FEN1;ERCC4;EXOG
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.44606349205542956,1.1164284837855236,0.32947976878612717,0.7951796290011572,1.0,2/29,5.33%,ACER2;HYAL2
prerank,glycine binding (GO:0016594),0.5205660711783522,1.1121988703328587,0.33666666666666667,0.8028686724979316,1.0,4/11,20.05%,GRIN2B;GRIN3A;GLRA2;GNMT
prerank,actinin binding (GO:0042805),0.4707030374277577,1.1116860084484899,0.345718901453958,0.8001435938196694,1.0,4/21,4.79%,MAGI1;PROM1;PDLIM5;CSRP2
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.33424153248111965,1.1104300337129083,0.21906693711967545,0.7993909008436652,1.0,93/431,16.73%,MAP4K2;RPS6KA5;RND1;GBP5;ACVRL1;MAP4K3;INSR;ATP1A3;ATP1A1;SNRK;ATL2;RHOB;OXSR1;CDC42BPA;SYN3;GBP4;MAP3K6;MTG2;GCH1;CDC42BPG;KRAS;NRAS;ACVR1;SCG5;ATP7A;RRAS;RAB39A;MAP4K4;STK38;TUBB;STK38L;NLK;GLUD1;ATL1;GBP3;MYH9;PGK1;PXK;TUBB4B;UHMK1;MAST1;P2RX7;AKT3;MFHAS1;SIK2;LRRK2;LMTK2;HSPA1B;ATP5F1A;MTPAP;NVL;TLK1;OAS2;ABCF2;RAB35;CAD;MMAA;EIF2B2;TUBA8;MLKL;DHX9;ARF3;TAP1;RRAGD;RHEBL1;RRAS2;MINK1;RAC1;ABCC6;GBP2;NEK11;GSS;MARK2;BTK;VPS4A;RHOT2;RND2;TUBA1A;RRAD;RHOH;RAN;RHEB;MAP3K20;PANK3;RRM1;ARL8A;ARL5B;PFKM;RAB27B;P2RY1;RIT2;GBP7;ARFIP2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.4766419138810827,1.1100111308939615,0.3541666666666667,0.7963475710771001,1.0,3/18,4.46%,STXBP6;CDC42EP1;PDLIM5
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5367699535432607,1.1019785178422743,0.37954939341421146,0.8145998872204155,1.0,4/10,15.25%,CASP8;CASP2;CASP1;CASP7
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.4442009697036088,1.1018382654297705,0.35179640718562877,0.8107782124157795,1.0,12/27,24.82%,POLR2G;POLR3B;POLR1F;POLR2D;POLR1D;POLR2I;MED21;POLR2C;POLR2B;POLR2J;PRIMPOL;POLR1C
prerank,endopeptidase activator activity (GO:0061133),0.5353461853521924,1.0982757825147713,0.3798319327731092,0.8166168672628331,1.0,4/10,20.86%,APH1A;VSIR;PSMD14;APH1B
prerank,alpha-tubulin binding (GO:0043014),0.4284632684311474,1.0962031427381815,0.3352192362093352,0.8184482127483269,1.0,3/31,3.59%,TRPV4;FYN;TTLL7
prerank,protein homodimerization activity (GO:0042803),0.33187792313450665,1.094818562643102,0.2337011033099298,0.818193382114066,1.0,87/589,12.46%,PECAM1;FBLN5;HIP1;CEACAM1;RASIP1;STK10;PDGFB;TRIM14;FLT4;SYNE1;HIP1R;F11R;TBX1;NOD1;GBP5;B2M;IZUMO1;RBPMS;DAB2IP;CAV2;TGFB2;LRRFIP1;ADRB2;HNF4A;CADM1;SPPL2A;GBP4;HHEX;ACTN4;GCH1;EXT1;BLOC1S6;DEFA6;ACVR1;SLK;SSBP1;CAMK2D;TRIM6;KARS1;TPD52;IRAK2;GBP3;MYH9;WARS1;TOX3;EXD2;ZBTB16;LRRK2;TMEM192;ELAVL1;STAT1;HSPB1;MTPAP;CEBPA;PTPRO;HOOK1;BCL2L1;FLRT3;ZHX3;TENM3;ACOX1;TPD52L1;MIGA1;MMAA;NECTIN1;TCF3;ADAM10;MAP3K11;TYR;TAP1;TYROBP;CLCN1;CCDC88A;ABCG4;TENM4;NPM1;HIF1AN;GBP2;INPP5F;GSS;ACHE;RBM11;TRIM8;SOX6;FBXO4;HMGCS1;TPM4
prerank,GTPase binding (GO:0051020),0.3373835904945206,1.0937829277061515,0.3042071197411003,0.816998393810424,1.0,42/194,15.77%,FGD5;UNC13B;RASIP1;RABGAP1;ARHGEF2;CAV1;IQGAP1;TBC1D30;EHD1;SGSM1;RAPGEF4;RAB34;RAPGEF6;PKN1;FGD6;FNBP1L;SIKE1;SH3BP4;WHAMM;RAB3GAP2;LRRK2;RANGAP1;MYO1C;NCKAP1;RRAGD;CYFIP1;STRN3;EXOC8;RANBP2;RANBP1;RANBP9;OCRL;USP6NL;GNB2;RHOH;RAB11FIP4;BNIP3;LCP1;YBX1;PAK2;AP3M1;PEX5L
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.4700328599817579,-1.0907861638785838,0.3508771929824561,0.8268708070878359,1.0,4/10,8.86%,SLCO2B1;SLCO3A1;SLC22A6;SLCO2A1
prerank,symporter activity (GO:0015293),-0.46406828594740474,-1.0896812650257557,0.343980343980344,0.8211504547717265,1.0,10/10,53.63%,SLC5A5;MFSD2A;SLC4A4;SLC46A2;SLC28A2;SLC5A6;SLC28A3;SLC5A8;SLC28A1;SLC5A12
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.35848470574318425,-1.0885722967006732,0.32456140350877194,0.815688739279923,1.0,4/26,4.38%,PTN;PPP1R1A;SET;BOD1L1
prerank,1-phosphatidylinositol binding (GO:0005545),0.4899870160687233,1.0884456964695253,0.3626373626373626,0.8278726304025563,1.0,5/15,17.41%,EPB41;SNX10;ZFYVE9;ZFYVE16;SCARB1
prerank,adenylyltransferase activity (GO:0070566),0.4573238863324663,1.087663368894725,0.37169517884914466,0.825941373194498,1.0,6/21,8.15%,GPHN;KARS1;SELENOO;MTPAP;TENT4A;OAS2
prerank,tumor necrosis factor receptor binding (GO:0005164),0.5123186235265015,1.0853026501873466,0.3560732113144759,0.8286292937248612,1.0,3/12,9.57%,TRAF1;STAT1;BABAM2
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.38222350452793696,-1.0831861429711287,0.3435754189944134,0.8227209429752089,1.0,5/20,9.81%,LPGAT1;MOGAT3;AGPAT4;LPCAT2;DGAT1
prerank,metalloexopeptidase activity (GO:0008235),-0.3013545202464033,-1.0823285316537483,0.3333333333333333,0.816262381720746,1.0,14/51,13.36%,AEBP1;CPQ;MMP14;ANPEP;CPE;AGBL3;METAP1D;CPXM2;MMP16;CPXM1;ZMPSTE24;ENPEP;METAP1;RNPEP
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3224161228390125,1.0810690525239655,0.22422422422422422,0.8364072117242468,1.0,82/831,9.64%,PRDM16;MECOM;EPAS1;SOX17;SOX13;KLF8;ERG;IRF6;GATA6;GATA2;TAL2;MSX1;DACH1;EBF1;KLF2;CASZ1;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;ZFP69;EGR3;FOXO1;ELK3;NR1I3;KLF12;HEY1;TAL1;OLIG2;KLF7;IRF2;ZNF296;ZNF235;LRRFIP1;HNF1A;HNF4A;KLF3;KLF6;SOX18;HHEX;ACTN4;TEAD4;HEY2;KLF4;SIM2;LEF1;MAFK;IRF9;ZBTB46;SP4;MAFF;FOXF2;MEF2C;SMAD2;ZBTB48;FOSL2;GATA3;BCL6B;RXRG;ZBTB16;GTF2IRD1;STAT1;PURA;EBF3;RBL1;CEBPA;NLRC5;NFE2L2;NR1D1;SNAI2;KLF11;ZBTB40;FOXP1;JUN;TCF7L1;TCF3;EGR1;ZNF182;DHX9
prerank,exoribonuclease activity (GO:0004532),0.51157319175299,1.0796478832786296,0.3814935064935065,0.8361484762106685,1.0,6/12,22.44%,ZC3H12A;EXOSC3;EXOSC8;EXOSC9;EXOSC10;EXOSC1
prerank,triglyceride lipase activity (GO:0004806),0.4614238003096831,1.077214115386423,0.3942161339421613,0.8387806345778642,1.0,2/20,5.21%,PNLIP;LCAT
prerank,receptor tyrosine kinase binding (GO:0030971),0.3910254717302117,1.076549221664382,0.3796178343949045,0.8365729415633228,1.0,15/56,17.42%,PITPNM3;PTPN14;CBL;ANGPT1;HYAL2;DUSP3;STAP1;PTPN1;TOB1;GRB14;RACK1;NCK1;ELMO2;SOCS5;PTPN2
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.44193818870634044,-1.0758306250351646,0.3771712158808933,0.8263718743139022,1.0,5/12,7.81%,IGF1;SHC1;IRS1;PIK3R1;IGF2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3210108561640284,1.074367843696038,0.2605210420841683,0.8384931837521109,1.0,76/731,9.99%,PRDM16;MECOM;SOX17;SOX13;KLF8;ERG;IRF6;GATA6;GATA2;TAL2;DACH1;EBF1;KLF2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;FOXO1;ELK3;NR1I3;KLF12;HEY1;TAL1;OLIG2;KLF7;IRF2;ZNF296;ZNF235;LRRFIP1;HNF1A;HNF4A;KLF3;KLF6;SOX18;HHEX;TEAD4;HEY2;KLF4;LEF1;MAFK;IRF9;SP4;MAFF;FOXF2;MEF2C;SMAD2;ZBTB48;FOSL2;GATA3;BCL6B;RXRG;TRIM24;ZBTB16;GTF2IRD1;STAT1;EBF3;CEBPA;NLRC5;NFE2L2;NR1D1;SNAI2;KLF11;ZBTB40;FOXP1;JUN;TCF7L1;TCF3;EGR1;ZNF182;DHX9;PLAG1;ZBTB14
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.422007913635816,1.073786294672293,0.3818443804034582,0.8361671742700181,1.0,8/28,18.53%,DAB2IP;TRAF1;MADD;STAT1;BABAM2;CASP8AP2;SIVA1;BID
prerank,phosphatidylcholine transporter activity (GO:0008525),0.4669356180996208,1.0733836400554468,0.3806646525679758,0.8333070904304083,1.0,6/17,15.39%,ATP10A;PLTP;ABCB4;PITPNA;ATP8B1;ABCA7
prerank,sterol binding (GO:0032934),-0.29568332884134046,-1.0727969282111698,0.31336405529953915,0.8267376852515046,1.0,18/56,17.12%,APOD;SIDT1;ABCA1;GRAMD1C;RORA;OSBPL8;SCP2;PTCH1;OSBP2;ERLIN1;INSIG2;CD81;GRAMD1A;OSBPL7;OSBPL11;NR1H3;SCAP;GRAMD1B
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.4419097385708761,-1.072353209337183,0.3553299492385787,0.8197494522419733,1.0,3/12,2.89%,PDE7B;PDE3A;PDE8B
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.32016484628491876,1.071572603673967,0.27354709418837675,0.8344337812705089,1.0,75/732,9.99%,PRDM16;MECOM;SOX17;SOX13;KLF8;ERG;IRF6;GATA6;GATA2;TAL2;DACH1;EBF1;KLF2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;FOXO1;ELK3;NR1I3;KLF12;HEY1;TAL1;OLIG2;KLF7;IRF2;ZNF296;ZNF235;LRRFIP1;HNF1A;HNF4A;KLF3;KLF6;SOX18;HHEX;TEAD4;HEY2;KLF4;LEF1;MAFK;IRF9;SP4;MAFF;FOXF2;MEF2C;SMAD2;ZBTB48;FOSL2;GATA3;BCL6B;RXRG;ZBTB16;GTF2IRD1;STAT1;EBF3;CEBPA;NLRC5;NFE2L2;NR1D1;SNAI2;KLF11;ZBTB40;FOXP1;JUN;TCF7L1;TCF3;EGR1;ZNF182;DHX9;PLAG1;ZBTB14
prerank,phosphatase binding (GO:0019902),0.35402312724097534,1.0710602799260003,0.36964078794901506,0.831928544272233,1.0,12/105,7.44%,KCNN4;CEACAM1;FLT4;ITGA1;FBXL2;IQGAP1;SH3YL1;CHCHD3;SMAD2;MAPK1;SHOC2;HSP90B1
prerank,rRNA binding (GO:0019843),0.4029581333592702,1.0691103776028603,0.36792452830188677,0.8332999896230312,1.0,22/42,29.74%,TST;MRPL18;NGRN;RPS14;DDX28;RPS9;CAVIN1;RPS5;DDX21;FASTKD5;ANG;MRPL11;NOP53;MRPS27;RPF2;MRPS18C;ERI1;RPS13;RPL11;ERAL1;MRPS18A;FASTKD2
prerank,MHC protein binding (GO:0042287),0.4591702414087937,1.0685080408427705,0.37871674491392804,0.8309382807189585,1.0,5/20,13.20%,TUBB;TUBB4B;ATP5F1A;TAP1;TAPBP
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.4166641876151226,1.06618700180568,0.3810930576070901,0.8330503331991735,1.0,2/32,6.04%,SLC6A6;SFXN1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.4050375598390298,-1.0651595762490245,0.37967914438502676,0.8320972072823076,1.0,8/15,25.05%,KMT2C;ASH2L;SETD1A;SETD1B;WDR5;SETD4;KMT2D;SETMAR
prerank,small GTPase binding (GO:0031267),0.33204178751607355,1.064498491283593,0.3743139407244786,0.8337520914541015,1.0,29/169,11.65%,FGD5;UNC13B;RABGAP1;ARHGEF2;CAV1;IQGAP1;TBC1D30;EHD1;SGSM1;RAPGEF4;RAB34;RAPGEF6;PKN1;FGD6;SIKE1;SH3BP4;WHAMM;RAB3GAP2;LRRK2;RANGAP1;MYO1C;NCKAP1;CYFIP1;STRN3;EXOC8;RANBP2;RANBP1;RANBP9;OCRL
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3916131368219668,1.0642156924928343,0.3704188481675393,0.8307199393586828,1.0,6/46,4.59%,GCNT1;MFNG;POMGNT1;EXT1;MGAT5;GCNT2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.4111004960112876,-1.0604943804917357,0.3675675675675676,0.8368932560388279,1.0,9/14,28.04%,ALDH4A1;MTHFD1;BLVRB;MTHFR;PYCR2;ALDH1L1;ALDH1L2;DHFR;PYCR3
prerank,tau protein binding (GO:0048156),0.40154922015493305,1.0604730948495653,0.38095238095238093,0.8371714308189202,1.0,18/40,21.11%,FYN;TTBK2;SMAD2;PRKAA1;ROCK1;TAOK2;MARK3;ACTB;CLU;MARK2;TTBK1;PIN1;PPP2CB;MAP2;GSK3A;DYRK1A;GSK3B;MARK4
prerank,mannosyltransferase activity (GO:0000030),-0.36824471498178746,-1.0592191297376847,0.3816568047337278,0.8322806326869251,1.0,7/21,20.25%,TMTC4;TMTC1;PIGB;POMT1;ALG8;ALG9;PIGZ
prerank,metal ion transmembrane transporter activity (GO:0046873),0.42045945204235446,1.0589628870678254,0.40263543191800877,0.8375174374675424,1.0,2/27,1.78%,ATP2A3;ATP2B4
prerank,NAD binding (GO:0051287),-0.35783322457291694,-1.0589573104340475,0.3566666666666667,0.8249556707016656,1.0,6/26,14.40%,ALDH1A1;ME1;SIRT3;BDH2;HPGD;SIRT2
prerank,lysine N-methyltransferase activity (GO:0016278),-0.37865957575802267,-1.0565589832859927,0.35543766578249336,0.8236608245286439,1.0,13/20,35.02%,EHMT1;SETD7;METTL21A;EEF1AKMT1;SETD4;EEF1AKMT2;ANTKMT;KMT5A;ATPSCKMT;ETFBKMT;EEF1AKMT3;EHMT2;METTL21C
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.36262990043804727,-1.0557039090883025,0.3785488958990536,0.8179845821824259,1.0,3/24,5.83%,DAPK1;CAMK1D;CAMK1
prerank,Tat protein binding (GO:0030957),0.5183737554466368,1.052802616877384,0.4338358458961474,0.8504375132297943,1.0,5/10,23.33%,GABARAPL1;ACTB;NPM1;DNAJA1;DLL1
prerank,C-C chemokine binding (GO:0019957),0.4290935574959367,1.0520905070011368,0.4009077155824508,0.848481652518958,1.0,3/22,14.74%,CCR1;CX3CR1;CXCR4
prerank,metal ion:proton antiporter activity (GO:0051139),-0.4262092774838858,-1.0500931451958633,0.38181818181818183,0.8260700121654095,1.0,5/13,19.40%,SLC9A2;SLC9B2;SLC9A9;SLC9A1;SLC9A6
prerank,kinase activity (GO:0016301),0.3431408986564227,1.0494713841929064,0.3995433789954338,0.8514377780213136,1.0,28/109,17.90%,ITPKB;IP6K3;PRKD1;PIK3C2A;IPPK;IDNK;PGM2L1;MAP4K4;PGK1;LRRK2;RFK;STK39;DGKH;PIK3C3;NMRK1;PIK3CB;PAPSS1;PANK3;AGK;DGKI;CKMT1A;TRRAP;PKN2;GK5;DOLK;TRIB3;CERKL;PIK3C2B
prerank,microtubule minus-end binding (GO:0051011),0.49156073441800335,1.0488617997908054,0.4218487394957983,0.8492089474399135,1.0,3/13,11.08%,MACF1;CAMSAP2;NUMA1
prerank,outward rectifier potassium channel activity (GO:0015271),0.48962201122101745,1.0484605574862023,0.4225589225589226,0.8465531868585316,1.0,1/11,0.28%,KCNQ1
prerank,histone demethylase activity (GO:0032452),-0.3393081938100465,-1.0475778152360338,0.3745928338762215,0.8257036107150542,1.0,10/27,20.14%,KDM7A;JARID2;JMJD1C;JMJD6;FBXL19;KDM4A;KDM6B;RIOX2;KDM8;PHF8
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.4059228330241407,1.047020109026738,0.40110650069156295,0.8464772723528519,1.0,11/34,22.04%,REXO2;EXD2;EXOSC3;CNOT6L;CNOT1;XRN2;ANGEL2;CNOT2;EXOSC9;EXOSC10;DIS3L2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.42042010658502926,1.0466912167736788,0.3958333333333333,0.8435619613809987,1.0,12/27,24.82%,POLR2G;POLR3B;POLR1F;POLR2D;POLR1D;POLR2I;TENT2;MED21;POLR2C;POLR2B;POLR2J;POLR1C
prerank,endopeptidase activity (GO:0004175),-0.2301607651614484,-1.045464031099321,0.29411764705882354,0.823683998789652,1.0,59/257,19.12%,TRABD2B;ADAMTS2;ADAMTS12;ADAMTSL3;THSD4;ADAMTSL5;BACE2;MMP14;HTRA3;ADAMTS17;RHBDL3;ADAMTS5;ADAMTS10;DPP4;USP33;USP20;BACE1;ADAMTS3;FAP;ADAM19;USP9X;ADAM9;USP13;USP11;ADAMTS15;ADAMTS9;F3;MMP2;ADAM33;USP1;CASP3;PSMB3;ADAMTSL4;MMP16;KLK2;ZMPSTE24;MMP19;UCHL1;SENP1;ADAMTS14;PCSK7;PSMA3;PSMB4;USP8;CTSC;ADAMTS16;MMP11;PSMB7;USP34;MBTPS1;CTSL;CASP4;MASP1;RHBDF1;HTRA4;ACE2;HTRA2;ADAMTS19;KDM8
prerank,miRNA binding (GO:0035198),0.41181019800201596,1.0449967010114196,0.41217150760719223,0.8442824898658449,1.0,9/30,17.51%,PUM2;ZC3H12A;ELAVL1;ZNF346;ZC3H7A;AGO4;DDX21;YBX1;TUT7
prerank,single-stranded RNA binding (GO:0003727),0.39338521755264866,1.040782380609815,0.4013793103448276,0.8517545084823471,1.0,9/43,13.08%,IFIH1;RBM7;ENDOV;POLR2G;DHX9;POLR2D;AGO4;RBM11;FXR1
prerank,RNA polymerase II complex binding (GO:0000993),-0.3318416755216981,-1.0379199581138618,0.3927392739273927,0.8368056690941875,1.0,12/32,16.43%,SCAF8;PAF1;ERCC5;PCIF1;CTR9;URI1;UVSSA;RTRAF;GTF2B;HNRNPU;PCF11;WAC
prerank,titin binding (GO:0031432),0.47797017884797666,1.0372662802023833,0.40879478827361565,0.8574853616017369,1.0,3/13,12.45%,MYBPC3;CAMK2D;CALM3
prerank,phosphate ion binding (GO:0042301),0.49973396830914585,1.0367883670749762,0.42560553633217996,0.8549398444552448,1.0,5/10,25.16%,CHST14;RELA;ADSS2;MTHFD2;RPH3A
prerank,iron ion binding (GO:0005506),-0.29688197736846156,-1.0365023908438311,0.3789954337899543,0.8328698814350262,1.0,13/48,14.64%,AGMO;KDM7A;NFU1;EGLN3;FTO;TET2;JMJD6;AOX1;FDX1;TET1;ETHE1;FXN;SCD
prerank,transition metal ion binding (GO:0046914),0.3129493361172764,1.0363633792497984,0.4061224489795918,0.8523612354857699,1.0,60/397,12.28%,NOS1;MYRIP;NOS3;ACE;CRIP2;GDA;ARHGEF2;POMGNT1;DUSP12;MSRB3;KLF7;IFIH1;ATOX1;GCH1;MGAT5;KLF4;FBXL5;ATP7A;LANCL1;TNFSF10;SHANK3;RNF125;SMPDL3A;ARG1;ASAH2;ARIH1;IL1A;PCK2;PGGT1B;TRIM24;CLIP1;EXD2;KDM3A;KPNB1;MT2A;MTPAP;PLSCR1;GRIN2B;CAD;FEN1;MBD1;KMT2B;DHH;EGR1;TYR;ADPRM;PRNP;PTPN1;TET3;TAB2;TNKS;MGAT1;ALKBH8;HIF1AN;XXYLT1;ISCA2;SAP30L;GALNT4;TRIM8;SUV39H2
prerank,DNA binding (GO:0003677),0.30995256887843503,1.0361558393794306,0.38716148445336007,0.8492127771430473,1.0,99/694,13.78%,PRDM16;MECOM;EPAS1;SOX13;ERG;IRF6;TAL2;KLF2;SMARCA2;TBX1;NR4A2;FOXO4;FOXO1;KLF12;AIM2;IRF2;LRRFIP1;HNF1A;HNF4A;ARID3B;APP;HHEX;FLI1;RBBP8;HEY2;HMBOX1;ING2;SIM2;LEF1;BCLAF3;SYCP2;MAFK;SSBP1;SP4;MAFF;FOXF2;SMAD2;RPL7;APEX1;GATA3;RTF1;CHCHD2;CHRAC1;SETX;ENDOV;RYBP;ZBTB16;ZC3H12A;STAT1;PURA;CEBPA;NFE2L2;POLR2G;TIGD3;SNAI2;FEN1;ERF;POGK;MBD1;JUN;TCF7L1;TCF3;STN1;EGR1;HMGB1;MLF1;DHX9;TIGD2;HP1BP3;ARID5A;ZBTB14;POLR2D;BRIP1;APLP2;NUP35;POLA1;POLG2;PCBP1;BRCA1;NR4A1;SMARCAD1;SAP30L;ILF2;MTERF2;ARID5B;SOX10;HINFP;SOX6;IRF5;XRN1;CBFB;GLYR1;POU3F2;GTF2A1;CR2;HIF1A;RAD1;ERCC4;RAD51D
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.38006100708429336,-1.0360531967543516,0.3967391304347826,0.8266551384553188,1.0,4/20,5.81%,SLC39A14;SLC30A10;SLC39A8;SLC39A13
prerank,hydro-lyase activity (GO:0016836),-0.31456072017868253,-1.035919581857154,0.4251968503937008,0.8195013294909124,1.0,16/41,29.83%,GMDS;HACD1;CA2;ACO1;ENO2;ECHDC3;EHHADH;ECHDC2;ENO3;ACO2;FAHD2A;ALAD;ECHS1;CA4;HACD3;L3HYPDH
prerank,tau-protein kinase activity (GO:0050321),0.4370732687618681,1.0356430043006988,0.42857142857142855,0.8468958742547384,1.0,12/20,21.11%,FYN;TTBK2;PRKAA1;ROCK1;TAOK2;MARK3;MARK2;TTBK1;GSK3A;DYRK1A;GSK3B;MARK4
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.36922243874383864,1.0356216383280314,0.41035353535353536,0.8433240307216828,1.0,9/60,7.26%,TEK;FLT1;TIE1;FLT4;MERTK;INSR;FGFR3;ALK;LMTK2
prerank,adenyl ribonucleotide binding (GO:0032559),0.3187179152119075,1.0351002065028354,0.4122533748701973,0.841123081084333,1.0,51/291,12.82%,RAPGEF2;MAP4K2;RPS6KA5;ACVRL1;MAP4K3;INSR;ATP1A3;ATP1A1;SNRK;OXSR1;CDC42BPA;SYN3;MAP3K6;CDC42BPG;ACVR1;ATP7A;RAPGEF4;MAP4K4;STK38;STK38L;NLK;GLUD1;MYH9;PGK1;PXK;UHMK1;MAST1;P2RX7;AKT3;SIK2;LMTK2;HSPA1B;ATP5F1A;MTPAP;NVL;TLK1;OAS2;ABCF2;CAD;EIF2B2;MLKL;DHX9;TAP1;ACSS2;MINK1;ABCC6;NEK11;GSS;MARK2;BTK;VPS4A
prerank,lysine-acetylated histone binding (GO:0070577),-0.37617674491276076,-1.0350200451431575,0.4011299435028249,0.8073966084433443,1.0,8/20,19.99%,PSME4;BRDT;TAF1;ZMYND8;BRD3;BRD9;BRD2;BRD7
prerank,acetylation-dependent protein binding (GO:0140033),-0.37617674491276076,-1.0350200451431575,0.4011299435028249,0.8073966084433443,1.0,8/20,19.99%,PSME4;BRDT;TAF1;ZMYND8;BRD3;BRD9;BRD2;BRD7
prerank,cytokine activity (GO:0005125),-0.24664101417245027,-1.0332580149948671,0.3917525773195876,0.8050162180289212,1.0,14/131,9.67%,BMP6;IL34;WNT4;BMP5;BMP7;BMP4;WNT6;WNT5A;TNFRSF11B;FGF2;CXCL16;WNT9A;VEGFA;IL17D
prerank,ATP binding (GO:0005524),0.31764878603371655,1.0292508890870504,0.40461215932914046,0.8524870548679805,1.0,47/266,12.82%,MAP4K2;RPS6KA5;ACVRL1;MAP4K3;INSR;ATP1A3;ATP1A1;SNRK;OXSR1;CDC42BPA;SYN3;MAP3K6;CDC42BPG;ACVR1;ATP7A;MAP4K4;STK38;STK38L;NLK;MYH9;PGK1;PXK;UHMK1;MAST1;P2RX7;AKT3;SIK2;LMTK2;HSPA1B;ATP5F1A;MTPAP;NVL;TLK1;OAS2;ABCF2;CAD;EIF2B2;MLKL;DHX9;TAP1;MINK1;ABCC6;NEK11;GSS;MARK2;BTK;VPS4A
prerank,frizzled binding (GO:0005109),-0.313562601516594,-1.028957995861033,0.376271186440678,0.8092393919262406,1.0,7/34,10.20%,WNT4;RNF43;WNT6;WNT5A;WNT9A;FZD7;SDCBP
prerank,chloride channel regulator activity (GO:0017081),0.4639919977272222,1.0282834966226506,0.4403225806451613,0.8513837867309615,1.0,4/14,9.30%,VTI1B;STX7;VAMP8;SGK1
prerank,death domain binding (GO:0070513),0.4889408146733308,1.0267618304141366,0.4293286219081272,0.851613227542479,1.0,6/11,19.51%,DAP;CRADD;IRGM;BCL2L1;RACK1;MCL1
prerank,"DNA binding, bending (GO:0008301)",0.45899176838968786,1.0251412164648885,0.4376012965964344,0.8520501164378468,1.0,5/14,14.54%,HHEX;LEF1;HMGB1;SAP30L;HMGB2
prerank,mechanosensitive ion channel activity (GO:0008381),0.46883429503564533,1.024214490974744,0.42549668874172186,0.8509175544377979,1.0,2/12,7.93%,PIEZO1;TMC7
prerank,5'-3' exonuclease activity (GO:0008409),0.46443103381104506,1.0235481187158155,0.4621710526315789,0.8492041060092356,1.0,7/14,20.19%,TRIR;FEN1;XRN2;XRN1;EXOG;DXO;CPSF3
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.4624175393907807,1.0221188425363774,0.44716692189892804,0.8492766105883947,1.0,3/15,7.29%,PIK3R6;CISH;SOCS6
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.3999602895899841,-1.0201645298287676,0.4246575342465753,0.8263012762162827,1.0,4/14,10.74%,USP9X;USP13;MINDY3;OTUD7B
prerank,double-stranded DNA binding (GO:0003690),0.30431315814796,1.0201620266892126,0.43259557344064387,0.8506970599152803,1.0,70/531,13.59%,ERG;IRF6;GATA6;GATA2;MSX1;KLF2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;ELK3;NR1I3;KLF12;HEY1;AIM2;OLIG2;IRF2;ZNF296;HNF4A;KLF3;KLF6;SOX18;FLI1;RBBP8;HEY2;HMBOX1;KLF4;LEF1;IRF9;MAFF;MEF2C;SMAD2;ZBTB48;APEX1;GATA3;BCL6B;RXRG;STAT1;PURA;NR1D1;SNAI2;FEN1;KLF11;FOXP1;MBD1;JUN;TCF7L1;EGR1;HMGB1;DHX9;ZBTB14;POLG2;PHOX2A;E2F7;NR4A1;KLF13;SOX10;TLX3;IRF5;ELF2;TGIF1;POU3F2;ZNF32;UNCX;TBX20;NFATC1
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.4153863481844654,-1.0192615496542274,0.43351063829787234,0.821484691239401,1.0,3/12,5.36%,BACE2;BACE1;HM13
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.378285675526457,1.0166808518067005,0.4456094364351245,0.8559619010116559,1.0,14/40,22.52%,PCMTD1;COMTD1;PCMT1;METTL2B;METTL2A;SETD3;FBLL1;GAMT;METTL18;ARMT1;METTL4;GNMT;LCMT1;FBL
prerank,androgen receptor binding (GO:0050681),-0.33205743476922944,-1.0160823066297777,0.4208860759493671,0.8229402104002698,1.0,4/25,5.22%,DDX5;PRKCB;SNW1;NSD1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.3936574793117648,1.0126841805308093,0.44923504867872044,0.8625851493855109,1.0,7/33,12.67%,REXO2;EXD2;EXOSC3;CNOT6L;XRN2;ANGEL2;XRN1
prerank,phosphatidylglycerol binding (GO:1901611),0.4680111792149815,1.0115768199234352,0.4683954619124797,0.8620475054090981,1.0,3/13,8.62%,PLTP;UQCC3;PITPNA
prerank,calcium-release channel activity (GO:0015278),0.447035662053705,1.0109278775814032,0.4631083202511774,0.8601876161068505,1.0,4/17,11.28%,ITPR3;MCOLN1;TPCN2;TRPM2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.3800277514303677,-1.0107211382056671,0.4411764705882353,0.8304832165356929,1.0,6/16,22.93%,SLC26A7;SLC26A2;SLC26A6;SLC4A8;CFTR;CLCN6
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4135008791014076,1.0100758631996816,0.4559505409582689,0.8590192326855985,1.0,3/24,7.42%,ITPKB;IP6K3;CMPK1
prerank,voltage-gated potassium channel activity (GO:0005249),0.3437935703358139,1.0085620382858078,0.45554202192448234,0.8594086421692858,1.0,5/80,3.68%,KCNQ1;KCNE3;KCNH8;KCNN3;KCNG3
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.3921741199377696,-1.007989458682581,0.3902439024390244,0.8313577611375559,1.0,2/14,2.86%,SLC26A7;SLC26A2
prerank,snRNA binding (GO:0017069),-0.2887567527214407,-1.0032584133089397,0.4700854700854701,0.8373427725067756,1.0,15/42,25.89%,SNRNP70;PRPF8;COIL;GEMIN5;PRPF31;SNRPA1;TUT1;SNRPA;HNRNPU;SNRPD3;LSM11;TOE1;NCBP2;LSM10;LARP7
prerank,syntaxin binding (GO:0019905),0.3539543231729583,1.0029568809904112,0.44696969696969696,0.8698444188662552,1.0,19/61,18.29%,UNC13B;RAB11A;CACNA1A;BLOC1S6;STX7;TMED10;LRRK2;VAMP8;TMED9;SYPL1;STXBP3;NSF;CPLX1;SNPH;STXBP5L;STXBP5;PTPN2;SYT1;SYT2
prerank,kinesin binding (GO:0019894),0.4042026353202126,1.002603927161177,0.4394366197183099,0.8671818873747975,1.0,8/27,16.27%,TTBK2;SPAG9;NEFH;ACTB;KLC2;PRC1;ARHGEF10;PLEKHM2
prerank,nuclear export signal receptor activity (GO:0005049),0.470656450134328,1.001677668877113,0.4741235392320534,0.8661405054205051,1.0,4/11,14.41%,XPO6;XPO1;RAN;NUP42
prerank,transcription coactivator binding (GO:0001223),-0.3490939898345271,-1.000712676665217,0.4503105590062112,0.83714740176344,1.0,5/20,17.12%,RORA;THRB;SMAD3;TERT;AR
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.3776709642304771,0.9993360698219493,0.4600280504908836,0.8685814816889383,1.0,7/37,10.20%,GARS1;VARS1;VARS2;KARS1;FARSB;WARS1;FARS2
prerank,cyclic nucleotide binding (GO:0030551),0.4174466245658184,0.9979592737314762,0.4766081871345029,0.8687014032550006,1.0,5/21,17.25%,RAPGEF2;RAPGEF4;POPDC3;PDE4D;KCNH1
prerank,MHC class II protein complex binding (GO:0023026),-0.4059702095507467,-0.9978078423772706,0.4430051813471503,0.837903710302606,1.0,3/11,17.89%,CD81;ATP1B1;CD74
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.44631297731681985,0.9962566212438608,0.48055987558320373,0.8694474099430096,1.0,7/16,26.64%,MTMR10;MTMR11;INPP5F;SYNJ1;MTMR14;MTMR2;MTMR9
prerank,ion channel activity (GO:0005216),0.33548198246041466,0.9959118724696476,0.4605911330049261,0.8669497617446861,1.0,13/80,11.28%,TRPV4;PIEZO1;MCUB;GRID1;GRIA1;MCOLN1;TMC7;GRIN2B;GRIN2C;GRIK5;GRIK2;GRIN3A;TRPM2
prerank,omega peptidase activity (GO:0008242),-0.25606309287878354,-0.995601971380386,0.45962732919254656,0.8367915421676326,1.0,28/89,21.75%,USP33;USP20;ASRGL1;USP9X;USP13;USP11;USP50;USP1;USP3;MINDY3;OTUD6B;GGT5;OTUD7B;USP22;UCHL1;CYLD;USP8;ZRANB1;STAMBPL1;GGT7;OTUD1;USP34;VCPIP1;JOSD2;USP2;TNFAIP3;USP46;USP31
prerank,phospholipase activator activity (GO:0016004),-0.4267938357134631,-0.9951981515673942,0.4738095238095238,0.8312239282861453,1.0,3/10,6.78%,ARHGAP6;STX4;SRC
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.3186274444382567,-0.9949061060392961,0.46283783783783783,0.8253192669256347,1.0,13/33,17.12%,SCAF8;PAF1;ERCC5;CTR9;LLPH;URI1;UVSSA;RTRAF;GTF2B;HNRNPU;PCF11;WAC;AR
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.4520360141517152,0.9937708456455695,0.48522550544323484,0.868963944560698,1.0,6/14,26.64%,MTMR10;MTMR11;SYNJ1;MTMR14;MTMR2;MTMR9
prerank,pentosyltransferase activity (GO:0016763),-0.29902502049592083,-0.9936482228917564,0.45017182130584193,0.8223048572988441,1.0,13/36,24.63%,LARGE1;PARP8;LACC1;SIRT3;ART3;PNP;SIRT2;QPRT;PARP3;PARP1;PARP6;PPAT;PARP2
prerank,adrenergic receptor binding (GO:0031690),0.4402821369631642,0.9927490886906971,0.49770992366412214,0.8680235827883145,1.0,2/16,5.17%,RAPGEF2;AKAP5
prerank,water transmembrane transporter activity (GO:0005372),0.4715758551080381,0.9893983028767712,0.4678260869565217,0.8729416815662377,1.0,1/11,2.23%,AQP11
prerank,translation initiation factor activity (GO:0003743),0.37702840868051013,0.9892692983774929,0.46534653465346537,0.8699070067245909,1.0,13/36,17.84%,EIF3B;EIF2B2;EIF1;EIF3K;EIF3I;EIF3F;EIF3G;EIF3A;EIF2S1;EIF2A;EIF3H;COPS5;EIF3M
prerank,chloride channel inhibitor activity (GO:0019869),0.4798352039971965,0.9877004303005472,0.49575551782682514,0.8702591156105006,1.0,3/10,7.40%,VTI1B;STX7;VAMP8
prerank,phospholipase binding (GO:0043274),-0.3967364147027901,-0.9874352501497737,0.4659400544959128,0.8322620963409678,1.0,3/13,6.78%,ARHGAP6;PRKN;SRC
prerank,kinase activator activity (GO:0019209),-0.31735911997914784,-0.9837476004092741,0.47435897435897434,0.8354164994140773,1.0,3/30,5.62%,PRKAG2;WNK1;GPRC5C
prerank,phosphatidylinositol kinase activity (GO:0052742),0.43809073747766725,0.9831219713955821,0.4728171334431631,0.8776652783323942,1.0,7/15,22.76%,PIK3C2A;PIK3C3;PIK3CB;ATM;PIK3C2B;PIK3R3;PIK3CA
prerank,acid-thiol ligase activity (GO:0016878),0.44755825420430306,0.9812361956107863,0.5065573770491804,0.8787757090611767,1.0,4/13,14.78%,ACSM3;ACSS2;AACS;SLC27A2
prerank,metalloaminopeptidase activity (GO:0070006),-0.37098457172125887,-0.9798815123513104,0.5026041666666666,0.8392661884928543,1.0,5/16,13.36%,MMP14;ANPEP;MMP16;ENPEP;RNPEP
prerank,GABA receptor activity (GO:0016917),0.40845182767822474,0.9793787009375636,0.4807987711213518,0.8799780049399115,1.0,7/21,21.41%,GABRQ;GABRA4;GABRA2;GABRE;GABRG3;GABRB1;GABRB3
prerank,syntaxin-1 binding (GO:0017075),0.4092263267923611,0.9790522879631811,0.49025487256371814,0.8773738703801376,1.0,9/22,18.19%,UNC13B;LRRK2;SYPL1;STXBP3;NSF;CPLX1;SNPH;STXBP5;SYT1
prerank,TBP-class protein binding (GO:0017025),0.4197700800871912,0.9780852522189252,0.47751937984496123,0.8763306088812056,1.0,9/21,17.58%,HHEX;BRF2;GTF2A1;PSMC1;TAF1B;PSMC5;TAF11;ESR1;DRAP1
prerank,regulatory RNA binding (GO:0061980),0.3711522795840455,0.9777480916655046,0.49407114624505927,0.8739581226558987,1.0,10/38,17.51%,PUM2;ZC3H12A;ELAVL1;ZNF346;ZC3H7A;DHX9;AGO4;DDX21;YBX1;TUT7
prerank,RNA polymerase binding (GO:0070063),0.42534491679075354,0.9769887950183018,0.5040783034257749,0.8725073064322872,1.0,6/18,15.68%,STOM;TCERG1L;DHX9;BRCA1;ANP32B;PKN2
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.3475150998109543,-0.9758633945023575,0.4689265536723164,0.8436347763656137,1.0,3/21,5.87%,FGF1;FGF2;KL
prerank,ATPase regulator activity (GO:0060590),-0.301948722987849,-0.9730672835456822,0.4866920152091255,0.844274446737158,1.0,16/38,23.64%,ATP1B3;TOR1AIP1;SIL1;ATP5IF1;FNIP1;DNAJB2;BAG1;BAG3;ATP1B1;TSC1;ATP1B2;GRPEL2;KATNB1;DNAJB4;DNAJC15;BAG2
prerank,ribosomal large subunit binding (GO:0043023),-0.4077891097819367,-0.9727196989390399,0.5035294117647059,0.8390249773907144,1.0,5/11,18.56%,NEMF;MRRF;CPEB2;NMD3;MALSU1
prerank,active ion transmembrane transporter activity (GO:0022853),-0.29797561974164066,-0.9717645514249491,0.5238095238095238,0.8353363000527579,1.0,9/37,12.97%,SLC22A8;SLCO2B1;SLCO3A1;SLC22A6;SLC22A4;SLCO2A1;COX10;COX7A2L;UQCRQ
prerank,tropomyosin binding (GO:0005523),0.4221907209818441,0.9714285021330229,0.48165869218500795,0.8825225888789451,1.0,1/16,0.60%,NEBL
prerank,fatty acid synthase activity (GO:0004312),0.4671082544500748,0.9709621717219792,0.5032051282051282,0.8803351581016705,1.0,4/10,21.90%,ELOVL4;ELOVL7;ELOVL5;OXSM
prerank,DNA secondary structure binding (GO:0000217),0.3808768267607314,0.9695156398493994,0.5021520803443329,0.8803786649855334,1.0,11/31,24.06%,RBBP8;MEF2C;HMGB1;RAD51D;RAD18;HMGB2;XPC;MEN1;BLM;GEN1;WRN
prerank,ligand-gated cation channel activity (GO:0099094),0.32746615386791916,0.9693018748209667,0.501891551071879,0.8776564372755509,1.0,11/75,11.28%,KCNN3;P2RX7;GRIA1;MCOLN1;GRIN2B;GRIN2C;ASIC2;GRIK5;GRIK2;GRIN3A;TRPM2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.44086252424060923,0.9688192272000375,0.4854202401372213,0.8755397607402982,1.0,9/13,31.65%,TRMT5;TRMT10B;TRMT1L;TRMT1;THUMPD2;TRMT10A;TRMT10C;FTSJ1;TRMT11
prerank,potassium:proton antiporter activity (GO:0015386),-0.4209846070375467,-0.9684366371656127,0.4964200477326969,0.8381408834058165,1.0,4/10,19.40%,SLC9A2;SLC9A9;SLC9A1;SLC9A6
prerank,protein heterodimerization activity (GO:0046982),0.3071336589543179,0.968139756833604,0.5442477876106194,0.873943241219575,1.0,36/178,16.40%,EPAS1;HIP1;PDGFB;NR4A2;ATP1A1;RALGAPA1;FBXO7;EXT1;MEF2C;IRAK2;BCL2L1;ZHX3;TENM3;MIGA1;TCF3;RRAGD;ABCG4;TENM4;CYBA;RALGAPB;NR4A1;TPM4;YWHAH;FXR1;GTF2A1;SDCBP2;HIF1A;RALGAPA2;USF2;RAN;ITGA3;FZD9;VAPA;TCOF1;TENM2;TENM1
prerank,retinoic acid receptor binding (GO:0042974),0.42320425858265986,0.9654523482174706,0.5086887835703001,0.8769549714099538,1.0,4/17,10.22%,NR4A2;ACTN4;ARID5A;CNOT1
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.4129744636708652,-0.9633809343927786,0.5314136125654451,0.8447915375761044,1.0,3/10,12.41%,CACNA1C;CACNB1;CACNB2
prerank,transcription corepressor binding (GO:0001222),-0.31581259421041763,-0.9594712725448716,0.50625,0.8486906420931996,1.0,8/27,15.93%,MTF2;RORA;LCOR;USP11;EHMT1;HDAC6;NEK6;PER3
prerank,cholesterol binding (GO:0015485),-0.2738907881179303,-0.9581482371612141,0.5230125523012552,0.8460670364579007,1.0,14/47,17.12%,APOD;SIDT1;ABCA1;GRAMD1C;OSBPL8;SCP2;PTCH1;OSBP2;ERLIN1;CD81;GRAMD1A;OSBPL7;NR1H3;GRAMD1B
prerank,voltage-gated ion channel activity (GO:0005244),0.42891060142665544,0.9575201799816934,0.507223113964687,0.8917124995496738,1.0,6/14,24.24%,ANO6;VDAC1;CACNA1E;VDAC3;HCN1;VDAC2
prerank,nucleotide diphosphatase activity (GO:0004551),-0.3749051467121608,-0.9568615512132617,0.5191815856777494,0.8434584961554331,1.0,3/14,4.91%,NUDT4;FHIT;ENPP1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.34504736329041663,-0.9562269799616063,0.505524861878453,0.8388527011146398,1.0,2/18,0.60%,ALDH1A1;ALDH1A2
prerank,solute:proton symporter activity (GO:0015295),-0.3585658666340086,-0.9551448144445372,0.5084269662921348,0.8357359902383666,1.0,4/16,11.75%,SLC2A13;SLC17A5;SLC39A8;SLC2A10
prerank,methylated histone binding (GO:0035064),-0.25884144333280945,-0.9542338161761231,0.5421052631578948,0.8319822190442736,1.0,20/62,20.27%,TDRD3;KDM7A;PYGO1;MTF2;MORC4;TAF1;ZMYND8;WDR5;NCAPG2;RRP8;MSH6;BPTF;MPHOSPH8;MSL3;KDM4A;TAF7;MORC3;KDM8;PHF8;ATRX
prerank,gated channel activity (GO:0022836),0.42747431308345846,0.9540894974802545,0.5210355987055016,0.8963160679377207,1.0,2/14,7.93%,PIEZO1;TMC7
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2876840226800867,0.9509385299033895,0.6146044624746451,0.9004207812714703,1.0,75/346,19.79%,LMO7;ASB4;TRIM14;RNF103;ZNRF1;TRIM69;CBL;HERC2;FBXO7;UBA7;FBXL14;FBXL5;TRIM11;TRIM6;RNF38;TRAF1;RNF125;RNF185;ARIH1;CUL3;UBE2Q1;UBE2D1;TRIM24;KLHL20;WWP1;UBE3A;RNF128;RNF141;RNF115;RBX1;ZNRF3;SIAH2;CUL2;TRIM25;TRIM47;RNF144B;TRIM17;FBXW2;NEDD4L;OBI1;BRCA1;DTX3L;RSPRY1;FBXO4;SMURF1;KCTD10;UBE2T;RMND5B;UBE2J2;RNF103-CHMP3;FBXO3;FBXO2;UBE2E1;TRIM2;UBE3B;NHLRC1;UBE2D3;IRF2BP1;TRAIP;RNF139;KLHL9;SEL1L;RNF150;FBXO6;FBXO10;MKRN1;XIAP;FBXL6;MALT1;ANAPC4;RNF166;MKRN2;BARD1;MAEA;RNF5
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.39637399118277594,-0.9485386515659958,0.5352798053527981,0.8408126186874558,1.0,2/10,9.62%,DSE;RENBP
prerank,peptidase activator activity (GO:0016504),0.3979316516155775,0.9484212417846345,0.5200617283950617,0.902974095865206,1.0,6/22,11.78%,CAV1;MAL;APH1A;VSIR;PSMD14;CASP8AP2
prerank,leucine zipper domain binding (GO:0043522),-0.4111993233789949,-0.9472181888130379,0.5233415233415234,0.8381486689120067,1.0,1/10,0.42%,PAWR
prerank,3'-5' exonuclease activity (GO:0008408),0.3501784909129055,0.94690045545075,0.5276315789473685,0.9032467439600417,1.0,11/45,17.49%,REXO2;APEX1;EXD2;TRIR;EXOSC3;CNOT6L;XRN2;ANGEL2;RAD1;EXD1;EXOSC9
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.42025175382376734,0.9462355264470609,0.5329052969502408,0.9015946735184689,1.0,4/15,14.60%,HS3ST1;HS3ST6;HS3ST5;NDST4
prerank,vinculin binding (GO:0017166),0.43887365888624924,0.9458041120450091,0.5268630849220104,0.8993632402855032,1.0,3/11,12.53%,UTRN;CTNNA1;SORBS3
prerank,methylation-dependent protein binding (GO:0140034),-0.2610344047660226,-0.942711236987184,0.5670103092783505,0.8431034724377777,1.0,18/57,20.27%,TDRD3;KDM7A;PYGO1;MTF2;MORC4;ZMYND8;WDR5;NCAPG2;RRP8;MSH6;BPTF;MPHOSPH8;MSL3;KDM4A;MORC3;KDM8;PHF8;ATRX
prerank,nucleosomal DNA binding (GO:0031492),-0.33235962877042935,-0.9406177426814996,0.5449101796407185,0.8426200024329175,1.0,8/21,22.69%,CHD4;SMARCB1;HDAC1;HMGA2;MTA2;MBD3;H1-0;ACTL6A
prerank,carbohydrate:cation symporter activity (GO:0005402),0.43614775268845885,0.9395892284603719,0.5194805194805194,0.9098705755212668,1.0,2/11,8.42%,SLC5A10;SLC2A9
prerank,cation transmembrane transporter activity (GO:0008324),0.33703442342803414,0.9388544095359731,0.5346260387811634,0.9082782120258555,1.0,4/48,8.63%,SLC6A6;SFXN1;SLC7A1;SLC15A4
prerank,neuropeptide receptor binding (GO:0071855),0.4235715850501301,0.9375157057598639,0.5365448504983389,0.9080870054905795,1.0,4/14,23.17%,GAL;APLN;NMU;NTS
prerank,ubiquitin-dependent protein binding (GO:0140036),0.4594168650042276,0.9371890563846539,0.535472972972973,0.9055761264578391,1.0,3/10,11.23%,ANKRD13A;DNAJC2;LAPTM5
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.3790367610904709,0.9358899274093113,0.5462304409672831,0.9052624655096312,1.0,12/28,24.98%,APEX1;ENDOV;FEN1;RPP38;EDC3;ELAC2;DROSHA;POP1;NUDT16;RNASEH2A;RNASEH1;NUDT16L1
prerank,aminopeptidase activity (GO:0004177),-0.30590438938916775,-0.9350023743185771,0.5777126099706745,0.8503655581154512,1.0,7/26,13.36%,MMP14;ANPEP;METAP1D;MMP16;ENPEP;METAP1;RNPEP
prerank,exonuclease activity (GO:0004527),0.34604475471865764,0.9349663332861854,0.5430916552667578,0.904229238393075,1.0,14/46,17.71%,REXO2;APEX1;EXD2;ZC3H12A;TRIR;EXOSC3;FEN1;XRN2;EXOSC8;RAD1;EXOG;EXD1;EXOSC9;DXO
prerank,histone deacetylase binding (GO:0042826),-0.23690519415712086,-0.9333793165354044,0.6024096385542169,0.848717493565279,1.0,20/88,15.36%,GLI3;CHD4;PRKN;TOP2B;NIPBL;KAT2B;NUDT21;DACT1;LCOR;CAMTA2;NACC1;BHLHE41;ZMYND15;HDAC4;HDAC1;AKAP8L;HDAC6;SIRT2;MTA2;BCOR
prerank,cytokine receptor activity (GO:0004896),0.3133567710637646,0.9333283887992203,0.5650602409638554,0.9048282750236876,1.0,9/83,7.41%,CCR1;LIFR;IFNGR1;CSF2RB;IL17RD;IFNAR1;IL1RAP;CMKLR1;IL20RB
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.40383999601679954,0.9272387761396407,0.5543964232488823,0.915177148791162,1.0,3/18,7.29%,PIK3R6;CISH;SOCS6
prerank,myosin II binding (GO:0045159),0.4625080399575102,0.9263746107944892,0.5563258232235702,0.9138407721329144,1.0,4/10,16.81%,SHROOM4;SHROOM1;STXBP5L;STXBP5
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.370800803029198,0.9263207319910975,0.5333333333333333,0.9108011566345385,1.0,8/24,22.78%,DAB2IP;CERT1;PLEKHA5;ARFIP2;GOLPH3L;GOLPH3;PLEKHA3;OSBPL5
prerank,metallocarboxypeptidase activity (GO:0004181),-0.30576620330684445,-0.9253611652844457,0.5772870662460567,0.8618484812792174,1.0,8/26,18.90%,AEBP1;CPE;AGBL3;CPXM2;CPXM1;AGBL1;CPA6;ACE2
prerank,G protein-coupled receptor activity (GO:0004930),0.2877854517821009,0.924739144864803,0.642781875658588,0.9112055171936797,1.0,26/239,12.93%,ADGRL4;S1PR1;ADGRE5;F2RL1;ADRB2;RRH;LGR5;GPR157;QRFPR;LANCL1;MRGPRE;LPAR6;GPR143;HCRTR1;NPR1;MC4R;CMKLR1;MTNR1B;ADGRA1;ELOVL4;ADGRB1;GLP1R;XPR1;GRM5;CX3CR1;GPR26
prerank,vitamin D receptor binding (GO:0042809),-0.3676631851260009,-0.9236441029337117,0.5356125356125356,0.8601948867909546,1.0,5/14,15.66%,SNW1;MED13;MED14;MED16;TAF7
prerank,mRNA methyltransferase activity (GO:0008174),0.42655754245814287,0.9232077078068388,0.5716510903426791,0.911453718015574,1.0,3/12,13.27%,TRMT61A;TRMT61B;METTL14
prerank,endopeptidase inhibitor activity (GO:0004866),0.31761942242402275,0.9227285102343807,0.5763546798029556,0.9095366767649049,1.0,13/82,11.08%,RECK;SERPINI1;APP;SPOCK2;TIMP3;SPOCK3;FURIN;PTTG1;GAPDH;ROCK1;PRNP;SPINT2;SPOCK1
prerank,chloride channel activity (GO:0005254),0.3251336475317242,0.9208901149101657,0.5774647887323944,0.9105937081015099,1.0,14/59,19.81%,CLIC4;ANO6;GABRQ;BEST1;TTYH3;CLCN3;CLCN1;GABRA4;GABRA2;GABRE;GLRA2;GABRG3;GABRB1;CLCN7
prerank,general transcription initiation factor binding (GO:0140296),0.37873708424561797,0.9208023183429125,0.564179104477612,0.9076989316570008,1.0,10/25,18.51%,HHEX;BRF2;GTF2A1;PSMC1;TAF1B;PSMC5;TAF11;ESR1;DRAP1;RELA
prerank,peptidase inhibitor activity (GO:0030414),-0.3007381169421352,-0.9206180799467661,0.6116838487972509,0.8616119159451178,1.0,7/33,11.61%,TFPI;GPC3;TIMP2;PSMF1;RENBP;SERPIND1;ITIH2
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.43097655433004556,0.91827750962402,0.573109243697479,0.9100479480307002,1.0,4/11,22.38%,SLC17A9;SLC35B3;SLC25A25;SLC25A42
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.4033948487847138,0.9176114692381285,0.5604395604395604,0.9084433348550535,1.0,3/16,12.22%,PIR;HGD;ALOXE3
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.28732757962918676,0.9173728247047547,0.6251366120218579,0.905914848260049,1.0,42/181,20.25%,LDB2;LMO2;TBXT;TAL1;HNF4A;ACTN4;RBBP8;HEY2;KLF4;BBS7;COMMD7;GABARAPL1;STAT1;HSPB1;RBL1;NFE2L2;JUN;TCF3;DHX9;MAD2L2;NFKBIA;ACTB;NPM1;HIF1AN;DMAP1;DTX3L;TBX20;HIF1A;NFATC1;CTNNB1;DUSP26;SPEN;MAPK14;SIN3A;TBX6;RELA;CRY1;MEF2A;NCOA7;JUP;DNAJA1;GSK3B
prerank,GTPase inhibitor activity (GO:0005095),-0.3638589689771885,-0.9168368876996853,0.5746268656716418,0.8649049438865788,1.0,5/13,13.27%,SLIT2;IQGAP2;IPO5;CPEB2;RTKN
prerank,phosphatase inhibitor activity (GO:0019212),-0.3211811386175654,-0.9146846402090678,0.5988857938718662,0.8645964914112585,1.0,3/20,4.38%,PTN;SET;BOD1L1
prerank,Wnt-activated receptor activity (GO:0042813),0.4083598362427928,0.9137838273257434,0.5506329113924051,0.910597848308022,1.0,5/15,14.82%,FZD6;TSPAN12;LRP5;FZD9;FZD3
prerank,manganese ion binding (GO:0030145),0.3282446506524925,0.9135163585194264,0.5690104166666666,0.9081017274302767,1.0,11/48,12.01%,POMGNT1;MGAT5;ARG1;PCK2;EXD2;MTPAP;FEN1;ADPRM;MGAT1;XXYLT1;GALNT4
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.36255029771227176,0.9110161213189195,0.5572065378900446,0.9104493437615934,1.0,3/26,7.46%,SLC6A6;SLC16A2;SLC16A4
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.38302658526707145,0.9106348533615166,0.5748865355521936,0.9082765369970583,1.0,8/22,20.23%,LANCL1;HSP90B1;AP2M1;CLU;MESD;LDLRAP1;SYT1;DNAJA1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.38418708264547824,-0.9081149303521197,0.5510688836104513,0.8747274036451093,1.0,5/10,20.14%,KDM7A;KDM4A;RIOX2;KDM8;PHF8
prerank,Hsp90 protein binding (GO:0051879),0.35165421824300686,0.9049534194824387,0.5827538247566064,0.9170074218574552,1.0,8/33,19.18%,NOD2;UNC45B;PTGES3;UNC45A;HIF1A;AHSA1;PPID;ERN1
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.2318535082202036,-0.9046270785093536,0.7039106145251397,0.8773296055325114,1.0,25/83,21.75%,USP33;USP20;USP9X;USP13;USP11;USP50;USP1;USP3;MINDY3;OTUD6B;OTUD7B;USP22;UCHL1;CYLD;USP8;ZRANB1;STAMBPL1;OTUD1;USP34;VCPIP1;JOSD2;USP2;TNFAIP3;USP46;USP31
prerank,signal sequence binding (GO:0005048),0.34857083486299234,0.9039556193210515,0.6008230452674898,0.9162113031904701,1.0,13/35,21.92%,AP2B1;TOMM20L;KPNB1;BABAM2;AP2M1;NFKBIA;NUP153;KPNA3;CABP1;PEX5L;IPO4;KCNIP2;BRAP
prerank,N-acetyltransferase activity (GO:0008080),0.3844372221629143,0.8993947942689119,0.5851735015772871,0.9225984777188261,1.0,1/19,1.42%,SATL1
prerank,SUMO binding (GO:0032183),0.42504290922100185,0.8982010083350903,0.5807504078303426,0.9220248533449991,1.0,4/13,18.76%,HERC2;CASP8AP2;HABP4;USPL1
prerank,ATP hydrolysis activity (GO:0140603),0.3406159802320001,0.896902623615891,0.6002710027100271,0.9216897088908947,1.0,7/41,11.83%,MYO1E;DDX4;KIF26A;HSPA1B;DHX9;ABCG4;CLU
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.3819708496198043,-0.895295053121038,0.6091127098321343,0.8924974909709089,1.0,5/11,25.40%,NAA60;NAA40;NAA50;NAA10;NAA15
prerank,lipase activity (GO:0016298),0.33646769816797445,0.8946484769705638,0.6108843537414966,0.923402612014948,1.0,4/43,8.33%,PITPNM3;PNLIP;LCAT;ABHD6
prerank,G protein-coupled receptor binding (GO:0001664),0.2895543766353598,0.8945013927633233,0.6613636363636364,0.9207453876250893,1.0,10/132,8.00%,CCDC88C;S1PR1;ACE;GNAQ;GNAL;HOMER2;GNAI2;HSPA1B;ARRB1;REEP2
prerank,endopeptidase regulator activity (GO:0061135),0.33271904512293926,0.892647094936689,0.6199722607489597,0.9216365947111147,1.0,11/40,22.35%,RECK;APH1A;SPINT2;VSIR;PSMD14;SLPI;CST3;PROS1;APH1B;USP14;A2M
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.4099105772154003,0.8901078656275524,0.606312292358804,0.9239720635631331,1.0,4/12,22.38%,SLC17A9;SLC35B3;SLC25A25;SLC25A42
prerank,cation:chloride symporter activity (GO:0015377),-0.3709413175733087,-0.8883520369318041,0.5990566037735849,0.9026386945033125,1.0,2/10,6.05%,SLC12A2;SLC6A1
prerank,thioesterase binding (GO:0031996),0.4195147624533182,0.8864619880872737,0.6161790017211703,0.9282343000081773,1.0,2/11,10.68%,TRAF1;RAC1
prerank,nuclear import signal receptor activity (GO:0061608),-0.3350541506997468,-0.8855524378033287,0.618421052631579,0.902939355775183,1.0,5/15,14.92%,KPNA1;TNPO3;RANBP6;IPO5;TNPO2
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.324914903565974,-0.8833433892030423,0.6318407960199005,0.9023240088529139,1.0,9/17,33.10%,AK5;CMPK2;AK1;NME2;NME6;NOL9;AK3;NME1;AK9
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.3728749608634133,-0.883195826447598,0.6226415094339622,0.8970129348399845,1.0,8/11,53.60%,CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3050178770703792,0.8787275151385942,0.63625,0.9409893532959197,1.0,7/70,8.01%,GCNT1;MFNG;POMGNT1;EXT1;GCNT2;POGLUT1;B3GNT3
prerank,chemokine activity (GO:0008009),-0.2715353083678098,-0.8783682167304786,0.659016393442623,0.9020824236743066,1.0,23/31,51.87%,CXCL16;CCL25;CXCL12;CKLF;CCL19;CCL2;CCL14;CCL28;CX3CL1;CCL5;CXCL5;CCL11;CXCL1;PF4;CCL7;PPBP;CCL8;CCL1;CCL3;XCL1;CXCL13;CXCL2;CCL13
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.3959724741934537,0.8750332934331971,0.6235864297253635,0.9452883758024796,1.0,6/13,17.88%,SH3BP4;ARHGDIA;CCDC88A;RANBP1;ITGB1BP1;GDI1
prerank,E-box binding (GO:0070888),0.33707621848931035,0.8745277717195519,0.6274238227146814,0.9433235184759984,1.0,5/34,9.35%,NEUROG2;TAL1;GATA3;SNAI2;TCF3
prerank,RNA binding (GO:0003723),0.2600125319461046,0.8744896224436316,0.92,0.9404371211728209,1.0,389/1321,24.62%,NANOS1;NANOS3;SORBS2;SYNE1;FASN;ESRP2;NOVA2;ZYX;FLNB;FKBP4;ADARB1;MACF1;RBPMS;IFIH1;LRRFIP1;VIM;MAP4;NPM3;BOP1;DHX32;DIAPH1;ACTN4;PELP1;KCTD12;TLR3;RPS21;RPL27;DDX4;TNS1;PUM2;MSN;RBM7;CCDC9B;SUMO2;SRP14;MBNL1;DHX37;ZCCHC9;SSBP1;DDX39A;KARS1;DDX41;RPL7;MRPL4;PPIE;MEX3B;MYEF2;KHDRBS3;APEX1;PHF6;MYH9;ASS1;FNDC3B;PABPC5;RTF1;BUD13;TUBB4B;PSMD4;LSM1;SETX;ENDOV;PLEC;HNRNPA0;ZC3H12A;MRPL41;ELAVL1;RANGAP1;NGRN;HSPB1;HSP90B1;HSPA1B;CCDC124;AATF;PURA;CTNNA1;KPNB1;EXOSC3;ATP5F1A;MTPAP;ZNF346;NVL;DNAJC2;U2SURP;ZC3H7A;OAS2;DCP1B;MRPS31;SCAF4;POLR2G;RPS14;MRPL1;RPS27A;RBM28;RPL35;ETF1;DDX28;ADAR;CACTIN;EIF3B;JUN;DSP;ZFP36L2;WDR46;RTN4;HMGB1;RPL21;DHX9;DKC1;HSPE1;CELF4;DUSP11;TRIM25;PRPF38A;TASOR;POLR2D;MRPL15;EIF1;EIF1AX;RPL37;ARHGEF1;FARS2;CNOT1;RPS28;RPL34;LARP1B;TUFM;HNRNPK;GTPBP1;AGO4;PTPN1;RPS9;XRN2;FIP1L1;ALKBH8;NPM1;EEF2;PTBP3;CAVIN1;ASCC3;PCBP1;BRCA1;MRPL23;TIAL1;RPS25;EIF3I;RBM11;ILF2;DHX40;GLRX3;HELZ2;VIRMA;NHP2;MARK2;CHTOP;RPL30;EIF3G;GCN1;NUFIP2;CCT4;TRMT2A;MSI2;SMNDC1;METAP2;FBLL1;SRSF9;RPS5;XRN1;RPL27A;AKAP1;GPATCH4;NOL8;FXR1;RPP38;RBM45;METTL14;HABP4;SRP9;DDX56;DDX21;NOL3;CLNS1A;HNRNPH2;FASTKD5;PSMC1;SART1;MRPL14;MRPL32;MRPS12;TFB2M;RAN;RPL23A;ELAVL2;COL14A1;TRMT10B;NUP42;SYF2;HMGB2;SF3B4;MAP3K20;CCT6A;RPS15;SRPRA;EIF3A;CRNKL1;EIF2S1;EIF2A;PIN4;RPL19;DDX55;EDC3;FAU;RPS18;YBX1;MRPL39;DDX6;RPL32;TEFM;RACK1;PTCD2;MTIF2;EIF3H;SLPI;PKN2;TCOF1;DHX38;SF3A1;ELAC2;UBFD1;SPEN;RBM15;TMSB4X;UTP18;ATXN2L;DROSHA;RPL37A;RPL18A;HADHB;LRPPRC;RPL22L1;MRPL54;EXD1;SRPK1;UNC50;POLDIP3;RPL7L1;TRNAU1AP;SEPSECS;SAFB2;NSUN5;TRMT1L;EXOSC9;TUT7;POP1;KHNYN;DXO;SPTBN1;LAS1L;RSRC2;CCDC47;DDX39B;RPUSD2;LSM14B;TIA1;NOL4;CSTF2;MKRN1;SRP19;DDX47;PTBP2;TDRD9;ZC3H15;MRM3;G3BP1;HNRNPUL1;SF3B6;NAP1L4;DCAF13;FTSJ3;LSM2;ZC3HAV1;MYO18A;IBA57;MKRN2;BARD1;PA2G4;MRPS30;DARS1;GFM1;ZC3H8;ANG;SMG7;SYNCRIP;RRP9;PPHLN1;YTHDC1;CPSF3;MRPL11;NOL7;STAU2;ACAA2;RCAN3;PWP2;C1D;SF3B2;TRMT1;DHX58;RSL24D1;ANKRD17;BAG4;RPL18;MRPS35;MRPS28;EIF2AK2;RPL39;SF3A3;MTCL1;IMP4;ZFP36L1;MBNL2;NSUN6;UBA1;CRKL;RPS19;NOLC1;EXOSC10;ZCCHC17;MRPS9;CSDE1;HEXIM1;FAM50A;RPL31;RPS8;LRRC47;JAKMIP1;NSRP1;RTCA;MEX3D;NOP53;ZNF106;EXOSC1;UBAP2;NQO1;FBL;SEC63;MRPS27;URB1;RPF2;TYW5;EDF1;ZNF638;NUDT16;TOP3B;TBRG4;KIN;ZCRB1;CNBP;TSFM;EIF4G1;WDR43;TCP1;POLR2B;DHX36;DHX57;PATL2;CPNE3;IREB2;HLTF;ZNF326;PRPF40B;UBE2O;FRG1;TUBA1B;ANXA11;CCT3;LRRC59;RPL3;RAE1;OASL;UTP20;OTUD4;USO1;EIF4ENIF1;RIMS1;MYO5A;MRTO4;GRN;PRPF6;ALYREF;RNASEH1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.4020131433096059,0.8712819119097518,0.6254125412541254,0.9437171620993432,1.0,3/13,8.63%,SLC7A7;SLC7A1;SLC15A4
prerank,thyroid hormone receptor binding (GO:0046966),-0.28736494616478286,-0.8704382725915454,0.6607142857142857,0.9140119388142258,1.0,10/28,19.64%,TRIP12;TACC1;NSD1;MED13;JMJD1C;GTF2B;MED16;TAF7;GTF2H1;GAS2L1
prerank,potassium channel regulator activity (GO:0015459),0.3180975360690546,0.8682870234238872,0.6615581098339719,0.9468357416975015,1.0,7/49,12.11%,KCNE3;ADRB2;DPP6;DPP10;SGK1;NEDD4L;ARPP19
prerank,bHLH transcription factor binding (GO:0043425),-0.3061866084787448,-0.8672854243649414,0.6568047337278107,0.9149493440099657,1.0,4/19,11.11%,FHL2;CREBBP;SMAD3;BHLHE41
prerank,store-operated calcium channel activity (GO:0015279),0.4174253670502993,0.8662603207802317,0.627906976744186,0.9480356139409176,1.0,4/10,14.44%,ORAI1;STIM2;TRPC7;TRPC5
prerank,protein kinase activator activity (GO:0030295),0.3099613289020647,0.8655667258771967,0.683944374209861,0.9464885092134537,1.0,15/60,19.75%,AFAP1L2;IQGAP1;MADD;IRGM;GPRC5A;GRM5;MARK2;CALM3;PAK2;RICTOR;DAXX;EPO;CD24;MAP2K1;CAB39
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.35490737405026496,-0.865193944031584,0.6536585365853659,0.913779639564484,1.0,4/12,21.71%,DHRS4;AIFM2;NDUFS7;CRYZ
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.3289633198430079,0.8641362883007514,0.6470588235294118,0.9464560946193219,1.0,4/38,8.37%,HIP1;DAB2IP;TECPR1;PLEKHA5
prerank,carboxypeptidase activity (GO:0004180),-0.2643090457017484,-0.8621855092105877,0.714765100671141,0.914496881480107,1.0,9/35,18.90%,AEBP1;CPE;AGBL3;CPXM2;NAALAD2;CPXM1;AGBL1;CPA6;ACE2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.2741698268418084,-0.8605885150026104,0.6915584415584416,0.9122296363378803,1.0,11/34,18.12%,NSD3;EHMT1;SETD7;DOT1L;METTL21A;KMT5B;EEF1AKMT1;SUV39H1;SETD4;N6AMT1;EEF1AKMT2
prerank,steroid hydroxylase activity (GO:0008395),0.377528686470181,0.8588895787642592,0.6246056782334385,0.9536144068260642,1.0,1/16,2.19%,CYP39A1
prerank,protein kinase C activity (GO:0004697),0.39269145297799646,0.8570996315342974,0.6268656716417911,0.9542477797738387,1.0,3/14,10.21%,PRKD1;PKN1;PRKCG
prerank,zinc ion binding (GO:0008270),0.2608643014639889,0.8569802688844821,0.7808930425752856,0.9515761983248203,1.0,39/293,12.28%,MYRIP;ACE;CRIP2;GDA;ARHGEF2;DUSP12;MSRB3;KLF7;IFIH1;GCH1;KLF4;LANCL1;TNFSF10;SHANK3;RNF125;SMPDL3A;ASAH2;ARIH1;PGGT1B;TRIM24;CLIP1;KPNB1;MT2A;PLSCR1;GRIN2B;CAD;MBD1;KMT2B;DHH;EGR1;PTPN1;TET3;TAB2;TNKS;ALKBH8;HIF1AN;SAP30L;TRIM8;SUV39H2
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.29868544524617946,-0.855465845376828,0.6751412429378532,0.9174664269625861,1.0,7/20,24.78%,CASK;AK6;MAGI3;CMPK2;AK1;LRGUK;DLG1
prerank,diacylglycerol kinase activity (GO:0004143),0.40206700799071393,0.8540707513801988,0.6420361247947455,0.9543009894081487,1.0,5/11,25.02%,DGKH;AGK;DGKI;DGKA;DGKB
prerank,hormone receptor binding (GO:0051427),0.38695122744632654,0.8521021858518771,0.625,0.9552192797711706,1.0,3/14,18.21%,JAK2;NPPC;NCOA6
prerank,ionotropic glutamate receptor binding (GO:0035255),0.414465751236059,0.8504036932380931,0.6461794019933554,0.9553991542500726,1.0,4/10,19.90%,SHANK3;SHISA6;NSF;SHANK2
prerank,DNA replication origin binding (GO:0003688),0.35285969132986633,0.8502002267737588,0.6452095808383234,0.952913957768753,1.0,5/23,15.08%,ORC3;DHX9;POLA1;ORC5;KAT7
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.2698480730290566,-0.8499132510039498,0.6774193548387096,0.9234103887125286,1.0,4/31,6.36%,SLC12A2;KCNK5;ABCC9;KCNQ4
prerank,GDP binding (GO:0019003),0.2919010631247249,0.8456291369116293,0.6829573934837093,0.9586039944744735,1.0,18/63,22.08%,KRAS;NRAS;RRAS;RAB35;RRAGD;RHEBL1;RRAS2;RAN;RHEB;RAB27B;RIT2;RAB27A;RAB5C;RRAGC;RAB31;RAB12;RALB;RAP1B
prerank,carboxylic ester hydrolase activity (GO:0052689),0.28358791196281774,0.8431534769584159,0.7069767441860465,0.9604634686756579,1.0,22/85,23.73%,AOAH;PNLIP;LCAT;PGAP1;PNPLA6;APMAP;ABHD6;GDPD1;ACHE;PON2;PON3;ABHD2;PLA2G12A;PLAAT3;BCHE;PNPLA2;ABHD4;LYPLA1;MGLL;ESD;GDE1;LYPLAL1
prerank,voltage-gated cation channel activity (GO:0022843),0.2831832776936787,0.8419255957529247,0.7313953488372092,0.9596953801194248,1.0,18/97,17.87%,KCNQ1;KCNH8;CACNA1A;KCNG3;GRIN2B;KCNC1;KCNH7;GRIN2C;TPCN2;GRIN3A;KCNC4;KCNA1;CACNA1E;KCNC2;KCNH5;KCNH1;GRIN2A;KCNQ3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.4126447968973683,0.8417736467958964,0.6509598603839442,0.957056950645068,1.0,1/10,1.85%,GDA
prerank,hexosyltransferase activity (GO:0016758),0.2784926825201935,0.8411458412975888,0.7269585253456221,0.9552066298098647,1.0,9/101,8.21%,GCNT1;MFNG;POMGNT1;B4GALT4;EXT1;GCNT2;POGLUT1;B3GNT3;A4GALT
prerank,MAP-kinase scaffold activity (GO:0005078),0.39898384182572294,0.8353729821440544,0.6491803278688525,0.9633336607820923,1.0,2/11,5.67%,IQGAP1;SPAG9
prerank,NF-kappaB binding (GO:0051059),0.33839905447644303,0.8350383595605941,0.6577777777777778,0.9609929447124133,1.0,8/24,25.64%,COMMD7;NFKBIA;NPM1;HIF1AN;RELA;GSK3B;RNF25;HDAC2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.29834894495719455,-0.8339921195580319,0.7325581395348837,0.95076509459238,1.0,7/20,17.93%,USP9X;UFSP2;SENP3;USP50;SENP1;OTULINL;SENP2
prerank,poly(A) binding (GO:0008143),-0.2979012908349049,-0.828324145725049,0.7259036144578314,0.9562144963743814,1.0,2/21,1.44%,RBMS3;RBMS1
prerank,protein kinase inhibitor activity (GO:0004860),-0.24384464180953233,-0.8239225214833431,0.7849462365591398,0.9594427577213577,1.0,14/42,22.93%,PARVA;DNAJC3;DUS2;SPRED1;SPRED2;GMFB;SH3BP5;QARS1;CDKN1A;PRKRIP1;IBTK;CIB1;TAOK3;GSKIP
prerank,retinoid X receptor binding (GO:0046965),0.391941575547728,0.8227346490962454,0.6689655172413793,0.9809101106049244,1.0,2/11,9.81%,NR4A2;ARID5A
prerank,ribonuclease activity (GO:0004540),0.2972621792010659,0.8214221056636208,0.7093469910371318,0.9803986972166717,1.0,22/56,24.62%,INTS11;ZC3H12A;EXOSC3;RNASE1;EXOSC8;RNASE6;EXOG;ELAC2;NOB1;EXOSC9;KHNYN;RNASE12;ERN1;ANG;RNASE4;CPSF3;EXOSC10;DIS3L2;EXOSC1;RNASEH2A;RNASE7;RNASEH1
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.3512608905869712,-0.819308792668314,0.7048780487804878,0.9625479311067437,1.0,4/10,9.31%,DPP4;FAP;PRCP;NAALAD2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.3596875601928792,0.8190246646998649,0.6865671641791045,0.979040040534012,1.0,2/16,7.57%,ANO6;TTYH3
prerank,intracellular chloride channel activity (GO:0061778),0.3596875601928792,0.8190246646998649,0.6865671641791045,0.979040040534012,1.0,2/16,7.57%,ANO6;TTYH3
prerank,magnesium ion binding (GO:0000287),0.2641336277173611,0.8185655495004347,0.8049886621315193,0.9769941798761791,1.0,44/135,24.29%,SNRK;OXSR1;CDC42BPA;MAP3K6;CDC42BPG;STK38;STK38L;NLK;THTPA;EXD2;ENDOV;MAST1;SIK2;LRRK2;MTPAP;PLSCR1;FEN1;XXYLT1;GSS;MARK2;RAN;RHEB;MAP3K20;SRPK1;CIB2;DXO;ERN1;PLSCR3;RRAGC;AASDHPPT;CDC42BPB;NT5C3A;ABL2;DIS3L2;GEN1;NUDT16;IDH3G;DHX36;MVK;BRSK2;WRN;MTHFD2;TESC;PPA2
prerank,dynactin binding (GO:0034452),-0.3335618241311845,-0.817574407585142,0.7233009708737864,0.9600885970803165,1.0,3/12,19.12%,SNX6;BICD2;SNX5
prerank,MAP kinase activity (GO:0004707),-0.3151989457101193,-0.8163100873000364,0.7277486910994765,0.9569809976197292,1.0,2/14,7.38%,MAPK4;MAPK6
prerank,deoxyribonuclease activity (GO:0004536),0.3697555735831737,0.8162764661474721,0.6859375,0.9783515240486312,1.0,3/14,13.68%,APEX1;DFFB;ERCC4
prerank,histone methyltransferase binding (GO:1990226),0.39057426966691555,0.8161191520632968,0.6894308943089431,0.9757783554543534,1.0,3/11,16.33%,LCORL;CTNNB1;CBX1
prerank,semaphorin receptor activity (GO:0017154),0.3892826229077075,0.815297983413643,0.6758147512864494,0.9743449353396728,1.0,2/11,3.97%,PLXNA4;PLXND1
prerank,motor activity (GO:0003774),0.2894877147086757,0.8147226767914972,0.722860791826309,0.972560142966005,1.0,11/60,15.66%,MYO1E;KIF26A;MYH9;KIF2A;MYL6;STARD9;PIN1;KIF24;KIF26B;KIF16B;KIF1A
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.25598002755322957,-0.8101613640488889,0.7731629392971247,0.962953892230354,1.0,8/31,16.94%,UBE2E2;UBE2N;TAF1;BIRC6;UBE2L3;UBE2G2;UBE2QL1;UBE2L6
prerank,lipoprotein particle receptor binding (GO:0070325),0.33015435387608144,0.8099621829592057,0.7178729689807977,0.9781279526170745,1.0,7/27,14.09%,APOA1;LANCL1;HSP90B1;AP2M1;CLU;MESD;LDLRAP1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.32362015959714324,-0.8096964061191412,0.7380952380952381,0.9584141698902201,1.0,2/13,5.00%,AGPAT4;LPCAT2
prerank,poly-purine tract binding (GO:0070717),-0.2713641526192293,-0.8073775524765902,0.7532894736842105,0.9571323167362441,1.0,12/27,27.36%,RBMS3;RBMS1;DAZAP1;DDX1;DDX3X;HNRNPU;PABPC1;PABPC4L;KHDRBS1;EIF4A3;HNRNPDL;PNPT1
prerank,G protein-coupled peptide receptor activity (GO:0008528),-0.21551166957241558,-0.8056657142031811,0.8956043956043956,0.9546957283341916,1.0,30/73,34.48%,LGR4;NPR3;EDNRA;SORCS2;BDKRB2;SORCS3;PTH1R;CYSLTR1;EDNRB;CYSLTR2;MC5R;GPR37L1;GLP2R;OPRK1;APLNR;VIPR2;CALCRL;CCKBR;NPSR1;TSHR;GALR1;S1PR2;LHCGR;GPR37;F2R;GRPR;PTH2R;KISS1R;GIPR;MAS1
prerank,lipase activator activity (GO:0060229),0.3903651872900378,0.8046720602753717,0.6729131175468483,0.9845703644409505,1.0,3/10,13.99%,FYN;BTK;APOH
prerank,beta-tubulin binding (GO:0048487),0.3125879733794276,0.8039966190605292,0.7026647966339411,0.982816498411562,1.0,4/31,9.10%,TRPV4;TTLL7;GABARAPL1;UXT
prerank,nuclear localization sequence binding (GO:0008139),0.3472277577516473,0.8034985011643757,0.7051482059282371,0.9808235115640621,1.0,7/18,21.92%,KPNB1;NFKBIA;NUP153;KPNA3;CABP1;IPO4;BRAP
prerank,phospholipase A2 activity (GO:0004623),-0.26754330752310373,-0.8032796449216849,0.7781350482315113,0.953677969247007,1.0,15/26,47.48%,PLA2G4A;PLA2G15;PLA2G6;PLA2G4C;PLA2G7;PLA2G4F;PLAAT1;PLA2G4B;PLA2G5;PLB1;ABHD3;PLA2G3;PLAAT5;PNPLA3;PLA2G4E
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.3341378088129665,-0.8028748878328625,0.7290748898678414,0.9490454190860127,1.0,1/11,0.37%,EGFR
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.25636114961953244,-0.802602338287605,0.8067484662576687,0.944272430639076,1.0,13/27,28.24%,PPARA;PRKN;DCUN1D3;ARIH2;UBE3D;RNF180;DCUN1D4;ZMYM2;SIAH1;TOLLIP;FOXL2;SIAH3;AUP1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.37711427649088636,0.7976427095896804,0.7170418006430869,0.9879623386508088,1.0,4/13,23.28%,DDT;ECI1;SREBF2;IDI1
prerank,histone methyltransferase activity (GO:0042054),-0.24971389953631146,-0.7971745793100247,0.8006230529595015,0.9484915359313345,1.0,8/32,16.44%,NSD3;KMT2C;EHMT1;SETD7;DOT1L;KMT5B;SUV39H1;N6AMT1
prerank,ubiquitin-specific protease binding (GO:1990381),0.33865823469172496,0.7945360198644116,0.693522906793049,0.9905480646076167,1.0,3/19,13.00%,SPATA2;BAG6;CHMP3
prerank,ADP binding (GO:0043531),-0.26380106252830177,-0.7933912424193454,0.7791411042944786,0.9496205254940994,1.0,5/25,13.18%,PRKAG2;ME1;GCLC;MYO9B;MSH6
prerank,GABA receptor binding (GO:0050811),0.37819545468215865,0.7907154922114685,0.6984924623115578,0.9942599610727542,1.0,2/11,6.18%,AKAP5;GABARAPL1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2765041602720655,0.7886316986230301,0.7821656050955414,0.9948008921682986,1.0,11/60,14.97%,DUSP1;LRRC39;PPM1F;LRRK2;PPP3CA;PP2D1;CDC14A;PDP1;PPM1D;PPM1L;PPP2CB
prerank,estrogen receptor binding (GO:0030331),0.30775891980695874,0.7857393393179573,0.7467438494934877,0.9966498325514502,1.0,12/32,19.36%,LEF1;SRARP;ARID5A;CNOT1;CTNNB1;ESR1;MMS19;NCOA6;STRN;PPID;DCAF13;WBP2
prerank,cysteine-type endopeptidase activity (GO:0004197),0.27074075352302535,0.78226470219046,0.8111111111111111,0.999498473457582,1.0,20/78,21.84%,CASP8;USP38;CASP2;CASP1;USP12;CAPN5;USP29;USP9Y;CASP7;PYCARD;USP35;CTSK;CTSO;CAPN1;MALT1;CTSH;USP47;CAPNS1;USP14;USP30
prerank,copper ion binding (GO:0005507),0.2912433173326864,0.7774793982909207,0.7652519893899205,1.0,1.0,12/42,22.31%,ATOX1;SNCG;ATP7A;IL1A;TYR;PRNP;CUTA;HEPH;ATP7B;ANG;CCS;SOD1
prerank,deubiquitinase activity (GO:0101005),-0.20028571265049913,-0.7757016889499265,0.9289940828402367,0.973386084876776,1.0,25/88,21.75%,USP33;USP20;USP9X;USP13;USP11;USP50;USP1;USP3;MINDY3;OTUD6B;OTUD7B;USP22;UCHL1;CYLD;USP8;ZRANB1;STAMBPL1;OTUD1;USP34;VCPIP1;JOSD2;USP2;TNFAIP3;USP46;USP31
prerank,mRNA binding (GO:0003729),0.23830561564731503,0.7728569969118514,0.9057591623036649,1.0,1.0,26/249,11.45%,NANOS1;NANOS3;ESRP2;NOVA2;ADARB1;RBPMS;PUM2;RPL7;PPIE;MYEF2;KHDRBS3;PABPC5;HNRNPA0;ZC3H12A;ELAVL1;DCP1B;RPS14;RPL35;ETF1;ELAVL4;DHX9;CELF4;HNRNPK;ANGEL2;PTBP3;PCBP1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.279808849875787,0.7718740068995736,0.7841634738186463,1.0,1.0,7/51,9.52%,SLC25A16;SLCO1C1;SLC35D2;SLC35E4;SLC16A2;CLCN3;SLC25A30
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.3756868097062073,0.7712125471324796,0.7419928825622776,1.0,1.0,6/10,20.39%,SETD3;ASH1L;NSD2;PRDM9;SETD2;SMYD2
prerank,mRNA 5'-UTR binding (GO:0048027),-0.2547106739661331,-0.7707443954741828,0.8134556574923547,0.9759647536247107,1.0,7/24,20.09%,CCT5;DDX3X;LARP1;NCL;LARP6;MRPS11;GNL3
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.36030148050061434,0.7693069952635876,0.7625418060200669,1.0,1.0,3/11,14.44%,ITPR3;TRPC7;TRPC5
prerank,telomeric DNA binding (GO:0042162),0.3006034058054453,0.7692241385213627,0.7582872928176796,1.0,1.0,11/32,24.06%,HMBOX1;ZBTB48;APEX1;PURA;STN1;CTC1;TERF2IP;SMG7;BLM;TERF2;WRN
prerank,ion gated channel activity (GO:0022839),-0.2595947752786786,-0.7681249900024758,0.8147138964577657,0.974673170728767,1.0,3/24,8.27%,KCNT2;ANO1;KCNT1
prerank,epidermal growth factor receptor binding (GO:0005154),0.31323562699401336,0.76577662931326,0.7525622254758418,1.0,1.0,3/25,10.33%,HIP1;PLSCR1;CCDC88A
prerank,nuclear receptor binding (GO:0016922),0.25272185163653293,0.7645484589289921,0.871824480369515,1.0,1.0,29/111,19.36%,NR4A2;ACTN4;LEF1;SRARP;PKN1;BRD8;KDM3A;STAT1;FOXP1;ARID5A;CNOT1;NR4A1;MED30;YWHAH;HIF1A;CTNNB1;MED17;MED4;TAF11;ESR1;DAXX;MMS19;NCOA6;STRN;CRY1;PPID;DCAF13;NCOA7;WBP2
prerank,cholesterol transfer activity (GO:0120020),0.3390127851346436,0.7642909679460739,0.7391952309985097,1.0,1.0,2/16,5.63%,APOA1;PLTP
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.30117748749269696,0.7635734886507524,0.8008784773060029,1.0,1.0,11/30,23.50%,ATP7A;SLC31A1;SLC30A1;SLC39A6;SLC25A28;ATP7B;SLC30A3;SLC39A3;SLC30A4;SLC39A12;TTYH1
prerank,nucleotidyltransferase activity (GO:0016779),-0.27572254200333024,-0.7624820103405823,0.7848837209302325,0.9779368080522084,1.0,8/19,21.03%,CRPPA;REV1;TENT4B;TERT;TUT1;PAPSS2;TUT4;CGAS
prerank,sterol transfer activity (GO:0120015),0.33443100062204756,0.7624106162416137,0.7496296296296296,1.0,1.0,2/17,5.63%,APOA1;PLTP
prerank,death receptor binding (GO:0005123),0.33927606017063244,0.761119323144464,0.75,1.0,1.0,5/15,20.14%,DAB2IP;MADD;CASP8AP2;BID;BDNF
prerank,organic cation transmembrane transporter activity (GO:0015101),0.3288057770656241,0.7603814410273345,0.7397034596375618,0.9986165506506738,1.0,4/16,22.38%,SLC44A1;SLC22A5;SLC29A4;SLC25A42
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.3494623567446109,0.7602889507603711,0.7265372168284789,0.9960453175203993,1.0,5/14,28.38%,CAPN5;CAPN1;CAPNS1;CAPN10;CAPN2
prerank,sulfotransferase activity (GO:0008146),0.29512646069779436,0.7601835419120374,0.7735583684950773,0.9934853421672161,1.0,4/33,6.88%,HS3ST1;CHST14;SULT6B1;CHST11
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.2898737850117997,-0.7593313404827312,0.7742782152230971,0.9775094367789233,1.0,5/15,35.76%,PLA2G4A;PLA2G4C;PLA2G4F;PLA2G4B;PLA2G5
prerank,O-acyltransferase activity (GO:0008374),0.3033046378870439,0.7585771991051506,0.7807017543859649,0.9933226316591977,1.0,5/30,10.81%,MBOAT2;LPCAT4;LCAT;LPCAT3;MOGAT1
prerank,ubiquitin binding (GO:0043130),-0.20251589420628693,-0.7575455246829543,0.93048128342246,0.9750957227986092,1.0,31/73,30.63%,PRKN;USP33;UBE2N;SMAD3;USP13;UBXN7;RNF31;UBXN2B;DNAJB2;TSG101;UCHL1;MDM2;OTULINL;SIRT2;SHARPIN;UBE2L6;UBAP1;TNFAIP3;RNF168;GGA3;TOLLIP;UBXN11;TOP2A;MVB12B;NEDD4;N4BP1;AUP1;RAD23A;NUP62;BIRC2;OTUB2
prerank,protein phosphatase regulator activity (GO:0019888),0.27062738691201116,0.7560774477373843,0.8002645502645502,0.9943296252074013,1.0,24/53,25.05%,MGAT5;PPP1R16B;SHOC2;LMTK2;PPP2R5C;PPP2R2C;ARPP19;CALM3;PPP1R15B;PPP4R1;RCAN2;BOD1;PPP1R16A;PPP1R9B;PPP1R7;PPME1;RCAN3;EIF2AK2;PPP2R5E;IGBP1;PPP1R15A;LGALS3;PPP2R2A;PPP2R1A
prerank,protein kinase regulator activity (GO:0019887),0.25317601473511636,0.7529926326612744,0.8510131108462455,0.9962585367871032,1.0,20/95,19.75%,CCNY;CCND2;CCND3;CCNE1;SMCR8;MADD;ELP4;GPRC5A;APC;NPM1;MARK2;SPRY4;CSNK2B;SH3BP5L;NCK1;DAXX;CXCL10;EPO;ELP3;CAB39
prerank,signaling receptor complex adaptor activity (GO:0030159),0.28828999227324703,0.7522042398285698,0.7991913746630728,0.9948200236341509,1.0,6/38,9.11%,SPATA2;CARD10;SHANK3;SPAG9;LRRK2;STAP1
prerank,hormone activity (GO:0005179),0.275165975849615,0.7509769397180331,0.8118279569892473,0.9938738185648257,1.0,7/54,19.39%,EDN1;GAL;NPPC;APLN;SST;PENK;VGF
prerank,nuclease activity (GO:0004518),0.2694638469748825,0.7458610061828127,0.829560585885486,0.9990212606247024,1.0,19/52,26.06%,APEX1;ZC3H12A;PLSCR1;DFFB;FEN1;RNASE1;XRN2;RNASE6;EXOG;RNASE12;ANG;RNASE4;DIS3L2;RNASEH2A;WRN;RNASE7;RNASEH1;ISG20L2;OGG1
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.3202436952120792,-0.7449526883020577,0.7813953488372093,0.9885117890183551,1.0,4/10,25.40%,NAA60;NAA50;NAA10;NAA15
prerank,four-way junction DNA binding (GO:0000400),0.32426508343670307,0.7442471172312886,0.7755102040816326,0.9987531526367477,1.0,7/17,24.06%,HMGB1;RAD51D;HMGB2;MEN1;BLM;GEN1;WRN
prerank,proton transmembrane transporter activity (GO:0015078),-0.22216517336780323,-0.7433418657897507,0.9098039215686274,0.9856915521526725,1.0,11/39,21.66%,ATP6V1B2;CLCN5;DMAC2L;COX10;COX7A2L;UQCRQ;CLCN4;UQCRH;SLC9A1;SLC11A2;ATP6V1F
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.23268155083161673,-0.7423868229286982,0.8896797153024911,0.976762345535658,1.0,14/34,27.31%,NDUFS3;NDUFA13;NDUFC2;NDUFV2;NDUFB10;NDUFS7;NDUFS6;NDUFB8;NDUFA1;NDUFB3;NDUFS5;NDUFS8;NDUFB2;NDUFS2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.23268155083161673,-0.7423868229286982,0.8896797153024911,0.976762345535658,1.0,14/34,27.31%,NDUFS3;NDUFA13;NDUFC2;NDUFV2;NDUFB10;NDUFS7;NDUFS6;NDUFB8;NDUFA1;NDUFB3;NDUFS5;NDUFS8;NDUFB2;NDUFS2
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.2707347285825381,-0.7413764899618706,0.8328611898016998,0.9729952413862484,1.0,8/17,34.17%,DPYD;BDH2;BLVRB;PTGR1;SRD5A3;PECR;PTGR2;MECR
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.2311428532873044,-0.7407090213892281,0.9016949152542373,0.9688733066973199,1.0,8/34,16.94%,UBE2E2;UBE2N;TAF1;BIRC6;UBE2L3;UBE2G2;UBE2QL1;UBE2L6
prerank,voltage-gated chloride channel activity (GO:0005247),0.36722776508254173,0.7387228342280643,0.7968197879858657,1.0,1.0,3/10,10.31%,ANO6;CLCN3;CLCN1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.30437238641389175,-0.7381329761855717,0.7876344086021505,0.9670349433537693,1.0,4/12,20.14%,KDM7A;JMJD1C;KDM4A;PHF8
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.2302523306434705,-0.7360425022222689,0.8754448398576512,0.9650071690284692,1.0,10/35,17.42%,RRN3;SMARCB1;TAF4;TAF1;DR1;HDAC1;GTF2B;PIH1D1;POU2F1;UBTF
prerank,lysophospholipase activity (GO:0004622),-0.2599833726995591,-0.7353090619785659,0.8519553072625698,0.9611048142880743,1.0,7/20,21.08%,PLA2G4A;PNPLA7;ASPG;ABHD12;PLA2G6;ENPP2;PLA2G4C
prerank,sodium channel activity (GO:0005272),0.2760010193550806,0.7338969403341075,0.8178025034770514,1.0,1.0,8/37,18.28%,SCN11A;SCN1B;ASIC2;GRIK5;GRIK2;SCN9A;GRIK1;SCN1A
prerank,alpha-actinin binding (GO:0051393),0.3025091670427862,0.732452522181533,0.8090225563909774,1.0,1.0,2/24,4.46%,MAGI1;PDLIM5
prerank,hyaluronic acid binding (GO:0005540),0.36018026371270095,0.7322222878624793,0.7902097902097902,1.0,1.0,2/10,5.51%,HYAL2;LAYN
prerank,glucuronosyltransferase activity (GO:0015020),0.3071341615125055,0.7322205741696414,0.8032305433186491,1.0,1.0,2/19,8.93%,EXT1;B3GAT2
prerank,hexosaminidase activity (GO:0015929),0.338203271287051,0.730889085744274,0.7579113924050633,1.0,1.0,2/12,5.33%,CEMIP2;HYAL2
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.28668036700511607,-0.7296381457025689,0.8345864661654135,0.9628402014838925,1.0,5/14,22.45%,AK5;CMPK2;AK1;NME2;NME6
prerank,glutathione transferase activity (GO:0004364),0.3014948707075178,0.7288951663155452,0.7987804878048781,1.0,1.0,2/23,4.89%,GSTA2;LANCL1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.2876013180407069,0.7268314485617955,0.8097345132743363,1.0,1.0,9/28,20.31%,LRRK2;SGK1;PRKCG;RPS6KA1;RPS6KB1;MAPK14;MAPKAPK5;MAP2K1;MAP3K9
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.3379247252462206,0.7255997319049273,0.8096,1.0,1.0,7/12,26.25%,STAT1;TBPL1;GTF2A1;RELA;H3-3A;FOS;RUVBL2
prerank,phospholipase activity (GO:0004620),0.24862911649229985,0.7199862313065594,0.8583959899749374,1.0,1.0,6/67,8.69%,PITPNM3;PLCB4;SMPDL3A;PNPLA6;ABHD6;GDPD1
prerank,NADPH binding (GO:0070402),-0.2941819635775007,-0.7185282829845437,0.8132992327365729,0.9710694482723184,1.0,6/13,28.01%,DUS2;NDOR1;CRYZ;CBR3;GRHPR;DHFR
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.30572986174211236,0.7170135110590738,0.8367952522255193,1.0,1.0,7/22,10.94%,CPSF1;HNRNPA0;ZC3H12A;ELAVL1;ELAVL4;ZFP36L2;EXOSC8
prerank,neuropeptide binding (GO:0042923),0.3071514712304804,0.7151489269222232,0.8078740157480315,1.0,1.0,3/18,20.71%,MC4R;GPR149;SORL1
prerank,transaminase activity (GO:0008483),-0.296829032974984,-0.712888762887238,0.8341708542713567,0.972957613635912,1.0,4/11,20.60%,ABAT;OAT;GOT1;AGXT
prerank,ubiquitin protein ligase activity (GO:0061630),0.22077612526548265,0.7124965960894514,0.9706498951781971,1.0,1.0,34/228,15.05%,TRIM14;ZNRF1;TRIM69;CBL;HERC2;TRIM11;TRIM6;RNF38;RNF125;RNF185;ARIH1;CUL3;UBE2D1;TRIM24;WWP1;UBE4A;UBE3A;RNF128;RNF115;RBX1;ZNRF3;SIAH2;TRIM25;RNF144B;TRIM17;NEDD4L;DTX3L;SMURF1;FBXO2;TRIM2;UBE3B;NHLRC1;UBE2D3;IRF2BP1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.3369128099721207,0.7107045751739447,0.8056872037914692,1.0,1.0,3/12,17.38%,CNOT6L;CNOT1;CNOT2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.2409048278249168,0.7091940074120133,0.8942189421894219,1.0,1.0,16/74,16.50%,PIK3C2A;IPPK;IDNK;PGM2L1;TRPT1;RFK;DGKH;PIK3C3;NMRK1;PIK3CB;PAPSS1;PANK3;AGK;DGKI;GK5;DOLK
prerank,DNA polymerase binding (GO:0070182),0.308815463780447,0.7088449432467793,0.8026905829596412,1.0,1.0,3/18,10.98%,HMGB1;PTGES3;POLG2
prerank,histone deacetylase activity (GO:0004407),0.3011573014162209,0.7087249200448029,0.8170542635658915,1.0,1.0,2/19,5.29%,HDAC9;HDAC11
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.23652256465146831,-0.703252730074385,0.9079365079365079,0.9787971143183183,1.0,8/25,24.63%,PARP8;SIRT3;ART3;SIRT2;PARP3;PARP1;PARP6;PARP2
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.26931713799964996,-0.7028128235143134,0.8635097493036211,0.9744259008005165,1.0,2/15,5.00%,AGPAT4;LPCAT2
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.273506540358856,-0.7020493047163942,0.8512820512820513,0.970427281402908,1.0,2/14,17.79%,DHRS3;AKR1A1
prerank,phospholipid transfer activity (GO:0120014),0.29003854777777177,0.7018257615091381,0.8320839580209896,1.0,1.0,4/21,8.62%,PLTP;GLTP;CERT1;PITPNA
prerank,acetyltransferase activity (GO:0016407),0.27344464600993645,0.7009564893017557,0.8559201141226819,1.0,1.0,2/31,5.21%,SATL1;LCAT
prerank,palmitoyltransferase activity (GO:0016409),0.2791042739789523,0.6974180302140044,0.8668596237337193,1.0,1.0,10/28,30.32%,ZDHHC22;ZDHHC14;ZDHHC5;ZDHHC23;ZDHHC13;GLUL;ZDHHC15;GOLGA7;ZDHHC7;ZDHHC20
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.19929320448949026,-0.6947765348615337,0.9450980392156862,0.9732558747625752,1.0,14/49,22.77%,IKBKE;TAB3;OPTN;PRPF8;ABRAXAS2;OTUD7B;HDAC6;WDR81;SHARPIN;ZRANB1;TNFAIP3;ZRANB3;RNF168;ZFAND2B
prerank,single-stranded DNA binding (GO:0003697),0.22911776468889064,0.6926562662133781,0.9234393404004712,1.0,1.0,17/93,15.87%,RBBP8;SSBP1;RTF1;PURA;POLR2G;STN1;HMGB1;DHX9;POLR2D;NUP35;POLA1;PCBP1;ERCC4;RAD51D;HMGB2;XPC;SPRTN
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.26187861945557606,-0.69254210092052,0.8615384615384616,0.9707711764596769,1.0,4/15,16.67%,SH3PXD2B;PLA2G4A;PLEKHF1;JPH2
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.264750724658017,0.6922207866345024,0.8519040902679831,1.0,1.0,5/35,16.15%,TRDMT1;TRPT1;TRMT5;ELAC2;GATB
prerank,damaged DNA binding (GO:0003684),0.25928236080112493,0.6881530789654839,0.8775235531628532,1.0,1.0,9/44,15.10%,RBBP8;APEX1;FEN1;HMGB1;RAD1;ERCC4;RAD18;HMGB2;XPC
prerank,protein phosphatase activator activity (GO:0072542),-0.2735456126842359,-0.6865207209370773,0.8706467661691543,0.9721693879718803,1.0,3/13,10.38%,CALM2;IGFBP3;B3GAT3
prerank,acylglycerol lipase activity (GO:0047372),0.32459561747019666,0.6838181469391091,0.8330464716006885,1.0,1.0,3/11,22.83%,ABHD6;ABHD2;MGLL
prerank,ATPase activator activity (GO:0001671),0.2846390071947557,0.6817389994635376,0.8599397590361446,1.0,1.0,6/20,20.23%,MYBPC3;DNAJB6;AHSA1;TOR1AIP2;DNAJC10;DNAJA1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.27883046996109395,0.6815950407374043,0.8424962852897474,1.0,1.0,2/21,11.89%,GRIA1;GRM5
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.2627583508117696,0.6814090641381069,0.876750700280112,1.0,1.0,5/33,10.43%,RNF125;RNF185;ARIH1;SIAH2;RNF144B
prerank,RNA stem-loop binding (GO:0035613),-0.2786253297992487,-0.6811762833553442,0.8405063291139241,0.9728265097563772,1.0,5/12,19.32%,DDX3X;EPRS1;CPEB3;RC3H1;LARP6
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.32102720916668903,0.6781626054704596,0.8496621621621622,1.0,1.0,2/11,9.68%,UBE4A;RBX1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.2095722626569165,0.6772439178230822,0.9822546972860126,1.0,1.0,33/232,15.05%,TRIM14;ZNRF1;TRIM69;CBL;HERC2;TRIM11;TRIM6;RNF38;RNF125;RNF185;ARIH1;CUL3;UBE2D1;TRIM24;WWP1;UBE3A;RNF128;RNF115;RBX1;ZNRF3;SIAH2;TRIM25;RNF144B;TRIM17;NEDD4L;DTX3L;SMURF1;FBXO2;TRIM2;UBE3B;NHLRC1;UBE2D3;IRF2BP1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.27935745520241106,-0.6769894050993795,0.8661800486618005,0.97202901563539,1.0,6/12,23.25%,TENT5A;TENT4B;TUT1;TENT5D;PAPOLB;PAPOLA
prerank,cysteine-type peptidase activity (GO:0008234),0.23599043884646342,0.676584621827165,0.9345911949685535,1.0,1.0,17/73,21.84%,CASP8;USP38;CASP2;TINAGL1;CASP1;USP12;USP29;USP9Y;CASP7;USP35;CTSK;CTSO;MALT1;CTSH;USP47;USP14;USP30
prerank,phosphatidate phosphatase activity (GO:0008195),0.3071403625103429,0.6728852618292744,0.8501628664495114,1.0,1.0,3/13,15.81%,PLPP1;PLPP4;PLPPR1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.28242080045702056,0.6722570100997214,0.8525345622119815,1.0,1.0,4/21,10.98%,CHRAC1;POLK;POLA1;POLB
prerank,acyl-CoA hydrolase activity (GO:0047617),0.2951159953645314,0.6696640649618972,0.8491704374057315,1.0,1.0,2/17,10.04%,PPT1;ACOT13
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.3276472165347597,0.6691842186684098,0.8164665523156089,1.0,1.0,3/10,16.68%,ANKRD13A;LAPTM5;DAXX
prerank,microtubule motor activity (GO:0003777),-0.1858772544100865,-0.6672664189652737,0.9787234042553191,0.9757736179447465,1.0,28/51,36.89%,KIF3C;KIF21A;KIF13B;SMC3;KIF13A;DYNLRB1;KIF3A;KIF9;KIF7;KIF5C;KIF11;KIF5B;KIF21B;KIF1C;CENPE;KIF27;KIF6;KIF18B;KIFC1;KIF22;KIF4A;KIF14;KIFC3;KIF1B;KIF19;DNAH17;KIF20A;DYNC1I1
prerank,chemokine binding (GO:0019956),0.2587874200088889,0.66677099622809,0.9092198581560283,1.0,1.0,4/30,14.74%,CCR1;HMGB1;CX3CR1;CXCR4
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.31860406728596535,0.6665868502776969,0.8481848184818482,1.0,1.0,11/11,68.16%,HCN1;KCNA10;CNGA1;CNGB1;CNGA3;CNGA4;CNGA2;AQP1;CNGB3;HCN4;HCN2
prerank,voltage-gated sodium channel activity (GO:0005248),-0.22831093186639073,-0.6665107006962983,0.8923076923076924,0.9718464731535195,1.0,3/22,6.67%,SCN7A;SCN2A;CACNA1G
prerank,sequence-specific mRNA binding (GO:1990825),0.3295835124097417,0.6661400211496544,0.830820770519263,1.0,1.0,2/10,9.64%,ETF1;DHX9
prerank,tRNA binding (GO:0000049),-0.19598477399603,-0.6638939404099771,0.9610894941634242,0.9694486601246675,1.0,11/43,17.16%,NEMF;SSB;TERT;AIMP1;TRMT9B;EIF2AK4;IGHMBP2;RPUSD4;DALRD3;ELP5;PTCD1
prerank,chemokine receptor binding (GO:0042379),-0.2001217815050458,-0.6623465643064743,0.954225352112676,0.966071663194002,1.0,18/35,43.90%,CXCL16;CCL25;CXCL12;CKLF;CCL19;CCL2;CCL14;CCL28;CCRL2;CX3CL1;CCL5;CXCL5;CCL11;CXCL1;PF4;CCL7;PPBP;CCL8
prerank,CCR chemokine receptor binding (GO:0048020),-0.2140442975924125,-0.6611782190436528,0.9478827361563518,0.9625543273713382,1.0,20/28,51.87%,CNIH4;CCL25;CCL19;CCR2;CCL2;CCL14;CCRL2;CX3CL1;CCL5;CCL11;CCL7;CCL8;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13;CCL13
prerank,N-methyltransferase activity (GO:0008170),0.2799370724496407,0.6609358483309737,0.8837555886736215,1.0,1.0,7/20,20.58%,METTL5;SETD3;TFB2M;METTL18;TRMT1L;GNMT;TRMT1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.3077808260880567,0.6605084628731661,0.8578595317725752,1.0,1.0,1/11,5.80%,ARG1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.27215608372661637,0.6600762448238819,0.8757575757575757,1.0,1.0,1/24,2.50%,ZDHHC22
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.2257802219379294,0.6565535508703343,0.9457831325301205,1.0,1.0,19/75,25.35%,ABCC4;GFUS;LDHC;GLYR1;LDHD;ME3;LDHAL6B;ADH5;HADHB;CBR1;HADHA;HADH;KCNAB1;KCNAB2;HSD17B4;AKR1B10;RDH11;RDH12;HMGCR
prerank,transcription coregulator binding (GO:0001221),0.23342873167468403,0.6504091737472621,0.9298701298701298,1.0,1.0,10/50,18.51%,LMO2;ZBTB16;NR1D1;CHD6;CTBP2;CTNNB1;ESR1;CNOT2;SMAD4;RELA
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.23050646444994394,0.6456562801115233,0.9357682619647355,1.0,1.0,16/57,23.04%,NDUFS4;NDUFA12;NDUFB5;COX5A;NDUFB7;CYB561A3;UQCRFS1;CYBRD1;UQCRC1;COX15;COX6A1;NDUFB4;CYB5A;NDUFA9;NDUFV1;NDUFC1
prerank,voltage-gated anion channel activity (GO:0008308),0.2912831150392262,0.6454883998612571,0.8707592891760905,1.0,1.0,5/15,19.52%,ANO6;CLCN3;CLCN1;VDAC1;VDAC3
prerank,methyl-CpG binding (GO:0008327),-0.22107356425379726,-0.6441420952815086,0.9316770186335404,0.9716675652589275,1.0,8/22,27.95%,MECP2;CXXC5;TET1;MBD3;ZBTB33;WDR77;ZCWPW1;ZBTB38
prerank,kinase inhibitor activity (GO:0019210),-0.20392994389621746,-0.6438776808416781,0.9796610169491525,0.9673637419634112,1.0,8/33,16.25%,PARVA;DNAJC3;DUS2;GMFB;SH3BP5;QARS1;CDKN1A;PRKRIP1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.3117869614804405,0.63872885600282,0.8693467336683417,1.0,1.0,1/11,5.95%,APEX1
prerank,O-methyltransferase activity (GO:0008171),-0.2708211940100262,-0.6354081510576475,0.9038961038961039,0.9687665009229269,1.0,5/10,28.34%,CMTR1;ASMT;BCDIN3D;COMT;CMTR2
prerank,cytochrome-c oxidase activity (GO:0004129),0.28296097438662265,0.6351554957072705,0.8740031897926634,1.0,1.0,4/15,20.57%,COX5A;COX15;COX6A1;CYB5A
prerank,MAP kinase kinase activity (GO:0004708),0.2830133368441354,0.6347541840865025,0.8774834437086093,1.0,1.0,7/15,26.59%,LRRK2;MAPK14;MAPKAPK5;MAP2K1;MAP3K9;MAPKAPK3;MAP2K4
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.26574545958849927,-0.6291425352813312,0.8875598086124402,0.9683580457442345,1.0,5/10,32.31%,KAT2B;CDKN1A;CDKN2C;INCA1;CDKN2B
prerank,solute:sodium symporter activity (GO:0015370),0.2554956973898125,0.6281810259272915,0.9171511627906976,1.0,1.0,2/27,9.08%,SLC5A10;SLC4A9
prerank,single-stranded DNA helicase activity (GO:0017116),0.2658167352464582,0.627277592757744,0.8987538940809969,1.0,1.0,3/19,15.37%,WRNIP1;DHX9;RFC2
prerank,DNA polymerase activity (GO:0034061),0.26192312384370436,0.6238300281968416,0.9041731066460588,1.0,1.0,4/22,10.98%,CHRAC1;POLK;POLA1;POLB
prerank,exopeptidase activity (GO:0008238),0.22454034194761816,0.6202097740240108,0.9506666666666667,1.0,1.0,14/50,23.06%,ACE;DPP6;DPP10;METAP2;CPM;LAP3;XPNPEP3;DPP8;CTSH;LNPEP;ERAP1;FOLH1;MME;NUDT16
prerank,Hsp70 protein binding (GO:0030544),0.24377979230553465,0.6169775028035062,0.9351198871650211,1.0,1.0,7/31,20.23%,NOD2;DNAJC2;MVD;PPID;DNAJC10;ERN1;DNAJA1
prerank,ferrous iron binding (GO:0008198),-0.21789928415807824,-0.6167642343117785,0.9577039274924471,0.9714807949586266,1.0,4/21,14.38%,EGLN3;FTO;TET2;FXN
prerank,ribosome binding (GO:0043022),0.2294744622207518,0.6142315772101608,0.9369127516778524,1.0,1.0,11/46,18.41%,ZC3H12A;ETF1;BAG6;EEF2;EIF6;EIF2S1;EIF2A;RACK1;EFL1;CCDC47;SRP19
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.2786543168775111,0.6138462482024973,0.8990384615384616,1.0,1.0,2/13,8.80%,ENDOV;FEN1
prerank,telomerase RNA binding (GO:0070034),0.2527087986881492,0.6078894027284681,0.9300595238095238,1.0,1.0,10/22,28.95%,DKC1;NHP2;XRN1;SMG7;EXOSC10;DHX36;WRAP53;HNRNPC;SMG5;NOP10
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.26310871017064313,-0.6071526039082725,0.9334975369458128,0.9727262747669339,1.0,3/10,14.34%,ECHDC3;EHHADH;ECHDC2
prerank,cardiolipin binding (GO:1901612),0.2960513557471678,0.6067860233923729,0.903169014084507,1.0,1.0,1/10,5.77%,UQCC3
prerank,neuropeptide receptor activity (GO:0008188),0.2345675657924574,0.6061150775488184,0.92524682651622,1.0,1.0,3/29,10.73%,GPR143;GAL;NPY5R
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.24938834471422258,0.597192240697795,0.9209302325581395,1.0,1.0,2/21,10.51%,P2RX7;GRIK2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.20678913360598258,0.5948548195268223,0.976857490864799,1.0,1.0,14/69,19.09%,CERS4;GLYAT;LPCAT4;NMT1;CERS6;CERS5;LPCAT3;MOGAT1;LIPT1;ZDHHC14;ZDHHC5;PLAAT3;SOAT1;ELP3
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.2518368453739812,-0.5920873946784647,0.9316455696202531,0.9760815933449183,1.0,2/11,6.61%,HNRNPA2B1;RAD50
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.27416399574756056,0.5825240092576524,0.926948051948052,1.0,1.0,4/11,24.71%,RDH14;AKR1B10;RDH11;RDH12
prerank,muscle alpha-actinin binding (GO:0051371),0.2602614357358316,0.5814255454857973,0.9347471451876019,1.0,1.0,4/15,22.17%,PDLIM5;MYPN;PDLIM1;PRICKLE4
prerank,serine-type endopeptidase activity (GO:0004252),0.19739983394026572,0.580600259874736,0.9876847290640394,1.0,1.0,6/80,11.60%,PRSS53;PCSK5;RHBDD1;FURIN;PROC;PIK3IP1
prerank,3'-5' DNA helicase activity (GO:0043138),0.25636708256420176,0.5796066611324129,0.9376996805111821,1.0,1.0,6/16,26.36%,DHX9;ASCC3;BLM;WRN;HELQ;NAV2
prerank,CXCR chemokine receptor binding (GO:0045236),-0.24202766518762736,-0.5783193352168797,0.9585492227979274,0.9777496335235984,1.0,6/11,43.34%,YARS1;CXCL12;CXCL5;CXCL1;PF4;PPBP
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.26034373557785523,0.5737601499845874,0.9238249594813615,1.0,1.0,6/14,23.75%,ETFDH;ISCA2;NUBPL;RSAD2;RSAD1;IREB2
prerank,purinergic nucleotide receptor activity (GO:0001614),0.25420468917776695,0.5733473768298262,0.9251170046801872,1.0,1.0,4/15,23.48%,P2RX7;P2RY1;GPR34;P2RY12
prerank,inward rectifier potassium channel activity (GO:0005242),0.2300653090203676,0.5731165088031437,0.9657228017883756,1.0,1.0,1/24,2.72%,KCNN3
prerank,snoRNA binding (GO:0030515),0.22555215449884988,0.5718230991272485,0.9710564399421129,1.0,1.0,8/30,24.98%,DHX37;DKC1;NHP2;DDX21;RRP9;IMP4;NUDT16;NUDT16L1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.27278561315632815,0.5666596064863203,0.9253246753246753,1.0,1.0,3/10,23.72%,CYBA;NCF2;NOX1
prerank,nucleotidase activity (GO:0008252),0.25712500498402224,0.5642692765439782,0.9437299035369775,1.0,1.0,5/15,21.79%,BPNT1;NT5C3B;NT5C2;NT5C;NT5C3A
prerank,endoribonuclease activity (GO:0004521),0.22140465893054045,0.5611730429930566,0.972183588317107,1.0,1.0,8/32,20.19%,INTS11;ENDOV;ZC3H12A;EXOG;NOB1;KHNYN;ERN1;CPSF3
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.2665076575445644,0.5560793280465387,0.9443535188216039,1.0,1.0,11/11,73.37%,PRMT7;PRMT5;FBXO11;PRMT2;PRMT6;CARM1;NDUFAF7;PRMT3;PRMT1;PRMT9;PRMT8
prerank,pseudouridine synthase activity (GO:0009982),0.2610018087429808,0.5549785415433959,0.9367720465890182,1.0,1.0,3/13,17.96%,DKC1;TRUB1;RPUSD2
prerank,ribosomal small subunit binding (GO:0043024),0.2467039731680192,0.549552132207454,0.9504,1.0,1.0,3/17,15.60%,EIF1;NPM1;MTIF2
prerank,methyltransferase activity (GO:0008168),0.1996475476389054,0.5466915974433532,0.9814814814814815,0.9998932513608917,1.0,10/46,20.84%,COMTD1;MRM2;COQ3;GAMT;ARMT1;COQ5;FTSJ3;METTL4;NSUN4;LCMT1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.25017296572790376,0.542237347627687,0.9413629160063391,0.9995379990900817,1.0,3/14,17.57%,RPP38;ELAC2;POP1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.20464499576515555,0.5325264330661721,0.9763560500695411,1.0,1.0,6/34,19.75%,IQGAP1;IRGM;CALM3;RICTOR;MAP2K1;CAB39
prerank,peptide hormone receptor binding (GO:0051428),0.24811699723826253,0.5270265222310122,0.9376026272577996,1.0,1.0,11/11,75.21%,PSMC5;PTHLH;GPHA2;UCN3;GHRH;GPHB5;UCN2;VIP;CCK;ADCYAP1;GNRH1
prerank,endonuclease activity (GO:0004519),0.1937959190171145,0.524517617461091,0.9947575360419397,0.9994565528573879,1.0,11/49,20.19%,APEX1;INTS11;ZC3H12A;FEN1;ERCC4;EXOG;NOB1;KHNYN;ERN1;ANG;CPSF3
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.213626719997854,-0.5016964606777186,0.9696969696969697,0.9967897041282112,1.0,3/10,20.80%,CYLD;STAMBPL1;TNFAIP3
prerank,acetylcholine receptor activity (GO:0015464),0.20286542557419834,0.4838104495953755,0.9848024316109423,1.0,1.0,2/22,16.09%,CHRM3;HRH3
prerank,ribonuclease P RNA binding (GO:0033204),0.2341510377130377,0.4793576748735295,0.9862542955326461,1.0,1.0,2/10,17.57%,RPP38;POP1
prerank,NAD+ binding (GO:0070403),0.2294030367130832,0.47924538957351187,0.9758064516129032,1.0,1.0,3/12,19.20%,GLUD1;HADH;ZC3HAV1
prerank,CoA hydrolase activity (GO:0016289),-0.17422435049846496,-0.4725674796686817,0.9914772727272727,0.9974542020378896,1.0,2/16,16.28%,ACOT11;ACOT6
prerank,serine-type peptidase activity (GO:0008236),0.15518363237039196,0.46547578091323183,1.0,1.0,1.0,5/96,8.44%,PRSS53;PCSK5;RHBDD1;FURIN;PROC
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.19339961805339573,-0.46223147380693225,0.9952830188679245,0.9943757503281591,1.0,1/11,4.28%,NUDT4
prerank,ribonuclease P activity (GO:0004526),0.21613337779094158,0.44942078933630975,0.9833333333333333,1.0,1.0,2/11,17.57%,RPP38;POP1
prerank,5'-nucleotidase activity (GO:0008253),0.20116171927717585,0.4293796980242785,0.9917491749174917,1.0,1.0,4/13,21.79%,NT5C3B;NT5C2;NT5C;NT5C3A
prerank,phosphatase activator activity (GO:0019211),0.18938892063043497,0.4191054089478872,0.9966887417218543,1.0,1.0,5/14,25.95%,PPP2R5C;CALM3;PPP2R5E;PPP1R15A;CALM1
prerank,U6 snRNA binding (GO:0017070),0.18217463794206523,0.39833962900121206,0.9967689822294022,1.0,1.0,3/14,18.99%,PRPF4;DDX39B;LSM2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.17341779968033444,0.3896815667155884,0.9984101748807631,1.0,1.0,2/16,14.86%,CD38;SARM1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.1750875952242575,0.38754591975038943,0.9984447900466563,1.0,1.0,2/14,14.82%,CYBA;NCF2
prerank,neuropeptide hormone activity (GO:0005184),0.1557146076010134,0.37593805836718647,1.0,0.9987503328601652,1.0,21/22,73.33%,GAL;PENK;HCRT;GRP;CORT;OXT;AGRP;QRFP;GHRH;NPPA;UCN;CALCB;CRH;VIP;NMB;PNOC;NPFF;NPY;SPX;CCK;ADCYAP1
